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     Rh-catalyzed asymmetric hydrogenation has emerged as a powerful tool for the 
manufacturing of chiral pharmaceuticals.  While the mechanism is well understood, 
catalyst design a priori is not yet possible.  Supramolecular catalysis, the use of non-
covalent forces to affect a catalytic process, can afford the catalyst diversity required to 
uncover efficient catalysts and further our understanding.  Using a modular design and 
self-assembly, a large scale supramolecular catalyst screening in a catalyst scaffold 
optimization study of rhodium-catalyzed asymmetric hydrogenation was carried out. 
Analyzing the data yields some new insights into the roles of each module making up the 
supramolecular catalyst. Perhaps most surprisingly, the presence of a chiral recognition 
element positioned remote to the site of catalysis can significantly impact the catalytic 
activity and enantioselectivity.   
 
     1,1-Disubstituted alkenes are a challenging class of substrates for the asymmetric 
hydroboration reaction.  Differentiation of the prochiral faces has been met with few 
successes from either stoichiometric or catalytic approaches.  Takacs et al. revealed 
amide and ester groups direct the -selective Rh-catalyzed hydroboration of 1,1-
disubstituted-,-unsaturated alkenes.  In the work described herein, analogous oxime-
directing groups were used in an attempt to diversify the substrate scope.  Unlike the 
amide- or ester-directed examples, we find oxime-directed hydroboration proceeds 
through an unusual C-H activation/metallation that proves crucial to turnover of 
borylated products.  Whereas it was previously presumed that certain reduced byproducts 
were derived from adventitious H2 reduction, deuterium-labeling experiments suggest 
competing pathways from a common intermediate leading to both borylated and reduced 
products. 
 
     In 1993, the World Health Organization (WHO) declared tuberculosis (TB) a global 
public emergency.  Current drug treatments have reduced the mortality rate 40% since 
1990, but increasing numbers of drug-resistant tuberculosis strains have been reported.  
D-Cyloserine (DCS) is a second line drug for the treatment of TB.  In a collaborative 
effort with Professors Robert Powers (UNL-Chemistry) and Raul Barletta (UNL 
Veterinary and Biomedical Sciences), experiments with an isotopically-labeled DCS 
were proposed to elucidate the mechanism.  Previously reported routes were not 
amenable to the milligram quantities available for isotopically labeled serine starting 
material.  The synthetic route that will be described was used to produce both labeled and 
unlabeled DCS. 
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PREFACE 
 
     The introductory chapter of this dissertation serves as a review of supramolecular 
catalysts in which a metal structurally assembles the catalyst.  In contrast to previously 
published reviews, a direct analysis from the contribution of the supramolecular 
interactions on the catalytic reaction will be highlighted.  This chapter represents a subset 
of our investigation on supramolecular catalysts for a review in preparation.  The 
subsequent chapters cover research related to asymmetric synthesis, specifically, 
asymmetric catalysis and isotopically labeled-compound synthesis for a collaborative 
project.  The second chapter is a summary of our findings from the catalyst scaffold 
optimization of a supramolecular asymmetric hydrogenation catalyst; its focus is on 
catalyst structure-activity relationships.  The third chapter is an ongoing mechanistic 
investigation into an unusual C-H activation found during the oxime-directed rhodium-
catalyzed hydroboration.  The fourth chapter describes an asymmetric synthesis of an 
isotopically-labeled tuberculosis drug D-cycloserine to support a collaborative project 
with Professors Robert Powers (UNL-Chemistry) and Raul Barletta (UNL Veterinary and 
Biomedical Sciences.    
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CHAPTER ONE: SUPRAMOLECULAR CATALYSIS 
1.1 Introduction 
          The macromolecular frameworks which direct the three-dimensional assembly of 
enzymes commonly incorporate structural motifs such as hydrogen-bonding and metal 
complexation.  The active site of these enzymes must be somewhat rigid to selectively 
accommodate a complex substrate yet flexible enough to distort it as needed to 
accommodate the transition-state structure.
1
  The study of the interactions which govern 
the assembly of these macromolecules has been broadly named supramolecular 
chemistry.  Synthetic methodologies for supramolecular chemistry generally focus on the 
construction of macromolecules via non-covalent interactions including metal-ligand 
coordination, hydrogen-bonding, and dipole-dipole or ionic interactions, although van der 
Waals attractions and the avoidance of hydrophobic interactions likely also play 
important but less well-defined roles. When these reversible intermolecular forces are 
used to optimize a catalyst in effecting its reaction, this field is known as supramolecular 
catalysis.   
     A supramolecular approach to catalyst design has some potential advantages over 
traditional methods.  While monodentate ligands have been used very effectively in 
applications requiring the use of two or more equivalents of ligand, fine-tuning the 
catalyst from steric and electronic substituents effects alone by combinatorial strategies is 
often a challenge.  Bidentate ligands offer more control to precisely define the chiral 
space, but building large ligand libraries for screening by one ligand at a time synthesis 
can be very tedious.  Supramolecular approaches hope to offer the opportunity to control 
2 
 
the chiral space and provide the opportunity to construct large ligand libraries through 
self-assembly. The three common approaches to self-assembled supramolecular catalysts 
via non-covalent interactions: metal-ligand coordination, hydrogen-bonding, and dipole-
dipole or ionic interaction, are illustrated in (Figure 1A).  Metal-directed self-assembly 
forms the basis for the work described in Chapter 2 of this thesis, and therefore this 
introductory chapter will focus on similar approaches. 
     Typical architectural assemblies of a metal-directed self-assembled supramolecular 
catalyst are shown below (Figure 1B).  Bifunctional ligands with two binding sites can be 
used in an orthogonal binding approach.  A metal ion, participating in a structural role, 
binds preferentially to the primary binding site assembling the bidentate ligand.  The 
secondary binding site would then be available for chelation to a catalytically active 
metal ion.  Alternatively, addition of chelating bridging ligands to coordinating metal 
ions form discrete or networked metal-organic frameworks (MOFs).   These catalysts 
could participate in host-guest chemistry wherein a substrate’s conformation inside the 
cavity can lead to a chemo-, regio-, or stereoselective chemical transformation.  A 
catalytic active site(s) introduced to the inside of the cavity might successfully exploit the 
cavity to effect a size- or shape- selective reaction.  Lastly, self-assembling polymers may 
be formed with two orthogonally-binding ligands in an appropriately designed 
monomeric unit.  Addition of a structural metal and catalytically active metal self-
assembles the heterogeneous polymeric catalyst. 
 
3 
 
 
Figure 1 Design of a supramolecular catalyst.  A) Traditional approaches versus 
supramolecular approaches. B) Architectures common in metal-organized supramolecular 
catalyst systems.  
 
     This chapter will review progress in the design of asymmetric supramolecular 
catalysis via metal-directed self-assembly. Its organization features a different type of 
analysis from traditional reviews of the young, but rapidly developing, field.
2-14
  The 
focus of this brief review is to summarize the influence of the supramolecular catalyst 
scaffold/framework with, where possible, the direct comparison to the corresponding 
combination of monomeric ligands.  Included in this discussion is a brief review over the 
development of some metal-organic frameworks that have been used for asymmetric 
catalysis.  MOFs are often excluded from reviews on asymmetric supramolecular 
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catalysis; we argue that their synthesis via self-assembly and potential secondary 
interactions with substrates warrants their inclusion.  While organocatalysts are outside 
the scope of this review and not incorporated in this discussion, remarkable 
enhancements from supramolecular interactions have been observed in asymmetric 
organocatalytic MOF catalysis.
15-23
       
 
1.2 Homogeneous Organometallic catalysis – Neutral and anionic ligand-metal 
coordination to form supramolecular chelating ligands 
     Van Leeuwen and Reek, two of the major players in this field, jointly published one of 
the earliest examples using a Lewis acid-Lewis base interaction to assemble a chiral 
bidentate ligand (Figure 2).
24
  Zinc-porphyrins were used as templates to coordinate with 
a series of pyridyl-substituted BINOL-phosphite ligands.  Following the titration of the 
pyridyl-substituted ligands with bis-porphyrin template B by UV-Vis confirmed the 
expected ratio of 2 ligands to 1 template B.  The coordination behavior of the rhodium-
chelated ligands was further studied with high-pressure NMR spectroscopy under syn gas 
(20 bars 1:1 H2/CO, toluene-d8).  Upon addition of template B, the rhodium-hydride 
shifted from  = -9.5 to -11.1 ppm; this is believed to be a shielding effect of the 
porphyrin to rhodium.  Monodentate ligand L1 and the L1-(mono-porphyrin)template A, 
gave similar very low enantioselectivity (6-7% ee) in the rhodium-catalyzed asymmetric 
hydroformylation reaction.  Use of the bis-zinc porphyrin (template B) with two 
equivalents of pyridyl phosphite gave a modest increase in enantioselectivity up to 33% 
ee.  Since the combination of template A + L1 and L1 gave similar results, the increase in 
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enantioselectivity when using the combination of template B + L1 is construed to arise 
from supramolecular organization.   
 
Figure 2 Metal-porphyrin templates organize pyridyl phosphorus ligating groups.  
Adapted from Ref 24 with permission from The Royal Society of Chemistry 
 
     Van Leeuwen and Reek designed a new template by covalently linking one phosphite 
ligating group to the zinc-porphyrin.  Addition of a series of phosphine substituted 
pyridines generates a series of supramolecular catalyst scaffolds in situ.  These catalysts, 
named SUPRAPhos, have been successfully used for asymmetric hydroformylation,
25,26
 
asymmetric hydrogenation,
27
 and palladium catalyzed alkylation.
28,29
  Van Leeuwen and 
Reek demonstrated the asymmetric hydrogenation of a tri-substituted cyclic enamide in 
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one of the more remarkable examples of the influence of the supramolecular scaffold 
(Figure 3).
27
  This particular alkene substrate had proven notoriously difficult to reduce 
with high enantioselectivity via rhodium catalyzed asymmetric hydrogenation (Rh-
CAH).
30
  The monodentate control ligand, (BINOL)PO-Ph, was reactive but gave no 
asymmetric induction.  The chiral (BINOL)P-functionalized porphyrin C in combination 
with PPh3 also failed to afford high enantioselectivity.  However, the chiral (BINOL)P-
functionalized zinc porphyrin C in combination with ortho, meta- and para-
diphenylphosphine-substituted pyridines gave interesting results.  While the ortho- and 
para-substituted pyridylphosphines (L2 and L4, respectively) furnished low conversion 
and low enantioselectivity (44-62% yields, 27-47% ee), the meta-
pyridyldiphenylphosphine ligand (L3) afforded quantitative yield and high 
enantioselectivity (94% ee).  The 
31
P NMR of a 1:1 mixture of BINOL-zinc porphyrin C 
and L3 with Rh(cod)2BF4 confirmed formation of the desired 1:1 bidentate ligand to 
rhodium chelate.  Coupling constants were JP-P = 41 Hz, JRh-P = 263 Hz for the BINOL 
phosphite and JP-P = 41 Hz, JRh-P = 146 Hz for the phosphine.   
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Figure 3 SUPRAPhos library finds an effective asymmetric hydrogenation catalyst.  
Adapted from Ref 27 with permission from John Wiley and Sons. 
 
     In trying to assess the role of the supramolecular scaffold in his supramolecular 
catalysts, Reek reported a supramolecular hydroformylation catalyst in which the Lewis 
acid-Lewis base interaction changed the preferred coordination geometry at rhodium 
(Figure 4).
31
  UV-Vis spectra confirmed the expected binding of the two porphyrin 
moieties to the 4-pyridyl substituted phosphoramidite.  Using high pressure NMR, the 
authors determined the rhodium hydride was cis to the bulky monodentate ligand.  After 
coordination of the two zinc porphyrins, the H-coupling is consistent with a trans-
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coordination of hydride with respect to the phosphorus ligand.  This example illustrates 
how supramolecular organization may influence the preferred confirmation of rhodium 
species.  Asymmetric hydroformylation of 2-octene with monodentate phosphoramidite 
ligand L6 gave low conversion and low selectivity.  Use of phosphoramidite ligand L6 
coordinated to two equivalents of zinc porphyrin A, afforded the 2- and 3-branched 
isomers in 29% and 27% yields.  The selectivity was increased modestly as well.   
.   
 
Figure 4 Zinc template influences geometry of hydride and its implications in 
asymmetric hydroformylation of styrene. Adapted from Ref 31with permission from John 
Wiley and Sons. 
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     Takacs and coworkers were next publishing in this field and with a new approach of 
using a structural metal to bring two ligating groups together.
33-35
  Bisoxazolines of 
complementary chirality combine with Zn(II) to form the thermodynamically favored 
heteroleptic complex nearly exclusively as judged by NMR (Figure 5A). 
32
    When 
bisoxazolines with substituted tethers and ligating groups are used, the resulting 
heteroleptic complex constitutes a chiral bidentate catalyst that has been generated by in 
situ metal-directed self-assembly.  These catalysts have been used effectively in 
palladium-catalyzed asymmetric allylic amination,
33
 rhodium-catalyzed asymmetric 
hydroboration,
34,35
 and rhodium-catalyzed asymmetric hydrogenation.
36,37
  Selected 
examples are shown in Figure 5.   
     For the Pd-catalyzed asymmetric allylic amination (Figure 5B), carrying out the 
corresponding reaction using the reference monodentate phosphite, (TADDOL)POPh 
afforded the substituted product with moderate enantioselectivity, 48% ee.  Screening the 
reaction with a series of identically (TADDOL)P-functionalized scaffolds of 
incrementally varied structure afforded a range of selectivity from racemic to 82% ee.
33
  
The variation in selectivity noted for a large group of ligands with the same ligating 
groups gave rise to the idea of ligand (or catalyst) scaffold optimization.  In analyzing the 
data, we find that scaffolds bearing two ArCH2O- tethers generally afforded higher 
selectivity than tethers in which the (TADDOL)P-ligating groups were appended via 
ArO-linkages.  In contrast, asymmetric hydroborations of styrene derivatives found ArO-
linked tethers generally gave the higher enantioselectivity.
34,35
  Again, as perhaps inferred 
by the term “ligand/catalyst scaffold optimization”, we found that a different catalyst 
scaffold was required for optimum results with each ortho-substituted styrene suggesting 
10 
 
each substrate requires a slightly different catalyst pocket (or perhaps in analogy to 
biocatalysts, active site) for optimum results.  Consider the following selected examples 
for the hydroborations of ortho-methoxystyrene and ortho-fluorostyrene: catalyst L8 
gives 99% ee for ortho-methoxystyrene but only 76% ee for ortho-fluorostyrene; catalyst 
L9 gives 66% ee for ortho-methoxystyrene and 91% ee for ortho-fluorostyrene.  The 
results indicate that very subtle changes to the substrate can significantly alter 
requirements for an effective catalyst structure.   
     The results obtained in the asymmetric hydrogenation studies (the subject of the 
studies reported in Chapter 2 of this thesis) revealed that like the Pd-catalyzed allylic 
aminations, use of ArCH2O-linked tethers increases the efficiency and selectivity of a 
catalyst.
36,37
  However, this study also uncovered that use of these tethers comes with a 
cost; the catalyst becomes too flexible and fail to respond to incremental catalyst scaffold 
optimizations (i.e., are difficult to optimize) when two ArCH2O-linked phosphites are 
combined in the same scaffold.  In those studies we find that catalyst scaffolds bearing 
one ArO- and one ArCH2O-linked chiral phosphite provided a better balance between 
rigidity and flexibility (vide infra).       
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Figure 5 Selected examples of catalysis using Takacs supramolecular catalysts.  A) Self-
assembly of heteroleptic bisoxazoline-zinc complex affords heteroleptic complex.; B) Pd-
catalyzed allylic alkylation affords product in increased selectivity.; C) Substrate tailored 
Rh-catalyzed asymmetric hydroboration of ortho-substituted styrenes.; D) Rh-catalzyed 
asymmetric hydrogenation of two substrates with a mixed ArO- and ArCH2O- linked 
scaffold gives highest selectivity. 
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     While the Takacs group has thus far been unable to obtain a crystal structure of their 
supramolecular catalyst, several studies to obtain some structural information of these 
supramolecular catalysts were conducted.
35
    Circular dichroism (CD), an experiment 
which detects the differential absorption of left and right circularly polarized light was 
used to determine if any noticeable structural changes occurred with the addition of 
rhodium.  The CD spectrum for a zinc-chelated self-assembled ligand shows a large 
bisignate curve with a zero-crossing around 316 nm (Figure 6A).  Upon addition of 
rhodium, this bisignate curve is lost, suggesting a significant conformational change upon 
binding.  High resolution fast atom bombardment (FAB) mass spectrometry found a peak 
consistent with the expected hetero-bimetallic complex.  
31
P NMR data confirmed the 
data with expected JRh-P couplings of 249 and 254 Hz and JP-P coupling of 38.8 Hz.  DFT 
calculations using mixed basis sets (B3LYP/6-31G for non-metal atoms and 
B3LYP/LanL2DZ for metal atoms) were carried out to study the preliminary topography 
around rhodium.  The models suggest that a chiral pocket may be formed around the 
catalytic center (Figure 6B). 
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Figure 6 Structural characterization of Takacs’ supramolecular catalyst.  A) CD spectra 
indicates a structural change occurs from addition of rhodium to zinc-chelated self-
assembled ligand.  B) DFT model (B3LYP/6-31G for non-metal atoms and 
B3LYP/LanL2DZ for metal atoms) of supramolecular catalyst suggests a chiral pocket 
may form around catalytic site.  Reproduced from Ref. 35 with permission from the 
Royal Society of Chemistry. 
 
     Van Leeuwen developed a new strategy using supramolecular interactions to relay 
chirality through an organizational metal to two achiral ditopic ligands. (Figure 7).
38
  
Combinations of phosphine-substituted Schiff bases and chiral diols self-assemble around 
titanium forming chiral bidentate ligands.  The chiral TADDOL diol combined with 
achiral phosphine L11 alone gave poor selectivity in the rhodium-catalyzed asymmetric 
hydrogenation reaction.  In contrast, the titanium-assembled L12 and L13 afforded 81-
87% ee.  
1
H NMR characterization of the heterobimetallic complex [Rh(L12)(nbd)]BF4 
complex found distinct chemical shifts in equal intensities for the two imine and methoxy 
hydrogens; this suggests  [Rh(L12)(nbd)]BF4 exists as a single diastereomer (Figure 8). 
31
P NMR data confirmed this conclusion with expected JRh-P couplings of 159 and 151 Hz 
and JP-P coupling of 30.8 Hz.  Furthermore, matrix-assisted laser desorption/ionization 
14 
 
(MALDI) mass spectrometry identified a peak corresponding to the expected mass of the 
[Rh(L12)(nbd)]BF4. 
 
   
Figure 7 Rh-catalyzed asymmetric hydrogenation with a catalyst relying on transfer of 
chirality from a remote diol.  Adapted with permission from J. Am. Chem. Soc.  2011, 
133, 18562-18565.  Copyright 2014 American Chemical Society 
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Figure 8 Supramolecular catalyst L13 selectively forms one diastereomer upon chelation 
to rhodium as evidenced by H NMR and 
31
P NMR.  Reprinted with permission from J. 
Am. Chem. Soc.  2011, 133, 18562-18565.  Copyright 2014 American Chemical Society 
 
1.3 Homogeneous Organometallic catalysis – Supramolecular capsules and boxes 
with enclosed catalytically active site 
          Hupp and Nguyen designed a supramolecular “box” with an encapusultated or 
enclosed site for catalysis inside the box (Figure 9).
39
  Zinc porphyrin templates (T or T’) 
bearing tin porphyrin bridging ligands (A or C) were used to form the outer walls that 
enclose a catalytically-active manganese porphyrin (M).   Tin porphyrins were ligated by 
chiral N-acetyl protected phenylalanine to create a chiral environment around the 
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manganese active site.  Conditions were reported under which the encapsulated catalyst 
could be assembled via a one-pot synthesis.   Fluorescence spectroscopy was used to 
confirm the location of the manganese porphyrin as inside the assembly.  The addition of 
manganese porphyrin to a solution of AAT4 results in fluorescence quenching from the 
surrounding zinc porphyrin; nearly complete quenching was observed at a 1:1 
stoichiometry of AAT4 : M.   While chiral assemblies CMCT4 and CMCT’4 gave only 
12-14% ee for the asymmetric sulfur oxidation of methyl p-tolyl sulfide, the control 
reaction of manganese porphyrin M with N-acetyl-D-phenylalanine afforded completely 
racemic product.  This supramolecular system is reportedly the first example of remote 
asymmetric induction from the surrounding environment of an achiral abiotic 
homogeneous catalyst.   
17 
 
 
 
Figure 9 Enantioselective sulfoxidation reactions catalyzed by supramolecular porphyrin 
boxes.  *Reactions were stopped <25% yields to compare reaction rates of oxidizing 
subunit M alone compared to when it is enclosed in supramolecular box. Reprinted with 
permission from J. Am. Chem. Soc.  2008, 130, 16828-16829.  Copyright 2014 American 
Chemical Society 
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     Reek devised a system to encapsulate a chiral bidentate phosphoramidite ligand inside 
a molecular “box” (Figure 10).40  The zinc-salphen D was used as a template to 
coordinate with bispyridyl-substituted phosphoramidite ligand L14.  Reek had previously 
reported a similar approach using an achiral catalyst to affect the regioselective 
hydroformylation of unfunctionalized alkenes. 
41
   Circular dichroism (CD) was used to 
monitor complexation of L14 as titrated with zinc salphen D.  A single inflection point in 
the series of CD spectra was observed after a 1:1 stoichiometry was reached; this 
suggests the formation of a discrete assembly that does not undergo any significant 
structural changes after the molecular box assembles.  Diffusion-ordered NMR 
(DOSY),
42
 an NMR technique used to approximate the hydrodynamic radius of a 
molecule in solution, was used to estimate a hydrodynamic radius of 1 nm; the result 
closely matches the dimension expected from the computational model for L15-Rh(acac) 
as determined using Spartan
©
 PM3.  The addition of rhodium acac affords the L15-
Rh(acac) complex.  Its 
31
P NMR spectrum shows the expected doublet (JP-Rh = 290 Hz), 
and electrospray ionization mass spectrometry found a peak corresponding to the L15-
Rh(acac) species.   
     L15-Rh(acac) catalyzed the asymmetric hydroformylation reaction of 2-octene 
demonstrating that the unusual catalyst systems could be used for the asymmetric 
hydroformylation reaction of an non-functionalized (i.e., lacking a strong directing 
groups) internal alkene.  Due to alkene isomerization, obtaining high yields is challenging 
for these troublesome hydroformylation substrates.
41
   Interactions with the 
supramolecular catalyst scaffold had little or no effect on the regioselectivity for trans 2-
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octene, although an increase in enantioselectivity was observed for the reaction with the 
supramolecular catalyst compared to that with the chiral phosphoramidite L15 alone (i.e., 
72% to 22% ee).  Cis 2-octene afforded more dramatic effects. The encapsulated catalyst 
L15-Rh(acac) favored formation of the 3-substituted carboxaldehyde isomer with a 
concurrent substantial increase in enantiomeric excess from 4% to 86% ee; however, the 
yields were low for the reasons stated above.  When the reaction times were extended in 
an attempt to obtain more practical yields, a slight drop in regioselectivity and 
enantioselectivity was accompanied by the increase in yield.  Starting from cis-2-octene, 
(S)-2-ethylheptanal was formed in 57% yield and 76% ee. 
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Figure 10 Self-assembly of a confined chiral rhodium catalyst for the asymmetric 
hydroformylation of unfunctionalized alkenes.  
a
At 40°C for 5 days. Adapted with 
permission from J. Am. Chem. Soc.  2012, 134, 2860-2863.  Copyright 2014 American 
Chemical Society 
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1.4 Homogeneous Organometallic catalysis – Self-assembly of supramolecular 
nanovessels for asymmetric catalysis 
 
     A number of research groups have pursued the idea that supramolecular assemblies 
could also function as a “nanovessel” or “molecular flask.”  Encapsulated guests might be 
forced to adopt a preferred reactive confirmation once confined inside the vessel.  If the 
nanovessel is chiral, it might promote enantioselective catalysis inside the vessel; 
Bergman and Raymond have reported the only two examples of using host-assemblies to 
catalyze an enantioselective transformation (Figure 11).
43,44
  
44
  It should be noted that 
Fujita also reported a [2+2] cycloaddition promoted by a chiral supramolecular assembly, 
but a stoichiometric equivalent of catalyst was required.
45
  Bergman and Raymond’s 
supramolecular assemblies possess a well-defined cavity for guest recognition and 
encapsulation and function well in aqueous environments.
46-53
  The clusters are 
assembled via coordination of six bis(catecholate)-functionalized ligands with four 
gallium metals; three catecholate groups coordinate to each gallium ion in an octahedral 
arrangement possessing either a right(Δ)- or left(Λ)-handed helicity at the metal center 
(Figure 11A).
54
  Racemic L16 was resolved with (S)-N-methylnicotinium iodide. Ion 
exchange chromatography with tetramethyl ammonium and potassium iodide salts 
affords the “empty” resolved host rendering it capable of exchange with a cationic 
substrate.
55
  CD spectra of the resolved hosts show the expected two mirrored images.  
ΔΔΔΔ-L16 was shown to promote a simple, but quite remarkable, aza-cope 
rearrangement in up to 64% ee and up to 74% yield (Figure 11A).  This was an especially 
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significant conceptual advance since the cavity bears no specific identifiable coordinating 
groups to influence the selectivity; yet the reaction shows some selectivity.   
     Bergman, Toste, and Raymond recently reported a more robust nanovessel for 
asymmetric catalytic rearrangements with neutral substrates (Figure 11B).
44
  Modifying 
the vertices of the bis(catecholate) ligand with chiral amide directing groups 
accomplishes two purposes:  1) The hydrogen-bonding interaction between the amide N-
H and the catecholate oxygen gives the structure more strength; and 2) The chiral amide 
is capable of promoting chiral self-assembly eliminating the need for classical resolution.  
Using the tether derived from (R)-(-)-3,3-dimethyl-2-butyl amine affords the ΔΔΔΔ-L17 
host, while its antipode gives the ΛΛΛΛ -L17 host.  The CD-spectrum of ΔΔΔΔ-L17 and 
ΛΛΛΛ -L17 were mirror images of one another.  The absolute configuration of ΔΔΔΔ-
L17 was determined by X-ray crystallography which clearly indicated the presence of 
hydrogen-bonding between the amide NH and catecholate at the vertices.  The pure 
enantiomers incorporate 12 potassium ions capable of rapidly exchanging with guest 
molecules.  Stereochemical analysis by 
1
HNMR after the addition of a chiral ammonium 
guest molecule further confirmed the enantiomeric purity of the capsules.  Inclusion of an 
enantiopure guest molecule to each enantiomer of L17 afforded two different complexes 
as judged from their distinctly different 
1
HNMR spectra due to diastereomeric 
interactions.   
     The catalyzed carbonyl-ene cyclization of a simple monoterpenoid substrate was 
examined with chiral hosts L16 and L17.  Chiral host L16, which had been designed for 
a cationic guest molecule, did not catalyze the carbonyl-ene cyclization of the 
monoterpenoid substrate. This suggests no reaction occurs outside or on the surface of the 
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nanovessels; the latter point can be problematic and difficult to assess.  The two 
enantiomers of L17, ΔΔΔΔ-L17 and ΛΛΛΛ -L17, afforded products in similarly high 
yield (92-94%) and matching diastereoselectivity and enantiopurity, but opposite 
configuration.    
 
 
Figure 11 Chiral supramolecular host chemistry and its application to enantioselective 
catalysis of charged and neutral substrates.  A) Space filling model of L17 and the first 
reported example of a chiral host used in catalytic amounts catalyzing an asymmetric 
reaction (the Aza-Cope rearrangement) Adapted with permission from J. Am. Chem. Soc.  
2009, 131, 17530-17531.  Copyright 2014 American Chemical Society; B) Crystal 
structure of L18 and application in enantioselective monoterpene-like cyclization of 
neutral substrates.  Adapted with permission from J. Am. Chem. Soc.  2013, 135, 18802-
18805.  Copyright 2014 American Chemical Society 
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1.5 Heterogeneous Organometallic catalysis – metal-organic frameworks (MOFs) 
    Metal-organic frameworks (MOFs) are porous three-dimensional coordination 
polymers composed of organic bridging ligands and inorganic connecting points; while 
MOF catalysts are often considered separately from supramolecular catalyst systems, it 
seems more fitting to include them in this summary of recent advances in supramolecular 
asymmetric catalysts. Incorporating chirality and a catalytically active site in the bridging 
ligands transforms the MOF into a (supramolecular) heterogeneous asymmetric catalyst.  
These pores inside the MOF are capable of enzyme-like shape- and size- selectivity 
altered by modifying the bridging ligands, often done in a combinatorial fashion.  A pore 
too large often fails induce chirality to the catalytic reaction, while a pore too narrow or 
small limits substrate access.  Some benefits to using MOFs for asymmetric catalysis 
over traditional homogenous catalysts are their reusability, often lower tendency toward 
catalyst deactivation, and in ideal cases enzyme-like substrate size selectivity.  Although 
the first report of MOFs use as asymmetric catalysts was less than 20 years ago, the 
burgeoning field has advanced significantly for both organocatalyzed and metal-
catalyzed reactions.
56-58
  
     The
 
first generation of asymmetric MOF catalysts tried to exploit induction from an 
inorganic coordination sphere to a remote achiral catalytic site (Figure 12A).  
Independently, Kim 
59
 and Lin
60
 reported similar strategies in 2000-2001.  In Kim’s 
report, the chiral MOF D-POST-1 was synthesized from tartaric acid-derived ligands 
with zinc at the connecting points (Figure 12B). X-ray crystallography revealed the void 
volume of the channels makes up 47% of the total volume, and 47 water molecules were 
found in each unit cell.  The use of D-POST-1 to catalyze the esterification of racemic 1-
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phenyl-2-propanol afforded the esterified product in 8% ee.  Although the enantiomeric 
excess was low, this publication demonstrated for the first time the use of a chiral MOF 
in an asymmetric transformation.   
 
     Eight years after Kim’s first report, Tanaka reported modest selectivity could be 
obtained with a chiral MOF catalyst using the strategy of chiral relay.
61
  Slow diffusion of 
the chiral bridging ligand 2,2’-dihydroxyl-1,1’-binaphthalene-1,1’-dicarboxylic acid 
(L18) with Cu(NO3)2 formed the chiral MOF [Cu2(L18)2(H2O)2] • MeOH • 2H2O (Figure 
12C).  Single crystal X-ray diffraction found that the four carboxylate oxygen atoms are 
each coordinated to the Cu(II) ion.  Thermogravimetric analysis (TGA) found 19% of its 
mass was lost upon heating from 25-to-120 °C; this is attributed to loss of entrapped 
solvent molecules.  Removal of the guest solvent molecules in vacuo converted the 
crystalline MOF into an amorphous solid as shown by X-Ray powder diffraction; 
however, crystallinity could be regained upon exposure to solvent vapor.  The MOF was 
used in the asymmetric epoxide ring-opening of cyclohexene and cyclopentene oxides 
with aromatic amines.  In a neat solution of amine and epoxide, MOF [Cu2(L18)2(H2O)2] 
catalyzed the reaction giving the product in 51% yield and 51% ee.  Hydrogen-bond 
donors such as BINOL have been shown to participate in organocatalyzed epoxide 
openings.
62
  As a control experiment, the authors found that, while addition of (S)-
BINOL to a mixture of amine and epoxide afforded ring-opened product, the 3% yield of 
product obtained was nearly racemic.  The poor selectivity from the BINOL control 
reaction was interpreted as indicating that chirality form the BINOL subunits was relayed 
to the copper paddlewheels which were the sites responsible for catalyzing the 
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enantioselective epoxide opening.  An alternative explanation is cooperative participation 
from the BINOL chiral hydrogen-bond donor and the Lewis acidic Cu center.  To 
distinguish whether the catalysis was occurring inside the pores or on the surface, bulky 
arylamine nucleophiles, reactants that presumably cannot access the MOF pore interiors, 
were examined; aromatic amines with an ortho-methyl or para-methyl gave nearly 
racemic products and in much lower yield (i.e., 3-13%). 
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Figure 12 First generation of metal-organic frameworks use as asymmetric catalyst.  A) 
General strategy using chiral relay to remote catalytically active site.  B) Kim’s tartrate-
derived MOF and its use in the resolution of racemic alcohols. Reproduced from Ref 59 
with permission from Nature Publishing Group C) Tanaka’s BINOL derived bridging 
ligand forms MOFs and its use in the asymmetric ring-opening of meso-epoxides. 
Reproduced from Ref 61 with permission from Royal Society of Chemistry 
28 
 
     In the second generation of MOF catalysts, the bridging ligand was used to 
immobilize a successful homogenous catalyst asking the question, how does 
incorporation inside a MOF influence catalyst reactivity (Figure 13A).  Lin and co-
workers immobilized ruthenium BINAP-derived catalysts on a porous zirconium 
amorphous surface with great success (Figure 13B).
63
    X-ray powder diffraction 
confirmed L19-Ru-Zr was amorphous.  IR spectra exhibit O-H stretching vibrations 
consistent the presence of MeOH solvates, and thermogravimetric analysis (TGA) 
confirmed the presence of solvates resulting in a ca. 20% loss of mass from when heated 
from 20-to-200 °C.  Ru-BINAP-DPEN, the homogeneous analogue of L19-Ru-Zr, gives 
80% ee in the hydrogenation of acetophenone.
64,65
  Under similar conditions, L19-Ru-Zr 
affords the product in 96% ee; a series of ketones were studied and all afforded >90% ee 
(see reference 63).  To examine the durability of this heterogeneous catalyst, L19-Ru-Zr 
was recycled; the catalyst was reused eight times with no decrease in selectivity, although 
after the sixth recycle, the reaction did not go to completion.  Similar strategies in 
homogeneous catalyst immobilization were reported by Hupp for immobilizing a 
manganese epoxidation catalyst.
66
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Figure 13 Second generation of metal-organic frameworks use as asymmetric catalyst.  
A) General strategy immobilizing chiral ligating groups into scaffold of MOFs.  B) Lin’s 
immobilization of Ru-BINAP-DPEN in a porous zirconium solid affords higher 
selectivity than homogeneous analogue.  Reproduced from Ref 63 with permission from 
John Wiley and Sons. 
 
     Post-synthetic modification of a chiral MOF is a powerful new strategy that relies on 
incorporating orthogonally bifunctional groups bridging ligands (Figure 14A).  Lin 
demonstrated this idea in a MOF assembled from pyridine-substituted BINOL derivative 
L20 and Cd(II) ions (Figure 14B).
67
  Single crystal x-ray crystallography found three 
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Cd(II) ions, six chloride ions, and three L20 ligands in the unit cell.  The diameter of the 
channels inside the MOF were large (1.6 x 1.8 nm across); PLATON calculations found 
54% void space accessible to guests.   Two-thirds of the BINOL ligands were found H-
bonding with neighboring unit cells limiting their availability for post-synthetic 
modification.  Nonetheless, added Ti(OiPr)4 was found to react with the one-third of 
available chiral diols.  This strategy was studied further with a series of MOFs composed 
of tetra-substituted BINOL derivatives.
68
  The BINOL derivatives were functionalized 
with carboxylate-terminated tethers of varying lengths.  Carboxylate-bridged copper 
paddlewheels were formed upon addition of copper(II) leaving the diols available for 
sequential Ti(OiPr)4  addition.  Crystal structures of a series of model MOFs (that is, 
methyl ether derivatives of diols) found the approximate void space to vary 69-90% 
dependent on tether length.  To evaluate effectiveness of these functionalized MOFs in 
catalysis, the Lewis acid catalyzed addition of alkyl zincs to aldehydes was explored.  
The homogeneous catalyst derived from BINOL afforded the product in 88% ee.  MOFs 
derived from L20 and L22-24 afforded 82-84% ee with similar conversions to the 
homogenous catalyst.  Only the MOF derived from L21 gave poor selectivity; this was 
attributed to the pore size being too small resulting only in non-selective surface 
catalysis.  Similar results were found when substrates larger than acetophenone were 
used; they gave low selectivity and low yields.   
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Figure 14 Tunable MOFs for asymmetric catalysis.  Adapted with permission from J. 
Am. Chem. Soc.  2005, 127, 8940-8041.  Copyright 2014 American Chemical Society. 
Reproduced from Ref 68 with permission from Nature Publishing Group. 
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     Due to the crystalline nature of many MOFs, some details of their active sites are more 
accessible by crystallography than typically is obtained for homogeneous catalysts.  In 
the course of their structure-activity studies, Lin and co-workers analyzed a MOF catalyst 
that gave low selectivity (ca 30% ee) in the titanium-catalyzed addition of alkyl zinc to 
aldehydes (Figure 15).
69
  X-ray diffraction studies revealed substantial intermolecular 
BINOL-chelation that seems to account for the poorly selective catalyst. 
 
Figure 15 Interpenetrated networks form non-selective catalysts.  Reproduced from Ref 
69 with permission from John Wiley and Sons. 
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1.6 Heterogeneous Organometallic catalysis – Heterobimetallic polymers 
     Supramolecular polymers are chains of monomeric units held together by non-
bonding forces.
71
  When catalytically active functional groups are built into the 
monomeric subunits, the supramolecular polymer affords a heterogeneous catalyst.  Ding 
and co-workers recently reported a series of heterobimetallic polymeric catalysts that 
show promise for rhodium-catalyzed asymmetric hydrogenation (Figure 16A).
75
  
MonoPhos (i.e., (BINOL)PNMe2) and a 2,2’:6’,2”-terpyridine unit were connected by an 
alkyne linker.  Upon the addition of Fe
2+
 salts, the Fe-bridged bis(MonoPhos) ligand 
structures were formed.  Their structures were characterized by UV/Vis, IR, elemental 
analysis, and high resolution mass spectrometry.  When cationic rhodium(I) was added to 
a solution of iron complex in dichloromethane, a solid precipitated from solution.  Its 
analysis by powder x-ray diffraction showed the particles to be amorphous and by 
scanning electron microscope to be micron-sized.  A series of heterogeneous catalysts 
with varying counterions were similarly prepared and isolated.  As a model reaction these 
heterobimetallic oligomer or polymer catalysts were screened in heterogeneous 
asymmetric hydrogenation (Figure 16B).  For the substrates examined, L25 was found to 
be both remarkably reactive and selective, proving superior to even the homogeneous 
rhodium catalyst prepared with the chiral monodentate MonoPhos ligand.  Furthermore, 
L25 could be recycled more than ten times with no loss in catalytic activity or selectivity.   
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Figure 16 Formation of a heterobimetallic heterogeneous catalyst.  A) Preparation via 
sequential addition; B) Asymmetric hydrogenation using heterogeneous catalyst gives 
excellent selectivity compared to monodentate ligand.  Adapted from Ref 75 with 
permission from John Wiley and Sons. 
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1.7 Conclusions and future outlook 
 
     Computational modeling has yet to reach the point where it is feasible to design a 
priori an efficient tailor-made asymmetric catalyst.  Thus catalyst development still 
requires novel discovery strategies and some luck to find successful hits.  Supramolecular 
approaches to catalyst discovery is still a young field, but the results reported to date 
demonstrate some benefits through combinatorial synthesis and control of the active site 
topography that remains difficult using the traditional approaches involving  monodentate 
or covalently-linked ligands.   
     Where does the field of supramolecular asymmetric catalysis go next?  Cragg, 
Grothaus, and Newman analyzed the sources of new drugs (for human consumption) for 
the treatment of diseases from 1998-2008, a total of 1024 compounds.
76
  Remarkably, 
while 57% of the drugs were either synthetically modified or inspired from the structures 
of natural products, only 6% were the actual isolated natural product itself.  The ability to 
modify a polyfunctional natural product, that is, the post-synthetic modification of a 
natural product, is one direction for developing chemical transformations by 
supramolecular catalysis.  The challenge lies in building enzyme-like site-specific 
selectivity at a targeted site in a polyfunctional molecule.
77
  Scott Miller and co-workers 
have reported a series of small peptide catalysts for site-selective transformations on 
challenging natural product substrates.
78-82
  Exploiting the control of active site 
topography and/or binding pocket accessibility to successfully target site-selective 
reactions on a complex natural product would add significant value to supramolecular 
catalysis. 
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     A second area, identifying new reaction pathways, could be productively addressed 
with the right supramolecular catalyst.  For example, David MacMillan recently 
discovered conditions for a new -amino C-H arylation reaction from “reaction discovery 
screening.”83  Using the reaction discovery approach in a controlled supramolecular 
combinatorial screen for new reactions seems a likely and exciting future direction for the 
field. 
  
1.8 References 
1. Ringe, D.; Petsko, G. A. How enzymes work. Science (Washington, DC, U.  S. ) 2008, 
320, 1428-1429. 
2. Breit, B. Supramolecular approaches to generate libraries of chelating bidentate ligands 
for homogeneous catalysis. Angew.  Chem. , Int.  Ed. 2005, 44, 6816-6825. 
3. Karakhanov, E. A.; Maksimov, A. L.; Runova, E. A. Design of supramolecular metal 
complex catalytic systems for organic and petrochemical synthesis. 
Russ.  Chem.  Rev. 2005, 74, 97-111. 
4. Gasparini, G.; Dal Molin, M.; Prins, L. J. Dynamic Approaches towards Catalyst 
Discovery. Eur.  J.  Org.  Chem. 2010, 2429-2440. 
5. Meeuwissen, J.; Reek, J. N. H. Supramolecular catalysis beyond enzyme mimics. 
Nat.  Chem. 2010, 2, 615-621. 
6. Chakrabarty, R.; Mukherjee, P. S.; Stang, P. J. Supramolecular Coordination: Self-
Assembly of Finite Two- and Three-Dimensional Ensembles. 
Chem.  Rev.  (Washington, DC, U.  S. ) 2011, 111, 6810-6918. 
7. Carboni, S.; Gennari, C.; Pignataro, L.; Piarulli, U. Supramolecular ligand-ligand and 
ligand-substrate interactions for highly selective transition metal catalysis. Dalton 
Trans. 2011, 40, 4355-4373. 
8. Deuss, P. J.; den Heeten, R.; Laan, W.; Kamer, P. C. J. Bioinspired catalyst design and 
artificial metalloenzymes. Chem.  - Eur.  J. 2011, 17, 4680-4698. 
37 
 
9. Wiester, M. J.; Ulmann, P. A.; Mirkin, C. A. Enzyme Mimics Based Upon 
Supramolecular Coordination Chemistry. Angew.  Chem. , Int.  Ed. 2011, 50, 114-
137. 
10. Dong, Z.; Luo, Q.; Liu, J. Artificial enzymes based on supramolecular scaffolds. 
Chem.  Soc.  Rev. 2012, 41, 7890-7908. 
11. Bellini, R.; van der Vlugt, J. I.; Reek, J. N. H. Supramolecular self-assembled ligands 
in asymmetric transition metal catalysis. Isr.  J.  Chem. 2012, 52, 613-629. 
12. Briere, J.; Oudeyer, S.; Dalla, V.; Levacher, V. Recent advances in cooperative ion 
pairing in asymmetric organocatalysis. Chem.  Soc.  Rev. 2012, 41, 1696-1707. 
13. Kumagai, N.; Shibasaki, M. Catalytic chemical transformations with 
conformationally dynamic catalytic systems. Catal.  Sci.  Technol. 2013, 3, 41-57. 
14. Ballester, P.; Vidal-Ferran, A.; van Leeuwen, P. W. N. M. Modern strategies in 
supramolecular catalysis. Adv.  Catal. 2011, 54, 63-126,, 6 plates. 
15. Seo, J. S.; Whang, D.; Lee, H.; Jun, S. I.; Oh, J.; Jeon, Y. J.; Kim, K. A homochiral 
metal-organic porous material for enantioselective separation and catalysis. Nature 
(London) 2000, 404, 982-986. 
16. Ingleson, M. J.; Barrio, J. P.; Bacsa, J.; Dickinson, C.; Park, H.; Rosseinsky, M. J. 
Generation of a solid Bronsted acid site in a chiral framework. 
Chem.  Commun.  (Cambridge, U.  K. ) 2008, 1287-1289. 
17. Vaidhyanathan, R.; Bradshaw, D.; Rebilly, J.; Barrio, J. P.; Gould, J. A.; Berry, N. 
G.; Rosseinsky, M. J. A family of nanoporous materials based on an amino acid 
backbone. Angew.  Chem. , Int.  Ed. 2006, 45, 6495-6499. 
18. Banerjee, M.; Das, S.; Yoon, M.; Choi, H. J.; Hyun, M. H.; Park, S. M.; Seo, G.; 
Kim, K. Postsynthetic Modification Switches an Achiral Framework to Catalytically 
Active Homochiral Metal-Organic Porous Materials. J.  Am.  Chem.  Soc. 2009, 131, 
7524-7525. 
19. Ferey, G.; Mellot-Draznieks, C.; Serre, C.; Millange, F. Crystallized Frameworks 
with Giant Pores: Are There Limits to the Possible?. Acc.  Chem.  Res. 2005, 38, 
217-225. 
20. Falck, J. R.; Kodela, R.; Manne, R.; Atcha, K. R.; Puli, N.; Dubasi, N.; Manthati, V. 
L.; Capdevila, J. H.; Yi, X.; Goldman, D. H.; Morisseau, C.; Hammock, B. D.; 
Campbell, W. B. 14,15-Epoxyeicosa-5,8,11-trienoic Acid (14,15-EET) Surrogates 
38 
 
Containing Epoxide Bioisosteres: Influence upon Vascular Relaxation and Soluble 
Epoxide Hydrolase Inhibition. J.  Med.  Chem. 2009, 52, 5069-5075. 
21. Wang, M.; Xie, M.; Wu, C.; Wang, Y. From one to three: a serine derivate 
manipulated homochiral metal-organic framework. Chem.  Commun.  (Cambridge, 
U.  K. ) 2009, 2396-2398. 
22. Dang, D.; Wu, P.; He, C.; Xie, Z.; Duan, C. Homochiral Metal-Organic Frameworks 
for Heterogeneous Asymmetric Catalysis. J.  Am.  Chem.  Soc. 2010, 132, 14321-
14323. 
23. Lun, D. J.; Waterhouse, G. I. N.; Telfer, S. G. A General Thermolabile Protecting 
Group Strategy for Organocatalytic Metal-Organic Frameworks. 
J.  Am.  Chem.  Soc. 2011, 133, 5806-5809. 
24. Slagt, V. F.; van Leeuwen, P. W. N. M.; Reek, J. N. H. Bidentate ligands formed by 
self-assembly. Chem.  Commun.  (Cambridge, U.  K. ) 2003, 2474-2475. 
25. Goudriaan, P. E.; Jang, X.; Kuil, M.; Lemmens, R.; Van Leeuwen, P. W. N. M.; 
Reek, J. N. H. Synthesis of building blocks for the development of the SUPRAPhos 
ligand library and examples of their application in catalysis. Eur.  J.  Org.  Chem. 
2008, 6079-6092. 
26. Goudriaan, P. E.; Kuil, M.; Jiang, X.; van Leeuwen, P. W. N. M.; Reek, J. N. H. 
SUPRAPhos ligands for the regioselective rhodium catalyzed hydroformylation of 
styrene forming the linear aldehyde. Dalton Trans. 2009, 1801-1805. 
27. Jiang, X.; Lefort, L.; Goudriaan, P. E.; de Vries, A. H. M.; van Leeuwen, P. W. N. 
M.; de Vries, J. G.; Reek, J. N. H. Screening of a supramolecular catalyst library in 
the search for selective catalysts for the asymmetric hydrogenation of a difficult 
enamide substrate. Angew.  Chem. , Int.  Ed. 2006, 45, 1223-1227. 
28. Slagt, V. F.; Roeder, M.; Kamer, P. C. J.; Van Leeuwen, P. W. N. M.; Reek, J. N. H. 
Supraphos: A Supramolecular Strategy To Prepare Bidentate Ligands. 
J.  Am.  Chem.  Soc. 2004, 126, 4056-4057. 
29. Reek, J. N. H.; Roeder, M.; Goudriaan, P. E.; Kamer, P. C. J.; Van Leeuwen, P. W. 
N. M.; Slagt, V. F. Supraphos: A supramolecular strategy to prepare bidentate 
ligands. J.  Organomet.  Chem. 2005, 690, 4505-4516. 
30. Bernsmann, H.; van den Berg, M.; Hoen, R.; Minnaard, A. J.; Mehler, G.; Reetz, M. 
T.; de Vries, J. G.; Feringa, B. L. PipPhos and MorfPhos: Privileged Monodentate 
Phosphoramidite Ligands for Rhodium-Catalyzed Asymmetric Hydrogenation. 
J.  Org.  Chem. 2005, 70, 943-951. 
39 
 
31. Bellini, R.; Chikkali, S. H.; Berthon-Gelloz, G.; Reek, J. N. H. Supramolecular 
Control of Ligand Coordination and Implications in Hydroformylation Reactions. 
Angew.  Chem. , Int.  Ed. 2011, 50, 7342-7345, S7342/1-S7342/51. 
32. Takacs, J. M.; Hrvatin, P. M.; Atkins, J. M.; Reddy, D. S.; Clark, J. L. The selective 
formation of neutral, heteroleptic zinc(II) complexes via self-discrimination of chiral 
bisoxazoline racemates and pseudoracemates. New J.  Chem. 2005, 29, 263-265. 
33. Takacs, J. M.; Reddy, D. S.; Moteki, S. A.; Wu, D.; Palencia, H. Asymmetric 
Catalysis Using Self-Assembled Chiral Bidentate P,P-Ligands. J.  Am.  Chem.  Soc. 
2004, 126, 4494-4495. 
34. Moteki, S. A.; Takacs, J. M. Exploiting self-assembly for ligand-scaffold 
optimization: substrate-tailored ligands for efficient catalytic asymmetric 
hydroboration. Angew.  Chem. , Int.  Ed. 2008, 47, 894-897. 
35. Moteki, S. A.; Toyama, K.; Liu, Z.; Ma, J.; Holmes, A. E.; Takacs, J. M. Two-stage 
optimization of a supramolecular catalyst for catalytic asymmetric hydroboration. 
Chem.  Commun.  (Cambridge, U.  K. ) 2012, 48, 263-265. 
36. Takacs, J. M.; Chaiseeda, K.; Moteki, S. A.; Reddy, D. S.; Wu, D.; Chandra, K. 
Rhodium-catalyzed asymmetric hydrogenation using self-assembled chiral bidentate 
ligands. Pure Appl.  Chem. 2006, 78, 501-509. 
37. Thacker, N. C.; Moteki, S. A.; Takacs, J. M. Ligand Scaffold Optimization of a 
Supramolecular Hydrogenation Catalyst: Analyzing the Influence of Key Structural 
Subunits on Reactivity and Selectivity. ACS Catal. 2012, 2, 2743-2752. 
38. van Leeuwen, P. W. N. M.; Rivillo, D.; Raynal, M.; Freixa, Z. Enantioselective 
Supramolecular Catalysis Induced by Remote Chiral Diols. J.  Am.  Chem.  Soc. 
2011, 133, 18562-18565. 
39. Lee, S. J.; Cho, S.; Mulfort, K. L.; Tiede, D. M.; Hupp, J. T.; Nguyen, S. T. Cavity-
Tailored, Self-Sorting Supramolecular Catalytic Boxes for Selective Oxidation. 
J.  Am.  Chem.  Soc. 2008, 130, 16828-16829. 
40. Gadzikwa, T.; Bellini, R.; Dekker, H. L.; Reek, J. N. H. Self-Assembly of a Confined 
Rhodium Catalyst for Asymmetric Hydroformylation of Unfunctionalized Internal 
Alkenes. J.  Am.  Chem.  Soc. 2012, 134, 2860-2863. 
41. Kuil, M.; Soltner, T.; Van Leeuwen, P. W. N. M.; Reek, J. N. H. High-Precision 
Catalysts: Regioselective Hydroformylation of Internal Alkenes by Encapsulated 
Rhodium Complexes. J.  Am.  Chem.  Soc. 2006, 128, 11344-11345. 
40 
 
42. Kharlamov, S. V.; Latypov, S. K. Modern diffusion-ordered NMR spectroscopy in 
chemistry of supramolecular systems: the scope and limitations. Russ.  Chem.  Rev. 
2010, 79, 635-653. 
43. Brown, C. J.; Bergman, R. G.; Raymond, K. N. Enantioselective Catalysis of the Aza-
Cope Rearrangement by a Chiral Supramolecular Assembly. J.  Am.  Chem.  Soc. 
2009, 131, 17530-17531. 
44. Zhao, C.; Sun, Q.; Hart-Cooper, W. M.; Di Pasquale, A. G.; Toste, F. D.; Bergman, 
R. G.; Raymond, K. N. Chiral Amide Directed Assembly of a Diastereo- and 
Enantiopure Supramolecular Host and its Application to Enantioselective Catalysis 
of Neutral Substrates. J.  Am.  Chem.  Soc. 2013, 135, 18802-18805. 
45. Nishioka, Y.; Yamaguchi, T.; Kawano, M.; Fujita, M. Asymmetric [2 + 2] Olefin 
Cross Photoaddition in a Self-Assembled Host with Remote Chiral Auxiliaries. 
J.  Am.  Chem.  Soc. 2008, 130, 8160-8161. 
46. Fiedler, D.; Leung, D. H.; Bergman, R. G.; Raymond, K. N. Selective Molecular 
Recognition, C-H Bond Activation, and Catalysis in Nanoscale Reaction Vessels. 
Acc.  Chem.  Res. 2005, 38, 349-358. 
47. Fiedler, D.; van Halbeek, H.; Bergman, R. G.; Raymond, K. N. Supramolecular 
Catalysis of Unimolecular Rearrangements: Substrate Scope and Mechanistic 
Insights. J.  Am.  Chem.  Soc. 2006, 128, 10240-10252. 
48. Pluth, M. D.; Bergman, R. G.; Raymond, K. N. Supramolecular Catalysis of 
Orthoformate Hydrolysis in Basic Solution: An Enzyme-Like Mechanism. 
J.  Am.  Chem.  Soc. 2008, 130, 11423-11429. 
49. Hastings, C. J.; Fiedler, D.; Bergman, R. G.; Raymond, K. N. Aza Cope 
Rearrangement of Propargyl Enammonium Cations Catalyzed By a Self-Assembled 
"Nanozyme". J.  Am.  Chem.  Soc. 2008, 130, 10977-10983. 
50. Mugridge, J. S.; Szigethy, G.; Bergman, R. G.; Raymond, K. N. Encapsulated Guest-
Host Dynamics: Guest Rotational Barriers and Tumbling as a Probe of Host Interior 
Cavity Space. J.  Am.  Chem.  Soc. 2010, 132, 16256-16264. 
51. Hastings, C. J.; Backlund, M. P.; Bergman, R. G.; Raymond, K. N. Enzyme-like 
Control of Carbocation Deprotonation Regioselectivity in Supramolecular Catalysis 
of the Nazarov Cyclization. Angew.  Chem. , Int.  Ed. 2011, 50, 10570-10573, 
S10570/1-S10570/9. 
41 
 
52. Wang, Z. J.; Brown, C. J.; Bergman, R. G.; Raymond, K. N.; Toste, F. D. 
Hydroalkoxylation Catalyzed by a Gold(I) Complex Encapsulated in a 
Supramolecular Host. J.  Am.  Chem.  Soc. 2011, 133, 7358-7360. 
53. Wang, Z. J.; Clary, K. N.; Bergman, R. G.; Raymond, K. N.; Toste, F. D. A 
supramolecular approach to combining enzymatic and transition metal catalysis. 
Nat.  Chem. 2013, 5, 100-103. 
54. Caulder, D. L.; Raymond, K. N. The rational design of high symmetry coordination 
clusters. J.  Chem.  Soc. , Dalton Trans. 1999, 1185-1200. 
55. Davis, A. V.; Fiedler, D.; Ziegler, M.; Terpin, A.; Raymond, K. N. Resolution of 
Chiral, Tetrahedral M4L6 Metal-Ligand Hosts. J.  Am.  Chem.  Soc. 2007, 129, 
15354-15363. 
56. Ma, L.; Abney, C.; Lin, W. Enantioselective catalysis with homochiral metal-organic 
frameworks. Chem.  Soc.  Rev. 2009, 38, 1248-1256. 
57. Yoon, M.; Srirambalaji, R.; Kim, K. Homochiral Metal-Organic Frameworks for 
Asymmetric Heterogeneous Catalysis. Chem.  Rev.  (Washington, DC, U.  S. ) 2012, 
112, 1196-1231. 
58. Falkowski, J. M.; Liu, S.; Lin, W. Metal-Organic Frameworks as Single-Site Solid 
Catalysts for Asymmetric Reactions. Isr.  J.  Chem. 2012, 52, 591-603. 
59. Seo, J. S.; Whang, D.; Lee, H.; Jun, S. I.; Oh, J.; Jeon, Y. J.; Kim, K. A homochiral 
metal-organic porous material for enantioselective separation and catalysis. Nature 
(London) 2000, 404, 982-986. 
60. Evans, O. R.; Ngo, H. L.; Lin, W. Chiral porous solids based on lamellar lanthanide 
phosphonates. J.  Am.  Chem.  Soc. 2001, 123, 10395-10396. 
61. Tanaka, K.; Oda, S.; Shiro, M. A novel chiral porous metal-organic framework: 
asymmetric ring opening reaction of epoxide with amine in the chiral open space. 
Chem.  Commun.  (Cambridge, U.  K. ) 2008, 820-822. 
62. Chawla, R.; Singh, A. K.; Yadav, L. D. S. Organocatalysis in synthesis and reactions 
of epoxides and aziridines. RSC Adv. 2013, 3, 11385-11403. 
63. Hu, A.; Ngo, H. L.; Lin, W. Chiral, porous, hybrid solids for highly enantioselective 
heterogeneous asymmetric hydrogenation of Î²-keto esters. Angew.  Chem. , Int.  Ed. 
2003, 42, 6000-6003. 
42 
 
64. Ohkuma, T.; Ooka, H.; Ikariya, T.; Noyori, R. Preferential hydrogenation of 
aldehydes and ketones. J.  Am.  Chem.  Soc. 1995, 117, 10417-10418. 
65. Doucet, H.; Ohkuma, T.; Murata, K.; Yokozawa, T.; Kozawa, M.; Katayama, E.; 
England, A. F.; Ikariya, T.; Noyori, R. Trans-[RuCl2(phosphine)2(1,2-diamine)] and 
chiral trans-[RuCl2(diphosphine)(1,2-diamine)]: shelf-stable precatalysts for the 
rapid, productive, and stereoselective hydrogenation of ketones. Angew.  Chem. , 
Int.  Ed. 1998, 37, 1703-1707. 
66. Cho, S.; Ma, B.; Nguyen, S. T.; Hupp, J. T.; Albrecht-Schmitt, T. E. A metal-organic 
framework material that functions as an enantioselective catalyst for olefin 
epoxidation. Chem.  Commun.  (Cambridge, U.  K. ) 2006, 2563-2565. 
67. Wu, C.; Hu, A.; Zhang, L.; Lin, W. A Homochiral Porous Metal-Organic Framework 
for Highly Enantioselective Heterogeneous Asymmetric Catalysis. 
J.  Am.  Chem.  Soc. 2005, 127, 8940-8941. 
68. Ma, L.; Falkowski, J. M.; Abney, C.; Lin, W. A series of isoreticular chiral metal-
organic frameworks as a tunable platform for asymmetric catalysis. Nat.  Chem. 
2010, 2, 838-846. 
69. Ma, L.; Wu, C.; Wanderley, M. M.; Lin, W. Single-Crystal to Single-Crystal Cross-
Linking of an Interpenetrating Chiral Metal-Organic Framework and Implications in 
Asymmetric Catalysis. Angew.  Chem. , Int.  Ed. 2010, 49, 8244-8248, S8244/1-
S8244/16. 
70. Song, F.; Wang, C.; Lin, W. A chiral metal-organic framework for sequential 
asymmetric catalysis. Chem.  Commun.  (Cambridge, U.  K. ) 2011, 47, 8256-8258. 
71. Li, S.; Xiao, T.; Lin, C.; Wang, L. Advanced supramolecular polymers constructed by 
orthogonal self-assembly. Chem.  Soc.  Rev. 2012, 41, 5950-5968. 
72. Roelfes, G.; Feringa, B. L. DNA-based asymmetric catalysis. Angew.  Chem. , 
Int.  Ed. 2005, 44, 3230-3232. 
73. Boersma, A. J.; Megens, R. P.; Feringa, B. L.; Roelfes, G. DNA-based asymmetric 
catalysis. Chem.  Soc.  Rev. 2010, 39, 2083-2092. 
74. Shi, L.; Wang, X.; Sandoval, C. A.; Li, M.; Qi, Q.; Li, Z.; Ding, K. Engineering a 
polymeric chiral catalyst by using hydrogen bonding and coordination interactions. 
Angew.  Chem. , Int.  Ed. 2006, 45, 4108-4112. 
43 
 
75. Yu, L.; Wang, Z.; Wu, J.; Tu, S.; Ding, K. Directed Orthogonal Self-Assembly of 
Homochiral Coordination Polymers for Heterogeneous Enantioselective 
Hydrogenation. Angew.  Chem. , Int.  Ed. 2010, 49, 3627-3630, S3627/1-S3627/34. 
76. Cragg, G. M.; Grothaus, P. G.; Newman, D. J. Impact of Natural Products on 
Developing New Anti-Cancer Agents. Chem.  Rev.  (Washington, DC, U.  S. ) 2009, 
109, 3012-3043. 
77. Gonzalez-Sabin, J.; Moran-Ramallal, R.; Rebolledo, F. Regioselective enzymatic 
acylation of complex natural products: expanding molecular diversity. Chem Soc 
Rev 2011, 40, 5321-5335. 
78. Lewis, C. A.; Miller, S. J. Site-selective derivatization and remodeling of 
erythromycin A by using simple peptide-based chiral catalysts. Angew.  Chem. , 
Int.  Ed. 2006, 45, 5616-5619. 
79. Lewis, C. A.; Longcore, K. E.; Miller, S. J.; Wender, P. A. An Approach to the Site-
Selective Diversification of Apoptolidin A with Peptide-Based Catalysts. 
J.  Nat.  Prod. 2009, 72, 1864-1869. 
80. Fowler, B. S.; Laemmerhold, K. M.; Miller, S. J. Catalytic Site-Selective 
Thiocarbonylation and Deoxygenation of Vancomycin Reveal Hydroxyl-Dependent 
Conformational Effects. J.  Am.  Chem.  Soc. 2012, 134, 9755-9761. 
81. Pathak, T. P.; Miller, S. J. Site-Selective Bromination of Vancomycin. 
J.  Am.  Chem.  Soc. 2012, 134, 6120-6123. 
82. Han, S.; Miller, S. J. Asymmetric Catalysis at a Distance: Catalytic, Site-Selective 
Phosphorylation of Teicoplanin. J.  Am.  Chem.  Soc. 2013, 135, 12414-12421. 
83. McNally, A.; Prier, C. K.; MacMillan, D. W. C. Discovery of an Î±-Amino C-H 
Arylation Reaction Using the Strategy of Accelerated Serendipity. Science 
(Washington, DC, U.  S. ) 2011, 334, 1114-1117. 
  
  
44 
 
CHAPTER TWO: OPTIMIZATION OF A SUPRAMOLECULAR HYDROGENATION 
CATALYST 
 
2.1 Rhodium-catalyzed asymmetric hydrogenation 
     Rhodium-catalyzed asymmetric hydrogenation (Rh-CAH) is one of the most useful 
reactions in asymmetric catalysis.  The addition of H2 to a prochiral alkene is atom 
economical and generates a minimal amount of waste.  The substrate scope is diverse, 
and there has been a substantial amount of research into the mechanism of the reaction 
over the last 30 years.   Historically, these traits have made the asymmetric hydrogenation 
one of the most studied reactions of asymmetric catalysis.  The origin of asymmetric 
hydrogenation date back to early studies by 2001 Nobel laureate William Knowles, who 
sought an efficient route to synthesize the rare amino acid L-DOPA for the treatment of 
Parkinson’s disease (Figure 1).1  The then practiced route utilized a Pd/C promoted 
hydrogenation followed by a chiral resolution.  While this route was effective in 
preparation of the desired L-isomer, it also generated a large amount of waste from the 
undesired D-isomer.  Wilkinson hypothesized it might be possible to bypass this 
resolution by producing only the L-isomer through an asymmetric hydrogenation. 
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Figure 1 Preparation of the Parkinson's drug (L)-DOPA with a chiral resolution step 
 
     In the mid 1960’s, Wilkinson developed the homogeneous catalyst, Rh(PPh3)3Cl, that 
proved quite reactive toward the hydrogenation of unhindered olefins.
 2
  A short time 
later, Horner and Mislow developed a chiral resolution for the preparation of chiral 
phosphines.
2
 The chiral phosphines were found to be stable to racemization under mild 
conditions and could be used to prepare a chiral variant of Rh(PPh3)3Cl.  As a model 
substrate for the (L)-DOPA precursor, the asymmetric hydrogenation of an N-acetyl 
protected dehydrophenylalanine derivative was explored (Figure 2).  Horner and 
Mislow’s chiral phosphines gave the reduced product in 28% ee.  The first generation 
substituted a propyl group for a cyclohexyl which increased the enantioselectivity only 
slightly.  Further modification resulted in the development of PAMP and CAMP which 
gave the products in 58% ee and 88% ee.   
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Figure 2 Evolution of monodentate phosphine ligands for the Rh-CAH 
 
          Bidentate phosphine catalysts started being explored in the early 1970’s.  It was 
believed the bidentate phosphine ligands would give a more rigid organized chiral space 
than the monodentate phosphines could achieve.  Kagan developed the chiral bidentate 
ligand DIOP derived from chiral sugars.
3
  DIOP was remarkable because the chirality 
was not on the phosphine itself, but on the backbone of the ligand.  Using DIOP the 
product was obtained in 83% ee (Figure 3).  Knowles connected two PAMP phosphine 
ligands with an ethylene bridge and named this ligand DIPAMP.  DIPAMP gave the 
highest levels of enantioselectivity achieved up to that point in time, 95% ee.     
47 
 
 
Figure 3 Evolution of chiral bidentate ligands for Rh-CAH 
 
     After being largely ignored in preference to chiral bidentate ligands, it was reported by 
Feringa and deVries in 2002 that certain monodentate BINOL phosphoramidites were 
very effective for the Rh-CAH of dehydroamino acid derivatives (Figure 4).
4
  Despite not 
having the added rigidity from a linker, these ligands can be equally effective as bidentate 
ligands.  Enantioselectivities of 92-99% ee were reported for both (E)- and (Z)-
dehydroamino acid derivatives.  A big advantage of these monodentate phosphoramidite 
ligands was their simple preparation from chiral diols enabling access to large libraries of 
chiral ligands for combinatorial screenings.  Since the initial report, phosphite and 
phosphoramidite monodentate ligands have been shown to be very effective for the Rh-
CAH of a wide variety of substrates.
5-12
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Figure 4 First report of effective BINOL phosphoramidite ligands in the Rh CAH 
 
    The mechanism of the rhodium-catalyzed asymmetric hydrogenation has been 
extensively studied over the last 30 years.
13-19
  Experimental evidence suggests two 
distinct pathways leading to the hydrogenated product (Figure 5).  If substrate 
coordination to rhodium occurs before oxidation addition of H2, the mechanism is known 
as the Halpern-Brown unsaturated pathway.
14,17,19
  If the order of addition is reversed and 
oxidative addition of H2 precedes substrate coordination, this is known as the dihydride 
pathway.
20-23
  While both have a common octahedral dihydride intermediate, the 
difference lies in whether stereoselection occurs from a square planar rhodium(I) or 
octahedral rhodium(III) complex.  Thus far, evidence for the dihydride pathway has only 
been observed when electron rich phosphine ligands were used.  
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Figure 5 Stereoselection in the rhodium-catalyzed hydrogenation can occur through one 
of two pathways 
 
     In the Halpern-Brown unsaturated mechanism, the stereoselection is first determined 
from the addition of H2 to the substrate-bound rhodium.  The mechanism is summarized 
below (Figure 6).  A doubly-solvated chiral rhodium(I) complex coordinates to the 
prochiral substrate affording two diastereomeric complexes differing in energy (Figure 6, 
A and A’).  Oxidative addition of H2 gives the octahedral Rh(III) complex through an 
“anti-lock and key” mechanism (Figure 6, C and C’).  That is, the minor diastereomer 
reacts more quickly than the major diastereomer.
14,17,19
  Landis and co-workers evaluated 
the different approaches of H2 to rhodium using DFT and ONIOM calculations finding 
significant energy differences between the different transition states.
24-26
  Labeling 
studies suggest the oxidative addition is irreversible when isotopic scrambling was not 
observed in presence of a D2 atmosphere.
16,17
  Migratory insertion of the alkene affords 
an alkyl metal hydride species (Figure 6, D and D’).  Reductive elimination gives the 
chiral reduced product while regenerating the Rh(I) catalyst (Figure 6, E and E’).  The 
mechanism is very well understood; the enantioselectivity can even be predicted using a 
quantum mechanics-guided molecular mechanics method (Q2MM).  For example, 
50 
 
building upon their previous mechanistic studies,
27
 Wiest and co-workers were able to 
corroborate experimental data for a series of widely used chiral bidentate phosphine 
ligands with predicted enantioselectivities.
28
  The overall agreement between 
experimental and predicted selectivity for all examples had an average unsigned error of 
0.8 kcal/mol.   
 
 
Figure 6 Halpern-Brown unsaturated mechanism for Rh-CAH 
 
     Conversely, the Rh(III) dihydride mechanism suggests oxidative addition to 
rhodium(I) occurs first, and the prochiral substrate’s coordination is the stereoselective 
step.
20-23
 Key evidence is observation of dihydride intermediates by H NMR at low 
temperatures.  Thus far, dihydride intermediates have only been observed when electron-
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rich P*-stereogenic phosphine ligands were used.  The dihydride intermediates have 
never been observed with substrate pre-coordinated, because the migratory insertion 
occurs too quickly.   This mechanism also provides stereochemical models where the 
predicted enantiomer from substrate precomplexation is not formed.
29
 
     Asymmetric hydrogenation is widely used in pharmaceutical applications today.
30
  
Because of this, many research groups are still pursuing this reaction for catalysts that are 
selective towards an ever growing library of compounds.  Their ultimate goal is to find a 
“privileged” catalyst generally reactive and selective for many substrates.  A 
supramolecular catalyst has the advantage of more chemical space to tailor the chiral 
pocket for the substrate.   
     Supramolecular chemistry has a long history, but as described in Chapter 1, the use of 
supramolecular catalysts for asymmetric catalysis is still at an early stage. The Takacs 
group has reported effective self-assembled supramolecular catalysts for reactions such as 
asymmetric allylic amination,
31
 hydrogenation,
32
 and hydroboration.
33,34
  The studies 
described in this chapter are those carried out for Rh-CAH; herein we describe the first 
in-depth investigation into the significance of each component of a self-assembled 
supramolecular hydrogenation catalyst.
35
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Figure 7 Pharmaceutical drugs synthesized with Rh-CAH as a key step.  Asymmetric 
reduction marked by red bond. 
      
2.2  Key components of a supramolecular catalyst 
     The Takacs supramolecular heterobimetallic catalyst can be divided into four 
customizable modules (Figure 8).
35
  The active site can be modified with different 
catalytically active metals such as Pd, Rh, or Ir (Figure 8, I).  The ligating group can be 
substituted with electronically different phosphorus ligands or nitrogen-based ligands 
(Figure 8, II).  The scaffold building tether can vary the connectivity pattern of either 
mono- or bi-aryl tethers while controlling the connectivity to the ligating group through 
either a benzylic or phenolic linkage (Figure 8, III).  Chirality-directed self-assembly 
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serves as the recognition elements which bring the complimentary bidentate ligand 
(Figure 8, IV).  
 
Figure 8 Strategy for optimization of a supramolecular catalyst.  Reprinted with 
permission from ACS Catal. 2012, 2, 2743-2752. ©2014 American Chemical Society 
 
     Combination of equimolar equivalents of a remote phosphorus bearing (S,S)-
bisoxazoline with a phosphorus bearing (R,R)-bisoxazoline in the presence of Zn(II) 
affords near exclusively the neutral heteroleptic complex SAL Zn(
S
T
R
T).  The 
heteroleptic complex binds with nearly perfect tetrahedral geometry around zinc while 
the homoleptic complex is distorted to avoid unfavorable steric interactions between the 
phenyl substituents.
36,37
  The difference in stability between the heteroleptic and 
homoleptic complexes, such as those whose crystals structures are shown (Figure 9, 
below) is estimated to be 4 kcal/mol or greater based on thermodynamic equilibria.  In 
the example illustrated below, if 
S
T = 
R
T and both P(OR)2 substituents are either (i) 
enantiomeric or (ii) achiral and otherwise identical on both subunits the zinc complex is 
meso by inversion symmetry.  However, if 
ST ≠ RT, the zinc complex lacks inversion 
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symmetry and is chiral.  In section 2.9, the impact of this will be described with respect to 
the asymmetric hydrogenation reaction.   
.   
 
Figure 9 Chirality directed self-assembly affords heteroleptic bimetallic complex 
 
          Scaffold optimization involves varying the substitution patterns of the tethers 
attached to the bisoxazoline.   The tethers were varied within a series of aryl and biaryl 
subunits of ortho-, meta-, or para-substitution (Figure 10).  Typically, it has been found 
that the optimal catalyst bears a scaffold that varies from substrate to substrate, and 
similarly for different reactions.  While some may see this as a disadvantage, we note the 
nature exploits the substrate selectivity as a hallmark of many biocatalysts (i.e., 
enzymes).  The power of scaffold optimization lies in the rather unique ability to tailor 
the catalytic pocket for each substrate.  In the course of the studies described below, one 
key feature will be that the flexibility of the catalyst can be tuned (or at least subtly 
varied) by changing the scaffold building tether subunit with either a benzylic or phenolic 
linkage to the ligating group.  While this difference results in only 1 or 2 additional or 
fewer of degrees of conformational freedom in a structurally large (ca 2 kD) 
supramolecular catalyst, the impact on a catalyst’s performance can be great.  This will 
be described in further detail in section 2.7. 
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Figure 10 Library of tethers used in SAL synthesis 
 
2.3 Ligating group and catalytic metal selection for catalyst scaffold optimization 
studies 
     The first step was selection of the ligating group. A series of chiral monodentate 
ligands were used to screen for candidates.  Chiral phosphite ligands have been reported 
to be effective for the Rh-CAH.
5,6,10,12
  The chiral diols BINOL, BIPHEP, and TADDOL 
were selected based upon their prior utility in asymmetric catalysis.  To ascertain a sense 
of a chiral ligating group’s effectiveness, two monodentate phosphite ligands modeling 
ultimate the tether backbone were synthesized with phenol (OPh) or benzylic (OBn) 
linkages.   
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.  
 
Figure 11 Strategy for selecting monodentate ligands for hydrogenation catalyst 
screening of substrates 
 
            Two prototypical enamides substrates were selected for this study, the dehydro 
phenylalanine derivative S1 and 1,1-disubstituted eneacetamide S2.  The substrates were 
screened with the TADDOL, BIPHEP, and BINOL derived phosphites with cationic 
Rh(nbd)2BF4 at 1 mol percent catalyst loading (Table 1).  After the reaction, yields were 
determined with N-benzyl acetamide as internal standard on GC. Catalysts with 
TADDOL ligands L1 and L2 were active but non-selective in the hydrogenation of S1 
and S2.  Biaryl backbones BIPHEP (L3, L4) and BINOL (L5, L6) gave higher 
selectivities than TADDOL.  BINOL was chosen as the ligating group for this study, 
because the selectivity was good yet had some room for improvement by catalyst scaffold 
optimization, especially considering the energetics of enantioselective reactions.  This 
was of course a risky proposal given that the previous hydrogenation study of BIPHEP-
SALs showed only incrementally increases over the monodentate ligands.  As a 
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benchmark for the scaffold optimization study, that is, a model system for the effect of 
mixed ArO- and ArCH2O- phosphite linkages, the combination of (BINOL)POPh with 
(BINOL)POBn was also run.  The effective use of mixtures of chiral monodentate 
ligands was first reported by Reetz
38
 and since that report has been exploited for its 
versatility in identifying new catalysts.
39
  In our hands, the L5/L6 combination of chiral 
monodentate ligands were no more effective than L5 or L6 alone.  This could suggest the 
an increase in selectivity from mixed scaffolds (something that we ultimately find, vide 
infra) results from supramolecular catalyst scaffold optimization rather than simply a 
mixed ligand effect.   
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Table 1 Ligating group selecting based on monodentate ligand screening
a 
 
    S1 S2 
Entry  Monodentate ligand ee (%)
b
 yield (%) ee (%)
b
 yield (%) 
1 (R)-(TADDOL)POPh L1 4 97 10 99 
2 (R)-(TADDOL)POBn L2 30 99 15 99 
3 (R)-(BIPHEP)POPh L3 67 99 67 99 
4 (R)-(BIPHEP)POBn L4 53 65 53 99 
5 (R)-(BINOL)POPh L5 69 99 86 99 
6 (R)-(BINOL)POBn L6 78 99 92 99 
7 L5 + L6
c
 78 99 92 99 
 
a
Reaction conditons:  1 mol% Rh(nbd)2BF4, 2.1 mol% monophosphite, DCE, rt, 16 h.  
Yields and enantioselectivity determined by chiral GC using N-benzyl acetamide as an 
internal standard.  
b
Unless otherwise noted, the (S)-enantiomer predominates the reaction.  
c
Equimolar amounts of each ligand. 
 
 
     The selection of metal precursor to be used in the catalyst scaffold optimization study 
was determined next.  Alternate diene precursors, counterions, and metals to 
Rh(nbd)2BF4 were examined under a standard set of hydrogenation conditions (i.e, 
59 
 
substrate S1 or S2, 1 mol% catalyst loading, BINOL phosphite L6, 30 psi H2, DCE, 16 
h).  Rh(cod)2BF4 gave comparable results as Rh(nbd)2BF4, which indicates that the diene 
precursor has little or no effect on the reaction. (We had assumed at the onset, as others 
do, that diene would simple be reduced under the reaction conditions.)  A “neutral” 
rhodium catalyst, [Rh(nbd)Cl]2 did not show any catalytic activity as one would expect 
for rhodium with a covalently bound counterion and the need for two-point binding of the 
substrate with the catalyst.  Substituting the [BF4]
-
 counterion with [TfO]
-
 or [B(C6F5)4]
-
 
(i.e., BArF) in the Rh(nbd)2X catalyst precursor gives catalysts that exhibit comparable 
reactivity and selectivity.  Consider the results summarized above and given its favorable 
solubility properties and commercial availability, Rh(nbd)2BF4 was used in the scaffold 
optimization studies.   
     Iridium-catalyzed hydrogenation has been effective for the enantioselective 
hydrogenation of substrates lacking strong directing groups, and we also briefly 
considered catalysts based on iridium as an alternative to rhodium for the catalyst 
scaffold optimization studies.
40,41
  However, Ir(cod)2BF4 is ineffective as a catalyst 
precursor under our stand reaction conditions with the selected chiral monophosphite 
ligands.  This is perhaps not surprising.  Effective iridium-catalysts typically employ P,N-
ligands.  Catalyst deactivation is believed to result from formation of bridged iridium-
hydride complexes.  Use of a non-coordinating counterion is important as strong 
coordination of the counterion inhibits olefin coordination and subsequent migratory 
insertion of an iridium di-hydride species.
42
  High concentrations of iridium-dihydride 
lead to the catalyst deactivation.     
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2.4 SAL screening of dehydrophenylalanine derivative S1 
     BINOL-derived monodentate phosphites proved to be both reaction and reasonably 
enantioselectivity for the Rh-CAH of prototypical substrates S1 and S2 under our 
prescribed reaction conditions.  The BINOL phosphite ligating group was appended to a 
series of SAL tethers.  Among the set of possible tethers shown in Figure 10, all of the 
monoaryl and biaryl tethers bearing a benzylic linkage to the ligating group were 
synthesized and included in the study.  Their inclusion reflects the preliminary evidence 
from the BIPHEP SALs and monodentate screening suggesting that ArCH2O-linked 
phosphites were generally more successful than the corresponding the ArO-linked series.  
For the ArO-linked series, the monoaryl tethers were excluded based on unpublished gel 
permeation chromatography (GPC) results suggesting that the ArO-linked tethers do not 
quantitatively form the desired bidentate chelate due to distance between restricted P-P 
distance between ligating groups.   
     BINOL-bisphosphite SALs were prepared by adding an equivalent of Zn(Et2) to 
combinations of appropriately (S,S) or (R,R)-bisoxazoline coupled tethers.  Rh(nbd)2BF4 
was then added to the resulting Zn complex providing a series of in situ generated 
supramolecular catalysts.  Initial screening of the pseudo-C2-symmetric SALs, scaffolds 
comprised of (R,R) and (S,S)-bisoxazline coupled to identical tethers, were used to 
determine whether all of the catalyst combinations should be examined.   Hydrogenation 
of S1 revealed a range of enantioselectivity from racemic to 93% ee with yields ranging 
from no reaction to quantitative (Figure 12).  While the large spread in the data looks 
promising in terms of scaffold optimization, only a couple catalysts give low 
enantioselectivity while the bulk of them give results within a relatively narrow range, 
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that is, 68–93% ee.  This is not what one would hope to see in a large scale scaffold 
optimization study. 
 
 
 
 
Figure 12 Hydrogenation of dehydrophenylalanine derivative S1 with BINOL SALs 
 
     Figure 13 summarizes the full data set from screening the BINOL-SAL derived catalysts with 
S1. Tethers labeled C-G are ArO-linked phosphites, while those labeled I-P are ArOCH2-
linked phosphites.  Catalysts bearing two ArO-linked tethers on the bidentate ligand are 
generally not reactive; see Figure 14 upper left quadrant.  Interestingly, while these 
ArO,ArO-linked scaffolds are not reactive, they are still more selective than the 
corresponding monodentate ligands which gave only 69% ee for (BINOL)POPh L5.  In 
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contrast, the ArCH2O,ArCH2O-linked scaffolds, that is, prepared from tethers I-P on both 
sides, are generally very reactive.  The mixed ArO,ArCH2O-linked scaffolds, with one 
tether selected from among tethers C-G and the other from among I-P, gave yields that 
had a exhibited wide variance from very low to quantitative.  Based upon these initial 
results, it was decided not to screen the remaining untested pseudoC2-symmetric ligands 
(i.e., the diastereomers of the ligands already screened) under the assumption that the box 
complex, the element that would differ in the diastereomer, was too far from the site of 
reaction and rather highly symmetric; the implication being that it the diastereomeric 
series of catalysts simply would behave similarly. 
. 
 
Figure 13 Full data set from BINOL SAL hydrogenation screening of 
dehydropheylalanine derivative S1 
 
(R,R)-Bisoxazoline linked tethers
C D E F G I J K L M N O P
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2.5 Comparing supramolecular scaffolds with similar ligating groups (BINOL-SALs 
vs BIPHEP-SALs)   
     The chiral backbones of BINOL and BIPHEP are similar, but the question remains, 
how does a supramolecular catalyst with a particular scaffold and BINOL ligating groups 
compare to that with BIPHEP ligating groups on that same scaffold?
32
  More specifically, 
if a non-selective catalyst with a BIPHEP ligating group is compared to a SAL with 
BINOL ligating groups, will their results correlate?  Out of the 93 BINOL scaffolds 
screened with substrate S1, 39 could be directly compared under the same reaction 
conditions to the BIPHEP ligands screened in the previous study.  When the data was 
sorted according to the ascending enantioselectivity from the BIPHEP SALs, it was very 
surprising to find only modest correlation between the two series of catalysts given the 
similarity of the ligating groups appended to the identical scaffold (Figure 14).   
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Figure 14 Comparison of BIPHEP SALs vs BINOL SALs in the hydrogenation of S1 
(sorted by BIPHEP SALs) 
 
          Sorting by tether connectivity to the ligating group, a trend was discovered 
amongst the data (Figure 15).   The ArO,ArO-linked scaffolds (i.e., 
C-G
T, 
C-G
T) exhibited 
markedly lower enantioselectivity for BIPHEP-SALs (9-58% ee) than the BINOL-SALs 
(68-84% ee).  The ArCH2O,ArO scaffolds (
I-P
T,
C-G
T) occupied the mid-range of 
selectivity within each series: BIPHEP-SALs (35-79% ee); BINOL-SALs (70-90% ee).  
ArCH2O,ArCH2O-linked SALs (
I-P
T,
 I-P
T) were on average the most selective within each 
series: BIPHEP-SALs (76-82% ee); BINOL-SALs (83-92% ee).   
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Figure 15 Comparison of BIPHEP vs BINOL SALs with respect to benzyl vs phenyl 
connectivity to ligating group in the hydrogenation of S1 (sorted by BIPHEP) 
 
     The data might be consistent with a measure of catalyst scaffold flexibility.  With each 
ArCH2O-linked tethers (
I-P
T), the scaffold has an additional degree of rotational freedom 
relative to the corresponding ArO,ArO-linked scaffolds (
C-G
T,
 C-G
T).  The ArO,ArO-
linked scaffolds are perhaps too rigid which results in less effective catalysts.  As the 
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degree of flexibility is increased to the other extreme in this study, that is, 
ArCH2O,ArCH2O-linked scaffolds, the extent to which catalyst scaffold optimization 
impacts the level of enantioselectivity is generally minimal.  These data suggest that the 
delicate balance between flexibility and rigidity required for an effective catalyst.  Why 
this effect is observed more clearly with the BIPHEP-SALs than the BINOL-SALs is not 
understood at this point.   
 
2.6 Catalyst scaffold optimization study for enacetamide S2 
     When a similar screening of catalysts was carried out for the para-chloro 
eneacetamide S2, the results spanned a wide range of enantioselectivity, racemic to 96% 
ee (Figure 16).  The data are arranged from lowest to highest enantioselectivity and color-
coded by tether type (ArCH2O- and/or ArO-linked) in Figure 17.  Catalysts comprised of 
only ArO-linked tethers (
C-G
T) afforded a range of selectivity from racemic to 90% ee.  
The mixed ArCH2O,ArO-linked tethers (
I-P
T,
 C-G
T) gave the widest range of 
anantioselectivity, ranging from racemic to 96% ee.  The ArCH2O,ArCH2O-linked 
tethers (
I-P
T,
 I-P
T) afforded the highest average level of enantiomeric excess and relatively 
narrow range of enantioselectivity, 74% to 94% ee.   
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Figure 16 Hydrogenation of S2 with BINOL SAL Zn (
S
T
R
T) series 
 
     The full data on yields and enantioselectivity are summarized in Figure 17. The yield 
data also show wide variations among the catalysts.  In spite of the close similarities 
among the catalysts screened, yields range from no reaction to quantitative.  Since all 
reactions were run under a standard set of reaction conditions for a standard reaction 
time, low yields (i.e., low catalyst turnover numbers) may reflect catalyst decomposition 
and/or a slow catalyst (i.e., low catalyst turnover frequency).  In either case the result is 
of significance from the standpoint of catalyst scaffold optimization.   
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Figure 17 Full data set from BINOL SAL hydrogenation screening of S2 
 
          (BINOL)SAL Zn(IC) was identified as the best scaffold among the supramolecular 
catalysts screened giving 96% ee and quantitative conversion for substrate S2.  As a side 
note, (BINOL)SAL Zn(IC) also gave the highest selectivity for substrate S1 as well.  In 
order to further assess catalyst efficiency, the screening results were analyzed with 
respect by comparing to percent yield against the percent enantiomeric excess.  Figure 18 
shows the percent yield plotted on the x-axis, and the percent enantiomeric excess on the 
y-axis; the values closest to the origin are not reactive and not selective.  The ArO,ArO-
linked scaffolds are predominantly found in this region.  The upper-quadrant represents 
catalysts which are both highly reactive and highly enantioselective.  This region is 
occupied mostly by scaffolds possessing at least one ArCH2O-linked tether.   
 
(R,R)-Bisoxazoline linked tethers
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Figure 18 Plot of catalyst performance (% ee vs % yield) in the catalyzed asymmetric 
hydrogenation of S2 coded by tether combination 
 
     Note that some data points in Figure 18 overlap. Surface plots examining the heavily 
occupied high yield-high enantioselectivity quadrant of Figure 19 better displays the 
number of redundant catalyst results.  In a system where catalyst scaffold optimization is 
effective, small modifications to the tether structures are expected to affect catalyst 
performance.  At the time this study was carried out, little thought had been given to how 
best to make use of catalyst scaffold optimization. That is, although usage of the term 
catalyst scaffold optimization was introduced into the literature by Takacs, others whose 
research fit into its description had given little strategic thought as how to productively 
apply the concept or even systematically evaluate its application beyond making a series 
0
10
20
30
40
50
60
70
80
90
100
0 20 40 60 80 100
en
an
ti
o
m
er
ic
 e
x
ce
ss
 (
%
) 
yield (%) 
C-G I-P C-G + I-P
70 
 
of random changes to the scaffold. Based on the study described here, we suggest that if 
changing the tethers has little effect on catalyst effectiveness, then the catalyst may be too 
flexible and unlikely to be optimized by such a study.  In this context, Graph A highlights 
the hydrogenation results from scaffolds with ArCH2O,ArCH2O-linkages, while graph B 
corresponds to results from mixed scaffolds (i.e., ArCH2O,ArO-linkages) (Figure 19).  
These plots reveal that, in general, the extra methylene linkage makes catalysts (in this 
case) more effective but less amenable to favorable scaffold optimization; in short, 
scaffolds that are too flexible, in this case, behave similarly to having no connected 
catalyst scaffold (i.e., similar to catalysts using two monophosphite ligands).  Mixed 
ArCH2O,ArO-linked scaffolds, which may be intermediate in terms of scaffold 
flexibility, give catalysts which exhibit a very broad range of selectivity and reactivity.  
  
Figure 19 Surface plots highlighting relative abundance of hydrogenation catalysts with 
closely-related scaffolds that are selective and efficient.  A) Scaffolds with two ArCH2O 
tethers.  B) Scaffolds with mixed ArO linkage and ArCH2O linkage.   
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2.7 Examining the effect of small changes to the most efficient catalyst 
     (BINOL)SAL Zn(IC) was found to be the best catalyst scaffold in this study, giving 
the highest selectivity for both substrates with near quantitative conversion.  The catalyst 
scaffold contains both an ArO-linked and an ArCH2O-linked tether suggesting the need 
for a balance between flexibility and rigidity as discussed in previous sections.  In this 
section, we drill down through the data to analyze how small changes to this optimal 
scaffold affect reactivity and selectivity. Is this a sharply unique optimum where any 
subtle change seriously erodes performance, or is this the best among a broad array of 
similar structures that differ incrementally in their performance?  
     The results obtained for several small systematic changes in the structure are 
summarized in Figure 20. Overall, the structural changes mostly led to noticeable but 
only incremental, changes in performance. For example, when the results obtained for 
catalysts wherein the phosphite ligating group on the ArO-linked tether varies from the 
ortho- to meta- to para-position, that is, (BINOL)SAL Zn(IE) and (BINOL)SAL Zn(IG) 
respectively, the enantioselectivity decreases from 93% to 89% to 88% ee for S1 and 
from 96% to 91% to 88% ee for S2; all reactions proceed in high yield under the standard 
reaction conditions.  Modifying to the biaryl in the (R)-bisoxazoline subunit, that is, from 
the meta- to para-linked biaryls as in (BINOL)SAL Zn(ID), affords a catalyst giving 
lower enantioselectivity for S1 (86% ee) and both lower enantioselectivity (85% ee) and 
yield (76%) for substrate S2.  Replacing the ArO-linked phosphite by an ArCH2O-linked 
phosphite (i.e., (BINOL)SAL Zn (IK)) or moving the monoaryl ArCH2O-linkage from 
meta to para (i.e., (BINOL)SAL Zn(JC)) had surprisingly little impact on the catalyst 
efficiency, 90-94% ee and quantitative yield for both substrates. 
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Figure 20 Incremental effect of varying the structure of an empirically determined 
optimal catalyst scaffold 
 
     An interesting question arose at this point during this study.  Is the optimum scaffold 
identified in this study also optimal for other ligating groups?  The corresponding 
(BIPHEP)SAL Zn(IC) and (TADDOL)SAL Zn(IC) catalysts were prepared and 
evaluated in comparison to (BINOL)SAL Zn(IC) and the corresponding monophosphites 
(Figure 21).  Remarkably, the structurally similar (BIPHEP)SAL Zn(IC) was a poor 
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catalyst giving low reactivity and enantioselectivity.  Furthermore, (TADDOL)SAL 
Zn(IC) was ineffective as well.  Unlike (BINOL)SAL Zn(IC), both analogues were less 
efficient than their corresponding monophosphites.  With the exception of 
(BIPHEP)POPh, BINOL, BIPHEP, and TADDOL monophosphites all gave near 
quantitative conversion. This is not to say that another catalyst scaffold could be found 
for BIPHEP and TADDOL, we might argue that would indeed be the case. The scaffold 
and ligating group are not independent contributors to catalyst efficient; they are 
intimately coupled. 
  
 
Figure 21 Influence of the ligating group on the performance of SAL Scaffold Zn(IC) 
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2.8 Influence of the chiral recognition element (BINOL) SAL Zn 
     If identical achiral substituents are appended to (R)-box and (S)-box, the heterochiral 
Zn complex is meso (achiral) as a consequence of inversion symmetry.  However, when 
the two substituents attached to (R)-box and (S)-box differ and are not enantiomers, the 
heterochiral zinc complex lacks a center of inversion and is chiral.  For example, a large 
optical rotation was observed for the mixed cyano/benzyl complexes.
36
 
 
Figure 22 Complexation of  a chiral pseudo-racemic Zn complex.  Reproduced from Ref 
36 with permission from the Centre de la Recherche Scientifique (CNRS) and the Royal 
Society of Chemistry 
 
     A subtle stereochemical feature of the catalysts examined raised the question of how 
the chiral recognition subunit impacts catalyst performance, if at all. Of the 169 
supramolecular catalysts studied with S2, all with the same (BINOL)PO-ligating group, 
13 have two identical tethers ; the remaining 156 are comprised of non-identical tethers.  
Consider the two complexes (BINOL)SAL Zn (IC) and (BINOL)SAL Zn(CI) (Figure 
23).  These scaffolds differ only by the interchange of the two tether subunits appended to 
the zinc core.  Since the two different tethers have chiral ligating groups of matching 
handedness but differ in the configuration of the chiral recognition subunit, the two 
ligands (and the derived supramolecular catalyst) are diastereomers.  Diastereomeric 
catalysts are not required to have similar reactivity and selectivity, but since the 
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recognition subunit is located quite far from the site of catalysis, it was not expected that 
a large difference in catalyst performance would be observed.   Nonetheless, the two 
diastereomeric catalysts exhibit a marked difference in enantioselectivity from 96% ee to 
87% ee for S2.   
 
Figure 23 Diastereomeric catalysts have different performances 
     When comparing enantioselectivity achieved via selective diastereomeric reaction 
pathways, it is important to consider the logarithmic relationship between enantiomeric 
excess and the differences in activation energies leading to (S)- and (R)-products.  For 
example, comparing the ΔΔGǂ (R/S) values of 96% ee and 87% ee translates to a 
difference in enantioselectivity (Δes) of 0. 73 kcal/mol for the diastereomeric 
(BINOL)SAL Zn(IC) and (BINOL)SAL Zn(CI) catalysts.  It seems quite remarkable that 
the bisoxazoline Zn complex, positioned far from the catalytically active site, has such a 
significant influence.  Since it is believed that H2 association and oxidative addition are 
the enantiodetermining steps, it seems reasonable to presume that the catalyst scaffold 
folds in such a way that the box complex impedes the approach of H2 for one of the 
diastereomers creating a matched/mismatched is relationship between the chiral elements 
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(i.e., recognition subunit and ligating groups) within the catalyst. 
 
Figure 24 Theoretical relationship between enantioselectivity and ΔΔGǂ   
 
     Is difference in performance between the diastereomeric (BINOL)SAL Zn(IC) and 
(BINOL)SAL Zn(CI) catalysts typical or an exception?  In total, 78 pairs of 
diastereomeric catalysts were identified in the screening set and compared for catalytic 
efficiency.  The tethers were sorted by their composition of ArO-linked and ArCH2O-
linked tethers.  To simplify the data, the Δes values were plotted unsigned (i.e., their 
absolute values) against the observed difference in reactivity (as judged by the yield 
obtained under the standard reaction conditions) (Figure 25).  As expected, most catalysts 
were not strongly influenced from the presence of the chiral box moiety and exhibited 
minimal changes in reactivity and/or Δes; see the data points clustered about the origin in 
Figure 25.  Generally, catalyst pairs that exhibited a substantial difference in 
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enantioselectivity also exhibited a large difference in reactivity as well; see the upper and 
lower right regions of the plot.   
     The data in Figure 25 are color-coded by type of linkage to the two ligating groups. 
Scaffolds composed of two ArCH2O-linkages, the most flexible catalysts, were impacted 
the least from the chiral recognition element.  The most rigid scaffolds, that is, those with 
only ArO-linkages had a significant number of catalysts that exhibited large differences 
in yield under standard reaction conditions.  The differences might be attributed to 
differing turnover frequency (i.e., reaction rates) and/or turnover numbers and catalyst 
deactivation; the data collected cannot distinguish between the two possibilities.  The 
scaffolds with mixed linkages of one ArO-linked and one ArCH2O-linked phosphite 
exhibited the largest influence from the chiral recognition element.  This is perhaps not 
unexpected as these catalysts were the most receptive to the scaffold optimization.   
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Figure 25 Differences in yield and enantioselectivity between 78 pairs of diastereomeric 
catalysts in the CAH of S2 with (BINOL)SAL Zn(
S
T
R
T).  Yellow circle points represent 
scaffolds with only tethers C-G, the blue squares only I-P, and the green diamonds are for 
mixed combinations of C-G and I-P 
 
          A few specific examples of matched/mismatched catalytic performances are 
highlighted in Table 2 to illustrate the wide range of effects found.  Examples were found 
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for the scaffolds with mixed tethers C-G and I-P(entries 1-7) and those comprised of 
only ArCH2O tethers I-P (entries 8-9) and ArO tethers C-G (10-11).   As a representative 
of catalysts which had little difference between reactivity or selectivity with the 
diastereomeric catalysts, (BINOL)SAL Zn(OG) (entry 1) and its complimentary 
diastereomer were both quite effective in the Rh-CAH of S2.  (BINOL)SAL Zn(LC) 
(entry 3) and (BINOL)SAL Zn(CL) gave similar reactivity but a significant difference in 
selectivity.  Not all diastereomeric catalysts efficiency comparisons result in changes in 
both selectivity and reactivity.  (BINOL)SAL Zn(NG) (entry 4) and its diastereomeric 
scaffold (BINOL)SAL Zn(GN) both gave high selectivity, yet one diastereomer was less 
reactive.   There were some striking examples where one diastereomer was quite effective 
while the other was unreactive and non-selective (entries 5-7).  While most of the flexible 
doubly ArCH2O-linked scaffolds showed no influence by the chiral recognition subunit, 
several examples were identified where significant differences in selectivity and/or 
reactivity were observed (entries 8-9).  The more rigid scaffolds containing only ArO-
linkages were less selective and reactive as a whole, several examples that were 
moderately selective were identified where their diastereomeric partners gave less 
effective catalytic performances (entries 10-11).   
Table 2 Selected examples where diastereomeric catalysts exhibit matched/mismatched 
reactivity and/or selectivity in the CAH of S2.
a
   
Entry 
Zn 
(
S
T
R
T) % yield (% ee) 
Zn 
(
S
T
R
T) yield (% ee) Δes (kcal/mol) 
1 OG 99 (94) GO 99 (93) 0.09 
2 IC 99 (96) CI 99 (87) 0.73 
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3 LC 99 (94) CL 93 (86) 0.53 
4 NG 99 (90) GN 58 (90) 0 
5 LD 96 (92) DL 23 (0) 1.88 
6 FP 85 (90) PF nr   
7 JF 98 (92) FJ 10 (37) 1.42 
8 KL 94 (94) LK 99 (86) 0.58 
9 KM 87 (92) MK 99 (74) 0.55 
10 EG 99 (84) GE 28 (68) 0.46 
11 EC 94 (84) CE 85 (75) 0.29 
a
All examples gave predominantly the (S) enantiomer 
     To further illustrate the importance of the chiral recognition element, the bisoxazoline 
zinc complex was eliminated and replaced with a relatively unstructured straight chain 
alkyl linker.  This approach was effective for Reetz and co-workers when used for the 
screening of simple to prepare bidentate ligands for the Rh-CAH of a series of prochiral 
substrates.
43
  In their report, reactivity and selectivity was affected varying the chain 
length between the two ligating groups.  In our case, the bidentate ligands were prepared 
from 1,n-diols (Table 3).  While reactivity for the ligands was generally high, selectivity 
varied wildly for S1 and S2.  The 1,4-butane diol derived bisphosphite was slightly more 
selective in the CAH than the monodentate ligands L5 or L6 for S1, but nowhere near as 
selective as (BINOL)SAL Zn(IC); the tether structure is important. 
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Table 3 Alkyl chain linked phosphites in the Rh-CAH of S1 and S2 
 
    S1 S2 
Entry Bidentate ligand  ee (%) yield (%) ee (%) yield (%) 
1 L7 20 99 26 93 
2 L8 87 99 68 90 
3 L9 71 99 64 87 
4 L10 13 90 53 99 
 
2.9 Characterization of Rh[BINOL(SAL) Zn(IC)](nbd)]BF4 
     A question that often arises is whether these supramolecular catalysts are (in all cases) 
monomeric or perhaps di- or oligomeric in these reactions (Figure 26).  The “in all cases” 
variant is of course not possible to answer definitively.  The first approach we tried, 
attempts to grow a crystal of Rh[(BINOL)SAL Zn(IC)(nbd)]BF4 suitable for X-ray 
analysis, were unsuccessful.   
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Figure 26 Catalytic species possible in solution for (BINOL)SAL Zn(
S
T
R
T) 
 
     Another common technique used to characterize bidentate ligands is NMR.  By 
comparing literature values for P-Rh-P coupling constants, the catalyst structure can be 
inferred.  The flexible nature of these supramolecular catalysts increases the difficulty in 
obtaining reliable structural information via NMR.  Dr. Shin Moteki was able to 
characterize a related (TADDOL)SAL bound to rhodium(I) with a triflate counterion.
44
  
The data was consistent for cis-chelation of the bidentate ligant to rhodium.  Rhodium 
complexes with biaryl-type phosphorus based ligands often have more complicated 
spectra from a reversible dimerization process wherein η-arene coordinated dirhodium 
complexes may be formed.  These interactions have been well characterized in Rh-
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BINOL phosphinite
45
 and  Rh-BINAP complexes.
46
 η6-Arene coordinated rhodium 
complexes to the related diphenylphosphine ligands have also been observed in Rh-dppe 
complexes.
47
  When 2 equivalents of (BINOL)POBn or (BINOL)POPh were added to 1 
equivalent of Rh(nbd)2BF4 in CDCl3, 2 sets of doublets corresponding to the bidentate 
rhodium complex and the η-arene coordinated dirhodium complex (Figure 27).  The 
upfield doublet corresponds to the η-arene complex; addition of MeOH disrupts the pi-
complexation and results in only the downfield doublet remaining.  
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Figure 27 
31
P NMR study showing dynamic behavior of BINOL phosphite-Rh 
complexes.   
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     (BINOL)SAL Zn(IC) gives two singlets in the 
31
P for two chemically distinct 
phosphite ligands (Figure 28).  However, upon addition of Rh(nbd)2BF4, a broad peak 
was formed.  Lowering the temperature to slow dynamic behavior in the catalyst did not 
resolve the broad peak.  The addition of MeOH or substrates S1 or S2 did not help either.   
 
Figure 28 
31
P NMR of (BINOL)SAL Zn(IC) 
 
     High-resolution mass spectrometry is another common technique for obtaining 
structural information.  However, methods such as fast atom bombardment (FAB) or the 
more mild matrix-assisted laser desorption/ionization (MALDI) technique were 
unsuccessful in characterizing the (BINOL)SAL scaffold; a parent ion was not found.  It 
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is not uncommon to have difficulty in characterization of an effective catalyst.  Catalysts 
may owe their efficiency due to their relative instability of their chemical intermediates.  
Joost Reek and co-workers recently reported the stability of a catalytic intermediate in the 
Pd-catalyzed allylic alkylation reaction had an inverse relationship to reactivity of the 
catalyst.
48
  That is, ineffective catalysts were more easily characterized from their added 
stability, while effective catalysts were difficult to detect.   
     Yet another technique of structural characterization typically used for polymers is gel-
permeation chromatography (GPC).  This technique uses a size-exclusion matrix to 
differentiate different sizes (i.e., the hydrodynamic radius of the structure) of molecules 
in solution (Figure 29).  The differentiation occurs as smaller molecules penetrate the 
stationary porous phase which slows their elution time from the column.  Larger 
molecules not able to pass into and then through the stationary phase will elute more 
quickly since they have fewer interactions inside the column.  This technique is 
commonly applied to polymers where polystyrene standards of large molecular weights 
can be used to determine the relative size of a synthesized polymer.     
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Figure 29 In size exclusion chromatography, smaller molecules spend more time 
interacting with the porous column, while larger molecules are able to pass through more 
quickly.   
 
     It should be possible to get some structural information if the retention times vary as a 
function of structural changes in going subunit to SAL to supramolecular catalyst.  
Ligands before and after zinc and rhodium addition were injected on a GPC column (4.6 
mm Jordi Gel DVB (cross-lined divinylbenzene stationary phase) column, Pore size 100 
Å, CHCl3 as the eluent).  No significant change was observed upon addition of zinc to the 
tethers (Table 4, entries 1-3).  The lack of a change in retention time is likely a result of 
the structural change not being significant enough to have the retention time effected.  
However, upon addition of rhodium, the complex exhibited a longer retention time (Table 
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4, entry 4).  We interpret this change in the following way; as rhodium chelates to the 
bidentate ligand, the structure is made more compact explaining the longer retention time. 
Table 4 GPC studies on BINOL catalysts 
 
Entry ligand 
Retention 
Time (min) 
1 BINOL tether I 7.5 
2 BINOL tether C 7.4 
3 (BINOL)SAL Zn(IC) 7.4 
4 [(BINOL)SAL Zn(IC)Rh(nbd)]BF4 8.1 
Conditions:  4.6 mm Jordi Gel DVB column, Pore size 100 Å, flow rate = 0.7 mL/min, 
mobile phase (CHCl3) 
     Scaffolds which bear only one ligating group are monodentate ligands and must form 
a dimer upon addition of rhodium.  Thus, these catalysts serve as excellent controls for 
effectively doubling the size of (BINOL)SAL Zn(IC) catalyst.  Because the truncated 
ligands only have one large BINOL phosphite, they are smaller than the bidentate 
scaffold and thus have longer retention times than the free (BINOL)SAL Zn(IC) scaffold 
(Table 5, entries 1 and 3).  Upon addition of rhodium, both of the catalysts eluted with 
shorter retention times suggesting an increase in the size of the catalyst (Table 5, entries 2 
and 4).  Since the rhodium-chelated truncated ligands had shorter retention times than 
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[(BINOL)SAL Zn(IC)]Rh(nbd)BF4, this result gives some evidence the desired 1:1 
catalyst rhodium complex is forming 
Table 5 GPC data on truncated BINOL catalysts 
 
Entry ligand 
Retention 
Time (min) 
1 (BINOL)SAL-Zn(I-truncated) 8.4 
2 [(BINOL)SAL-Zn(I-truncated)]2Rh(nbd)BF4 7.6 
3 (BINOL)SAL-Zn(C-truncated) 8.2 
4 [(BINOL)SAL-Zn(C-truncated)]2Rh(nbd)BF4 6.5 
Conditions:  4.6 mm Jordi Gel DVB column, Pore size 100 Å, flow rate = 0.7 mL/min, 
mobile phase (CHCl3) 
     These truncated ligands can also be used as hydrogenation catalysts to compare their 
reactivity.  The (BINOL)SAL Zn(I-truncated) and (BINOL)POPh are both phenol linked 
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phosphites (Table 6, entries 1-2).  Their reactivity however is significantly different under 
identical reaction conditions which may be a result of the truncated ligand being too 
bulky for effective catalysis.  The phenol ligating group keeps the bulky substituent 
nearby.  (BINOL)SAL Zn(C-truncated) and (BINOL)POBn are ArCH2O-linked 
phosphites (Table 6, entries 3-4).  These two catalysts gave comparable performance to 
one another.  The bulkiness of the truncated ligand may not be a factor from the increased 
degree of freedom in the benzylic linkage to the phosphite.  Since neither of the truncated 
ligands outperformed the bidentate (BINOL)SAL Zn(IC), this further supports the 
catalytically active species to be the bidentate catalyst. 
Table 6 Truncated monophosphite ligands do not out perform s(BINOL)SAL Zn(IC) 
    S1 S2 
Entry ligand ee (%) yield (%) ee (%) yield (%) 
1 BINOL-POPh 69 99 86 99 
2 (BINOL)SAL-Zn(I-truncated) 30 2 65 13 
3 BINOL-POBn 82 99 92 99 
4 (BINOL)SAL-Zn(C-truncated) 85 99 92 99 
5
c
 (BINOL)SAL Zn(IC) 93 96 96 99 
 
Reaction conditons:  1 mol% Rh(nbd)2BF4, 2.1 mol% monophosphite, DCE, rt, 16 h.  
Yields and enantioselectivity determined by chiral GC using N-benzyl acetamide as an 
internal standard.  
b
Unless otherwise noted, the (S)-enantiomer predominates the reaction.  
c
1 mol% of bisphosphite was used. 
 
 
 
2.10 Conclusions and future directions 
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          Structure-activity studies are commonly undertaken to determine which structural 
elements are important factors in the success of a catalyst system.  Small molecule 
catalysts, while often effective, omit some of the key structural features of enzymes due 
to their limited chiral space.  Supramolecular catalyst systems are being pursued with the 
hope to organize the topography around a catalytic pocket and thus more closely mimic 
enzyme-like structures.  However, much less is known about strategies for optimizing the 
performance of supramolecular catalyst systems.  Understanding which factors are 
important in a supramolecular catalyst will be crucial to design effective enzyme-like 
catalysts.  Among the more surprising aspects of this study is that the remotely positioned 
chiral recognition element can have a significant influence the effectiveness of the 
catalyst system in a matched/mismatched relationship with the chiral ligating groups.   
     Thus far, these supramolecular systems have only explored the hydroboration of 
styrenes, hydrogenation of prochiral enamides (present study), and asymmetric allylic 
amination.  In unpublished work, some striking success has been realized in finding 
catalysts that can distinguish between closely related sites for reaction, that is, site 
selective catalysts. It is expected that future studies will be directed along these lines 
focusing on complex transformations involving substrates with multiple potential sites of 
reaction.  The post-synthetic modification of natural products is a vastly underdeveloped 
aspect of organic synthesis.  Enzyme-like supramolecular catalysts hold promise for such 
transformations and should complement other approaches. For example, Scott Miller has 
reported some small peptide catalysts capable of post-synthetic modifications via a 
variety of transformations on polyfunctionized natural products.
49-55
  However, while the 
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use of synthetic peptide catalysts requires their de novo synthesis and are limited to 
solvents that promote hydrogen-bonding to preserve catalyst structural integrity, the 
bisoxazoline-zinc chiral recognition element exploits combinatorial diversification. Their 
utility may in part reflect the fact that their facile self-assembly by chiral discrimination is 
reminiscent of a “click” reaction, one that occurs rapidly and in near-quantitative yields.56   
     As supramolecular catalysis is developed, it is intriguing to think of the possibilities of 
substituting zinc for a metal which may participate in redox chemistry.  Ruthenium 
catalysts have been exploited by McMillan and co-workers for their redox properties and 
their compatibility with organocatalysts.
57
    Not only would substitution of zinc for 
ruthenium add another catalytic metal, it would also change the geometry around the 
metal from tetrahedral to octahedral.  Bonnet, Collin, and Sauvage reported the stepwise 
synthesis of an octahedral ruthenium complex with three different substituents.
58
  
Conditions may be found that allow for three complimentary groups, each with a role in 
the catalysis, to organize around the ruthenium center giving way to a diverse new family 
of self-assembled supramolecular catalysts.   
 
2.11 Experimental 
Reactions were carried out in a dry atmosphere (N2).  Dichloromethane (DCM), 
tetrahydrofuran (THF), and methanol (MeOH) were freshly distilled under the following 
conditions:  DCM from calcium hydride, THF from sodium metal and benzophenone, 
and MeOH from Mg.   All synthesized compounds were purified with flash 
chromatography with the indicated solvents using EMD Silica Gel 60 Geduran ®.  Thin 
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layer chromatography analyses were performed on Analtech Silica Gel HLF (0.25 m) 
precoated analytical plates and visualized with use of handheld short wavelength UV 
light, vanillin stain (ethanol, H2SO4, and vanillin), and Ninhydrin stain (ethanol, acetic 
acid, and ninhydrin).  All reactions were performed in a chemical fume hood or in a 
glovebox with a  nitrogen environment.  NMR spectra were recorded on either a 400 
MHz or a 300 MHz Bruker Advance NMR spectrometer using CHCl3 ( 7.27 ppm), 
CDCl3 ( 77.0 ppm), or CH2Cl2 ( 5.30 ppm) for reference.  Gas chromatography 
analysis was performed with a CP-Chirasil-Dex CB column (I.D. = 0.25 mm) using a 
temperature program of 140-200 
o
C at 1 
o
C/min).  Peaks are expressed as m (unresolved 
multiplet), q (quartet), t (triplet), d (doublet), s (singlet), bs (broad singlet).  IR spectra 
were recorded using an Avatar 360  FT-IR.  Optical rotations were measured in solutions, 
1.0 g/100 mL CH3Cl unless indicated otherwise, and recorded using an Autopol III 
automatic polarimeter.  HRMS analyses were performed by the Nebraska Center for 
Mass Spectrometry.  All phenolic tethers were prepared using procedures described in the 
literature. 
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Screening  protocols and compilation of screening data for SAL hydrogenation 
studies 
Screening protocol procedures for SAL hydrogenation screening 
 
Supporting Information Figure 1:  Hydrogenation chambers used for the hydrogenation 
screenings; Chamber A is used for up to 24 small scale screenings, and Chamber B can 
be used for up to 72 small scale screenings  or can accommodate sixteen 20 mL vials for 
large scale vials for screening. 
 
Stock solutions BINOL tether ((S,S)-I) (3.0 mg, 4.0 μmol) in 2.3 mL CH2Cl2 and 
BINOL tether ((R,R)-C) (3.4 mg, 4.2 μmol) in 2.2 mL CH2Cl2 were prepared.  An aliquot 
of each of the tether stock solutions (0.10 mL, .18 mmol SAL) was transferred to a vial 
containing three glass beads (added to aid with stirring).  A stock solution of ZnEt2 (2.0 
μmol/mL in CH2Cl2) was prepared from ZnEt2 (1.0 M in hexanes).  Approximately 0.10 
mL (.20 μmol ZnEt2) of the freshly prepared ZnEt2 stock solution was added to the 
hydrogenation vials and the vials were stirred on an orbital shaker (ca 125 
Chamber A 
Chamber B 
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revolutions/min) over a 30 minute period.  The CH2Cl2 was removed under reduced 
pressure (ca 30 min) and the catalysts were redissolved in dichloroethane (0.20 mL).  A 
stock solution of Rh(nbd)2BF4 (3.0 mg, 8.0 μmol) in dichloroethane (4.4 mL) was 
prepared and an aliquot of the Rh(nbd)2BF4 stock solution (0.10 mL, .18 μmol Rh) was 
added to each vial.  The resulting metal-ligand complex was stirred on an orbital shaker 
shaker (ca 30 min at 125 revolutions/min.)  A stock solution of N-(1-(4-
chlorophenyl)vinyl)acetamide (3.6 x 10
1
 mg, 0.18 mmol) in dichloroethane (1.0 mL) was 
prepared and an aliquot (0.10 mL, 1.8 x 10
-2
 mmol) was added to each reaction vial.  The 
vials were loaded into the hydrogenation chamber.  The chamber was purged with H2 (5 
X 30 psi).  The chamber was charged with H2 (30 psi) and lightly shaken (ca 125 
revolutions/min) at ambient temperature for 16 h, at which point the hydrogen pressure 
was released.  A stock solution of an internal standard, N-benzyl acetamide, was prepared 
(82 mg in 3.0 mL ethyl acetate).  An aliquot (0.10 mL, 1.8 x 10
-2
 mmol) was added to 
each of the reaction vials.  The organics were filtered through a small plug of silica gel.  
Ethyl acetate (1 mL) was used to rinse the vial and silica plug.  An additional wash (ethyl 
acetate, 0.5 mL) was used to rinse the silica plug.  Combined organics were then analyzed 
via gas chromatography CP-Chirasil-Dex CB column (I.D. = 0.25 mm) using a 
temperature program of 140-200
o
C at 1 
o
C/min).   The (S)-enantiomer eluted at 22.2 min 
(97.9%) and the (R)-enantiomer at 23.2 min (2.1%); []D = -154 (c = 0.5, EtOH); 
1
H 
NMR (400 MHz, CDCl3)  7.33-7.25 (4H, m), 5.76 (1H, bs), 5.11 (1H, m), 2.00 (3H, s), 
1.48 (3H, d, J = 6.9 Hz); 
13
C NMR (100 MHz)  169.11, 141.79, 133.06, 128.77, 127.58, 
48.20, 23.41, 21.69  
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Compilation of p-Cl screening with self-assembling ligands (SALs) with p-Cl 
eneacetamide 
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Phenol-linked tethers are C-G. 
Benzyl-linked tethers are I-P. 
(R,R)-Bisoxazoline linked tethers
C D E F G I J K L M N O P
ee (%) 57 65 75 80 65 87 92 93 86 80 93 89 94
yield (%) 16 37 85 70 63 100 100 100 93 53 100 73 97
ee (%) 69 67 68 22 0 77 80 88 0 0 0 87 0
yield (%) 35 13 93 11 0 11 74 23 23 0 0 11 0
ee (%) 84 64 80 27 84 87 90 92 65 90 86 92 92
yield (%) 94 14 100 9 100 100 100 100 85 100 100 100 100
ee (%) 82 90 0 70 0 92 37 83 0 0 86 86 0
yield (%) 32 10 0 12 0 92 10 24 0 0 20 25 0 LEGEND
ee (%) 60 60 68 68 67 86 85 85 85 82 90 94 92
yield (%) 22 3 28 16 95 30 96 90 73 88 58 100 100 0-29
ee (%) 96 85 91 80 89 87 91 93 92 88 90 92 93 30-69
yield (%) 100 76 100 56 100 100 100 100 100 100 100 100 100 70-89
ee (%) 94 92 91 92 90 92 91 93 91 90 91 92 87 90-94
yield (%) 100 100 100 98 100 100 100 100 100 100 100 100 100 95-100
ee (%) 94 86 86 57 87 90 91 91 86 74 88 90 91
yield (%) 100 79 100 19 100 100 100 100 100 100 100 100 100
ee (%) 94 92 91 87 92 90 92 94 88 88 90 92 93
yield (%) 100 100 100 67 100 100 100 94 100 100 100 100 100
ee (%) 70 0 89 87 88 88 92 87 80 91 86 91 94
yield (%) 43 0 100 14 100 100 100 92 100 100 75 100 100
ee (%) 91 78 89 87 90 92 93 92 87 84 89 91 93
yield (%) 100 34 100 52 100 100 100 100 100 100 100 100 100
ee (%) 70 20 87 82 93 94 93 89 87 89 90 93 94
yield (%) 100 33 100 39 100 100 100 88 58 78 100 100 100
ee (%) 93 40 91 90 91 91 93 94 89 92 93 94 94
yield (%) 100 80 100 85 100 100 100 100 100 63 100 100 100
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Compilation of Diastereomeric data  
 
 
Legend 
Yellow = phenol tethers = C-G 
Blue = benzylic tethers = I-P 
Green = mixed benzyl-phenol tethers (C-G) + (I-P) 
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Diastereomeric SALs Set A Diastereomeric SALs Set B
(S,S) (R,R) %ee DDG
‡
(S,S) (R,R) %ee DDG
‡
D(DDG
‡
) Abs D(DDG‡) 
Entry Tether Tether product XS1 %R %S (kcal/mol) Yield (%) Tether Tether product XS1 %R %S (kcal/mol) Yield (%) Set A - Set B D es (kcal/mol) D (% Yield)
1 C D 65 17.5 82.5 -0.92 37 D C 69 15.5 84.5 -1.00 35 0.09 0.09 2
2 C E 75 12.5 87.5 -1.15 85 E C 84 8 92 -1.45 94 0.29 0.29 -9
3 C F 80 10 90 -1.30 70 F C 82 9 91 -1.37 32 0.07 0.07 38
4 C G 65 17.5 82.5 -0.92 63 G C 60 20 80 -0.82 22 -0.10 0.10 41
5 D E 68 16 84 -0.98 93 E D 64 18 82 -0.90 14 -0.08 0.08 79
6 D F 22 39 61 -0.26 11 F D 90 5 95 -1.74 10 1.48 1.48 1
7 D G 0 50 50 0.00 0 G D 60 20 80 -0.82 3 0.82 0.82 -3
8 E F 27 36.5 63.5 -0.33 9 F E 0 50 50 0.00 0 -0.33 0.33 9
9 E G 84 8 92 -1.45 100 G E 68 16 84 -0.98 28 -0.46 0.46 72
10 F G 0 50 50 0.00 0 G F 68 16 84 -0.98 16 0.98 0.98 -16
11 I J 91 4.5 95.5 -1.81 100 J I 92 4 96 -1.88 100 0.07 0.07 0
12 I K 93 3.5 96.5 -1.96 100 K I 90 5 95 -1.74 100 -0.22 0.22 0
13 I L 92 4 96 -1.88 100 L I 90 5 95 -1.74 100 -0.14 0.14 0
14 I M 88 6 94 -1.63 100 M I 88 6 94 -1.63 100 0.00 0.00 0
15 I N 90 5 95 -1.74 100 N I 92 4 96 -1.88 100 0.14 0.14 0
16 I O 92 4 96 -1.88 100 O I 94 3 97 -2.06 100 0.18 0.18 0
17 I P 93 3.5 96.5 -1.96 100 P I 91 4.5 95.5 -1.81 100 -0.16 0.16 0
18 J K 93 3.5 96.5 -1.96 100 K J 91 4.5 95.5 -1.81 100 -0.16 0.16 0
19 J L 91 4.5 95.5 -1.81 100 L J 92 4 96 -1.88 100 0.07 0.07 0
20 J M 90 5 95 -1.74 100 M J 92 4 96 -1.88 100 0.14 0.14 0
21 J N 91 4.5 95.5 -1.81 100 N J 93 3.5 96.5 -1.96 100 0.16 0.16 0
22 J O 92 4 96 -1.88 100 O J 93 3.5 96.5 -1.96 100 0.08 0.08 0
23 J P 87 6.5 93.5 -1.58 100 P J 93 3.5 96.5 -1.96 100 0.39 0.39 0
24 K L 86 7 93 -1.53 100 L K 94 3 97 -2.06 94 0.53 0.53 6
25 K M 74 13 87 -1.13 100 M K 87 6.5 93.5 -1.58 92 0.45 0.45 8
26 K N 88 6 94 -1.63 100 N K 92 4 96 -1.88 100 0.25 0.25 0
27 K O 90 5 95 -1.74 100 O K 89 5.5 94.5 -1.68 88 -0.06 0.06 12
28 K P 91 4.5 95.5 -1.81 100 P K 94 3 97 -2.06 100 0.25 0.25 0
29 L M 88 6 94 -1.63 100 M L 80 10 90 -1.30 100 -0.33 0.33 0
30 L N 90 5 95 -1.74 100 N L 87 6.5 93.5 -1.58 100 -0.16 0.16 0
31 L O 92 4 96 -1.88 100 O L 87 6.5 93.5 -1.58 58 -0.30 0.30 42
32 L P 93 3.5 96.5 -1.96 100 P L 89 5.5 94.5 -1.68 100 -0.28 0.28 0
33 M N 86 7 93 -1.53 75 N M 84 8 92 -1.45 100 -0.09 0.09 -25
34 M O 91 4.5 95.5 -1.81 100 O M 89 5.5 94.5 -1.68 78 -0.13 0.13 22
35 M P 94 3 97 -2.06 100 P M 92 4 96 -1.88 63 -0.18 0.18 37
36 N O 91 4.5 95.5 -1.81 100 O N 90 5 95 -1.74 100 -0.07 0.07 0
37 N P 93 3.5 96.5 -1.96 100 P N 93 3.5 96.5 -1.96 100 0.00 0.00 0
38 O P 94 3 97 -2.06 100 P O 94 3 97 -2.06 100 0.00 0.00 0
39 I C 96 2 98 -2.31 100 C I 87 6.5 93.5 -1.58 100 -0.73 0.73 0
40 I D 85 7.5 92.5 -1.49 76 D I 77 11.5 88.5 -1.21 11 -0.28 0.28 65
41 I E 91 4.5 95.5 -1.81 100 E I 87 6.5 93.5 -1.58 100 -0.23 0.23 0
42 I F 80 10 90 -1.30 56 F I 92 4 96 -1.88 92 0.58 0.58 -36
43 I G 89 5.5 94.5 -1.68 100 G I 86 7 93 -1.53 30 -0.15 0.15 70
44 J C 94 3 97 -2.06 100 C J 92 4 96 -1.88 100 -0.18 0.18 0
45 J D 92 4 96 -1.88 100 D J 80 10 90 -1.30 74 -0.58 0.58 26
46 J E 91 4.5 95.5 -1.81 100 E J 90 5 95 -1.74 100 -0.07 0.07 0
47 J F 92 4 96 -1.88 98 F J 37 31.5 68.5 -0.46 10 -1.42 1.42 88
48 J G 90 5 95 -1.74 100 G J 85 7.5 92.5 -1.49 96 -0.26 0.26 4
49 C K 93 3.5 96.5 -1.96 100 K C 94 3 97 -2.06 100 0.09 0.09 0
50 C L 86 7 93 -1.53 93 L C 94 3 97 -2.06 100 0.53 0.53 -7
51 C M 80 10 90 -1.30 53 M C 70 15 85 -1.03 43 -0.27 0.27 10
52 C N 93 3.5 96.5 -1.96 100 N C 91 4.5 95.5 -1.81 100 -0.16 0.16 0
53 C O 89 5.5 94.5 -1.68 73 O C 70 15 85 -1.03 100 -0.66 0.66 -27
54 C P 94 3 97 -2.06 97 P C 93 3.5 96.5 -1.96 100 -0.09 0.09 -3
55 K D 86 7 93 -1.53 79 D K 88 6 94 -1.63 23 0.10 0.10 56
56 K E 86 7 93 -1.53 100 E K 92 4 96 -1.88 100 0.35 0.35 0
57 K F 57 21.5 78.5 -0.77 19 F K 83 8.5 91.5 -1.41 24 0.64 0.64 -5
58 K G 87 6.5 93.5 -1.58 100 G K 85 7.5 92.5 -1.49 90 -0.09 0.09 10
59 D L 0 50 50 0.00 23 L D 92 4 96 -1.88 100 1.88 1.88 -77
60 D M 0 50 50 0.00 0 M D 0 50 50 0.00 0 0.00 0.00 0
61 D N 0 50 50 0.00 0 N D 78 11 89 -1.24 34 1.24 1.24 -34
62 D O 87 6.5 93.5 -1.58 11 O D 20 40 60 -0.24 33 -1.34 1.34 -22
63 D P 0 50 50 0.00 0 P D 40 30 70 -0.50 80 0.50 0.50 -80
64 L E 91 4.5 95.5 -1.81 100 E L 65 17.5 82.5 -0.92 85 -0.89 0.89 15
65 L F 87 6.5 93.5 -1.58 67 F L 0 50 50 0.00 0 -1.58 1.58 67
66 L G 92 4 96 -1.88 100 G L 85 7.5 92.5 -1.49 73 -0.39 0.39 27
67 E M 90 5 95 -1.74 100 M E 89 5.5 94.5 -1.68 100 -0.06 0.06 0
68 E N 86 7 93 -1.53 100 N E 89 5.5 94.5 -1.68 100 0.15 0.15 0
69 E O 92 4 96 -1.88 100 O E 87 6.5 93.5 -1.58 100 -0.30 0.30 0
70 E P 92 4 96 -1.88 100 P E 91 4.5 95.5 -1.81 100 -0.07 0.07 0
71 M F 87 6.5 93.5 -1.58 14 F M 0 50 50 0.00 0 -1.58 1.58 14
72 M G 88 6 94 -1.63 100 G M 82 9 91 -1.37 88 -0.26 0.26 12
73 F N 86 7 93 -1.53 20 N F 87 6.5 93.5 -1.58 52 0.05 0.05 -32
74 F O 86 7 93 -1.53 25 O F 82 9 91 -1.37 39 -0.16 0.16 -14
75 F P 0 50 50 0.00 0 P F 90 5 95 -1.74 85 1.74 1.74 -85
76 N G 90 5 95 -1.74 100 G N 90 5 95 -1.74 58 0.00 0.00 42
77 G O 94 3 97 -2.06 100 O G 93 3.5 96.5 -1.96 100 -0.09 0.09 0
78 G P 92 4 96 -1.88 100 P G 91 4.5 95.5 -1.81 100 -0.07 0.07 0
100 
 
 
 
 
 
Screening protocol procedures scale-up reaction 
The following procedure is typical. To a solution of BINOL tether ((S,S)-I) (3.7 mg, 5.1 
μmol) and BINOL tether ((R,R)-C) (3.8 mg, 5.1 μmol) in dicloromethane (DCM, 1.0 mL) 
was added a solution of diethyl zinc (0.10 mL, 5.6 μmol) dropwise and 3 2 mm glass 
beads.  The resulting mixture was stirred on an orbital shaker (ca 125 revolutions/min) 
for 30 minutes and then concentrated in vacuo to afford (BINOL)SAL Zn(IC) which was 
diluted with dichloroethane (DCE, 2.0 mL) and used without further purification.  A 
solution of Rh(nbd)2BF4 (1.9 mg, 5.1 μmol) in DCM (0.20 mL) was added dropwise and 
(R,R)-Bisoxazoline linked tethers
C D E F G I J K L M N O P
ee (%) 73 68 80 84 72 89 86 88 83 80 77
yield (%) 2 6 8 11 2 100 21 24 7 5 4
ee (%) 74 86 75 0 82 88 86 86 87
yield (%) 9 36 5 0 48 17 3 2 3
ee (%) 89 84 92 92 85 90 89
yield (%) 38 5 96 73 95 100 100
ee (%) 85 85 86 84 88 LEGEND
yield (%) 13 4 11 7 6
ee (%) 0 93 80 0-29
yield (%) 0 18 30 30-69
ee (%) 93 86 89 88 88 87 89 90 87 89 87 89 88 70-89
yield (%) 96 100 100 100 100 100 100 100 100 80 100 100 93 90-94
ee (%) 91 87 91 88 89 90 91 88 91 89 91 89 95-100
yield (%) 100 85 100 70 100 100 100 100 100 100 100 100
ee (%) 90 88 83 91 91 87 80 87 88 86
yield (%) 95 100 7 100 100 90 16 100 100 100
ee (%) 89 88 90 89 88 88 91 86
yield (%) 92 54 100 100 27 100 100 100
ee (%) 70 91 86 86 88 84
yield (%) 5 100 100 89 100 20
ee (%) 90 84 86 84
yield (%) 7 16 7 30
ee (%) 92 83
yield (%) 10 36
ee (%) 83
yield (%) 50
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the resulting mixture was stirred for 30 minutes at ambient temperature under N2.  A 
solution of N-(1-(4-chlorophenyl)vinyl)acetamide (1.0 x 10
2
 mg, 5.1 x 10
2
 mmol) in DCE 
was then added and the vial was placed into a hydrogenated chamber.  The chamber was 
purged with hydrogen gas (5 x 20 psi) and then pressurized to 30 psi H2 and lightly 
shaken (ca 125 revolutions/minute) at ambient temperature for 16 hours.  The hydrogen 
pressure was released, and the crude reaction mixture was concentrated and purified by 
flash chromatography on silica gel using EtOAc/Hexanes (1:5) as the eluent yielding (S)-
N-(1-(4-chlorophenyl)ethyl)acetamide (98% yield) as a white solid: gas chromatography 
on a CP-Chirasil-Dex CB column (I.D. = 0.25 mm) using a temperature program of 140-
200
o
C at 1
o
C/min) show 95% ee; []D = -152 (c = 0.5, EtOH)[The configurations were 
assigned from comparing optical rotations with the reported values]; 
1
H NMR (400 MHz, 
CDCl3)  7.33-7.25 (4H, m), 5.76 (1H, bs), 5.11 (1H, m), 2.00 (3H, s), 1.48 (3H, d, J = 
6.92 Hz); 
13
C NMR (100 MHz)  169.11, 141.79, 133.06, 128.77, 127.58, 48.20, 23.41, 
21.69. 
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Synthesis of key compounds 
Synthetic route for S2-BINOL 
 
Preparation of IX 
 
 
To 1,3-benzene dimethanol (10.0 g, 72.4 mmol) and imidazole (19.7 g, 289 mmol) was 
added DMF (150 mL) under N2.  The reaction mixture was stirred (15 minutes) at room 
temperature then cooled (0
o
C) and TBDPS-Cl (21.4 mL, 72.4 mmol) was added dropwise 
over 5 minutes.  The reaction mixture was allowed to warm to room temperature 
overnight.  NaHCO3 (satd.) was added (100 mL) and the mixture was extracted with 
diethyl ether (3 x 100 mL).  The organic extracts were combined, dried with magnesium 
sulfate, filtered, and concentrated.  Flash chromatography on silica gel (25:75 ethyl 
acetate:hexanes) affords IX (19.7 g, 72.3 %) as a white solid.  TLC: Rf 0.30 (25:75 ethyl 
acetate:hexanes);  
1
H NMR (400 MHz, d-CHCl3)  7.81-7.78 (4H, m), 7.53-7.32 (10H, 
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m), 4.87 (1H, s), 4.71 (1H, s), 2.10 (1H, s), 1.20 (9H, s); 
13
C NMR (100 MHz, d-CHCl3) 
 141.44, 140.88, 135.68, 133.52, 129.82, 128.58, 127.83, 125.64, 125.41, 124.70, 65.52, 
65.38, 26.95, 19.41 IR (neat) 3330, 3064, 2856, 1600-1500, 1107 cm
-1
; HRMS (ESI):  
Calcd. For C24H28O2Si (M+Na)
+
: 399.1756, found 399.1769 m/z. 
 
Preparation of X 
 
IX (10.0 g, 26.7 mmol) and PPh3 (6.98g, 26.7 mmol) was dissolved in THF (150 mL) , 
stirred (15 minutes), then cooled (0
o
C).  A solution of CBr4 (8.81 g, 26.7 mmol) in THF 
(15 mL) was added dropwise.  The reaction mixture was allowed to warm to room 
temperature overnight (16 h).  The precipitate was removed by filtration through celite, 
washed with THF (2 x 50 mL), and the combined organic washes were concentrated.  
Flash chromatography on silica gel (5:95 ethyl acetate:hexanes) affords X (8.90 g, 76%) 
as a colorless oil.  TLC: Rf 0.70 (5:95 ethyl acetate:hexanes); 
1
H NMR (400 MHz, d-
CHCl3)  7.87-7.85 (4H, m), 7.58-7.38 (10H, m), 4.92 (2H, s), 4.60 (2H, s), 1.27 (9H, s); 
13
C NMR (100 MHz, d-CHCl3)  141.88, 137.80, 135.73, 133.48, 129.93, 128.86, 
127.94, 127.71, 126.820, 126.23, 65.35, 33.85, 27.04, 19.49; IR (neat) 2958, 2852, 1103, 
1070 cm
-1
; HRMS (ESI):  Calcd. For C24H27OSiBr (M+H): 461.0912, found 461.0912 
m/z. 
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Preparation of (S,S)-XI 
 
To a cooled solution (-78
o
C) of (S,S)-bisoxazoline [(S)-BOX] (5.0 g, 16.3 mmol) in THF 
(150 mL),  NaHMDS (1M in THF, 17.1 mL) was added dropwise over the course of 1 h, 
and stirred at -78
o
C for 2 hours.  A solution of X (7.17g, 16.3 mmol) in THF (15 mL) was 
added dropwise to the reaction mixture and slowly allowed to warm to room temperature 
overnight.  The reaction was quenched with the addition of NH4Cl (satd) and extracted 
with CH2Cl2 (3 x 100 mL).  The combined organic extracts were dried with MgSO4, 
filtered, and concentrated.  Flash chromatography on silica gel (33:33:33 ethyl acetate: 
hexanes: CH2Cl2) afforded (S,S)-XI (6.94 g, 64%) as a light yellow oil.  TLC: Rf 0.85 
(6:94 methanol:dichloromethane); Optical rotation: []D
20
 = -17.1
o
 (c 0.5, CH3Cl); 
1
H 
NMR (400 MHz, d-CHCl3)  7.80-7.78 (4H, m), 7.52-7.27 (18H, m), 7.05-7.03 (2H, m), 
5.28 (2H, t, J = 8.52 Hz), 4.85 (2H, s), 4.72 and 4.71 (2H, overlapping t, J = 8.12, 8.12 
Hz), 4.24-4.21 (1H, m), 4.20-4.11 (2H, m), 3.60-3.48 (2H, m), 1.21 (9H, s) ppm; 
13
C 
NMR (100 MHz, d-CHCl3)  165.55, 165.52, 142.18, 142.13, 141.47, 137.99, 135.66, 
135.55, 129.81, 128.80, 128.76, 128.70, 128.66, 127.84, 127.78, 127.65, 127.55, 126.87, 
126.74, 126.70, 126.52, 124.52, 41.51, 36.02, 26.99, 19.43 ppm.; IR (neat) 2951, 2849, 
1653, 1108, 1067 cm
-1
; HRMS (ESI):  Calcd. For C43H44N2O3Si (M+Na): 665.3199, 
found 665.3208 m/z. 
Preparation of (S,S)-XII 
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To a solution of (S,S)-XI (6.90 g, 10.4 mmol) in THF (100 mL) was added dropwise 
TBAF (1.0M in THF, 10.4 mL).  The solution was stirred at room temperature for 16 h.  
Water (35 mL) was added and the mixture was extracted with CH2Cl2 (3 x 60 mL).  The 
combined organic extracts were dried (MgSO4), filtered, and concentrated.  Flash 
chromatography on silica gel (7:93 methanol:CH2Cl2) affords (S,S)-XII (3.91 g, 88%) as 
a sticky white foam.  TLC: Rf 0.4 (6:94 methanol:dichloromethane); Optical rotation: 
[]D
20
 = -21.6
o
 (c 0.5, CH3Cl); 
1
H NMR (400 MHz, d-CHCl3)  7.35-7.21 (10H, m), 
7.23-7.21 (2H, m), 7.01-6.99 (2H, m), 5.21 and 5.19 (2H, overlapping t, J =8.40, 7.92 
Hz), 4.71-4.63 (4H, m), 4.18 (1H, t, J = 8.24 Hz), 4.11-4.04 (2H, m), 3.48-3.39 (2H, m); 
13
C NMR (100 MHz, d-CHCl3)  165.52, 165.50, 141.93, 141.87, 139.71, 137.09, 
129.25, 128.71, 128.63, 127.65, 127.58, 127.23, 126.69, 126.68, 75.43, 75.23, 69.49, 
64.80, 41.41, 35.53; IR (neat) 3243, 1658, 1555-1148, 1019 cm
-1
; HRMS (ESI):  Calcd. 
For C27H26N2O3 (M+H): 449.1841, found 449.1833 m/z. 
 
Preparation of BINOL tether (S,S)-5I and BINOL tether (R,R)-5C 
 
PCl3 (3.66 mL, 41.9 mmol) was added dropwise to (R)-BINOL (500 mg, 1.75 mmol) at 
room temperature, followed by the dropwise addition of a catalytic amount of N-methyl 
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pyrrolidine (4 drops).  The reaction mixture was heated to 74
o
C for 1.0 h.  (Careful 
monitoring of the temperature was done to ensure no racemization).  The crude reaction 
mixture was concentrated.  Toluene was added (3x20 mL) and subsequently removed 
under reduced pressure to remove excess PCl3 affording BINOL-PCl without further 
purification.  The freshly prepared BINOL-PCl was dissolved in THF(10 mL) and added 
to a solution of (S,S)-XII (596 mg, 1.40 mmol), catalytic DMAP (8.53 mg, 6.99 x 10-2 
mmol), and TEA (2.42 mL, 17.5 mmol) in THF (15 mL).  The reaction mixture was 
stirred overnight at room temperature.  The crude mixture was filtered through celite, and 
the precipitate was washed with THF (3 x 5 mL).  The filtrate was concentrated, and flash 
chromatography on silica gel (33:33:33 ethyl acetate: dichloromethane: hexanes) affords 
(S,S)-5I (758 mg, 73%) as a white foam.  Optical rotation: []D
20
 = -164
o
 (c 0.5, CH3Cl); 
1
H NMR (400 MHz, d-CHCl3)  7.91-7.81 (4H, m), 7.44-7.08 (20 H, m), 6.90-6.88  (2H, 
m), 5.12 and 5.10 (2H, overlapping t, J = 10.1 Hz and 9.92  Hz), 4.87 and 4.62 (2H, ddd, 
J1 = 7.72, 12.32 Hz, J2 = 7.92, 12.32 Hz), 4.59-4.54 (2H, m), 4.06 (1H, t, J = 8.16 Hz), 
3.99-3.91 (2H, m), 3.36 and 3.30 (2H, ddd, J1 = 7.80, 13.9 Hz, J2 = 8.56, 13.89 Hz); 
13
C 
NMR (100 MHz, d-CHCl3)  165.34 (JC,P = 8.44 Hz), 153.91, 148.82, 147.45,  141.98 
(JC,P = 5.82 Hz), 138.23, 137.83, 133.34, 132.91, 132.83, 131.82, 131.63, 131.32, 
130.46, 130.18, 128.81, 128. 73, 128.68, 128.63, 128.39, 128.26, 127.57, 127.51, 127.01, 
126.66, 126.62, 126.29, 125.93, 125.09, 124.93,122.78,  121.88, 121.56, 117.90,  75.36, 
75.14, 69.60, 69.58, 66.82, 62.34, 41.41, 35.78; 
31
P NMR (162 MHz, d-CHCl3)  139.0 
ppm ; IR (neat) 3040, 1653, 1589-1328, 1021, 939 cm
-1
; HRMS (ESI):  Calcd. For 
C47H37N2O5P (M+H): 741.2513, found 741.2540 m/z. 
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(R,R)-5C was prepared in the same manner starting with (R,R)-XIII (702 mg, 1.40 
mmol) affording (R,R)-5C (879 mg, 78%) as a white foam.  Optical rotation: []D
20
 = -
78
o
 (c 0.5, CH3Cl); 
1
H NMR 7.95-7.49 (4H, m),  7.47-7.02 (26 H, m), 5.19 and 5.17 
(2H, overlapping t, J = 10.5, 10.4 Hz), 4.67-4.58 (2H, m), 4.14-4.04 (3H, m), 3.52-3.49 
(2H, m); 13C NMR (100 MHz, d-CHCl3)  165.52 (JC,P = 11.04 Hz), 152.94, 148.77, 
148.66, 147.72, 147.66, 147.00, 142.00, 138.03, 137.86, 133.90, 133.85, 133.62, 132.80, 
132.46, 131.62, 131.37, 131.19, 130.99, 130.54, 130.41, 130.12, 129.87, 129.35, 128.64, 
128.54, 128.41, 128.37, 128.34, 128.13, 127.53, 127.49, 127.25, 127.06, 126.93, 126.68, 
126.65, 126.56, 126.47, 126.32, 126.11, 124.93, 124.70, 124.42, 123.82, 122.64, 121.78, 
121.68, 121.13, 120.99, 118.14, 74.26 (JC,P = 17.9 Hz), 69.57, 41.33, 35.89; 31P NMR 
(162 MHz, d-CHCl3)  144.8 ppm; IR (neat) 3028, 1646, 1585-1348, 1197, 956 cm
-1
; 
HRMS (ESI):  Calcd. For C52H39N2O5 (M+H): 803.2675, found 803.2709 m/z. 
 
 
 
 
 
 
Characterization of (BINOL)SAL Zn(IC) 
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Optical rotation: []D
20
 = -92
°
 (c 0.5, CH3Cl); 
1
H NMR  8.00-7.89 (9H, m), 7.56-6.96 
(47 H, m), 5.10-5.05 (1H, m), 4.87-4.82 (1H, m), 4.05-3.96 (4H, m), 3.83-3.78 (6H, m), 
3.67 (2H, s), 3.32-3.24 (4H, m); 13C NMR (100 MHz, d-CHCl3)  169.85, 169.69, 
152.91, 148.83, 147.90, 147.23, 145.33, 144.14, 137.14, 130.43, 130.08, 129.92, 128.40, 
128.83, 127.94, 127.55, 127.18, 127.06, 126.92, 126.29, 126.21, 124.89, 121.97, 121.91, 
121.72, 118.91, 72.92, 65.39; 
31
P NMR (162 MHz, d-CHCl3)  147.5 and 144.0 ppm; IR 
(neat) 3028, 2933, 1646, 1197 cm
-1
; HRMS (ESI):  Calcd. For C99H74N4O10P2Zn (M+H): 
1605.4250, found 1605.4299 m/z. 
 
BINOL-OPh (L5) 
 
TLC: Rf = 0.80 (10:90 EtOAc:hexanes); melting point: 95-100 °C (decomposition); 
Optical rotation: []D
20
 = -142.4
°
 (c 0.5, CH3Cl); 
1
H NMR  8.02- -
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7.23 (12H, m); 
13
C NMR (100 MHz, d-CHCl3)  151.18, 147.22, 147.10, 132.78, 132.47, 
131.76, 131.31, 130.61, 129.97, 129.89, 128.46, 128.40, 126.79, 126.69, 126.46, 126.36,  
125.32, 125.16, 124.48, 121.64, 120.41, 120.31; 
31
P NMR (162 MHz, d-CHCl3)  145.1; 
IR (neat) 2909, 2894, 1388-1201, 1069 cm
-1
.  
 
BINOL-POBn (L6) 
 
TLC: Rf = 0.75 (8:92 EtOAc:hexanes); melting point: 125-130 °C (decomposition); 
Optical rotation: []D
20
 = -440
°
 (c 0.5, CH3Cl); 
1
H NMR  8.08-7.96 (4H, m), 7.61-7.284 
(12 H, m), 5.04 and 4.82 (2H, dd, J1 = 12.19 Hz, 8.01 Hz, J2 = 12.19 Hz, 8.31 Hz); 
13
C 
NMR (100 MHz, d-CHCl3)  148.7, 148.6, 147.5, 137.4, 137.3, 132.8, 132.5, 131.6, 
131.1, 130.5, 130.2, 128.5, 128.4, 128.4, 128.1, 127.6, 126.7, 126.3, 126.3, 125.1, 125.0, 
124.0, 124.0, 122.6, 121.8, 121.8, 121.5, 64.7, 66.7; 
31
P NMR (162 MHz, d-CHCl3)  
140.8 ppm; IR (neat) 3044, 1589-1319, 939 cm
-1
. 
 
Preparation of BINOL(n-alkyl series) L4a–L4d  
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PCl3 (3.66 mL, 41.9 mmol) was added dropwise to (R)-BINOL (500 mg, 1.75 mmol) at 
room temperature followed by the dropwise addition of a catalytic amount of N-methyl 
pyrrolidine (4 drops).  The reaction mixture was heated to 74
o
C for 1.0 h.  (Careful 
monitoring of the temperature was done to ensure no racemization).  The crude reaction 
mixture was concentrated.  Toluene was added (3x20 mL) and subsequently removed 
under reduced pressure to remove excess PCl3 affording BINOL-PCl without further 
purification.  1,3-propanediol (86.4 mg, , 1.14 mmol) in THF (15 mL) was added TEA 
(0.728 mL, 3.41 mmol).  The solution was stirred for 15 minutes and the freshly prepared 
BINOL-PCl was dissolved in THF (10 mL) and added slowly to the reaction flask at 
room temperature.  The reaction mixture was stirred overnight at room temperature.  The 
crude mixture was filtered through celite, and the precipitate was washed with THF (3 x 5 
mL).  The filtrate was concentrated under reduced pressure.  Flash chromatography on 
silica gel (5:95 ethyl acetate : hexanes) affords alkyl n3BINOL ligand L7 (419 mg, 
52.4%) as a white foam.  Melting point: 92-95
°
C (decomposition); Optical rotation: 
[]D
20
 = -4.6
o
 (c 0.5, CH3Cl); 
1
H NMR (400 MHz, d-CHCl3)  8.01-7.88 (8H, m), 7.53-
7.27 (16H, m), 4.06 and 3.90 (4H, m), 1.85 (2H, m) ppm; 
13
C NMR (100 MHz, d-CHCl3) 
 148.76 (JC,P = 5.08 Hz), 147.52, 132.85, 132.61, 131.55, 131.02, 130.43, 130.12, 
128.39, 128.35, 127.03, 126.29, 126.24, 125.07, 124.90, 122.61, 121.87, 121.56, 61.18 
(JC,P = 6.07), 32.21 ppm; 
31
P NMR (162 MHz, d-CHCl3)  140.42 ppm; IR (neat) 3049, 
1589-1319, 927 cm
-1
; HRMS (ESI):  Calcd. For C43H30O6P2(M+H): 705.1596, found 
705.1609 m/z. 
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 n4-alkyl BINOL L8 was prepared according to the general procedure starting with 1,4-
butane diol (102 mg, 1.14 mmol) affording the product (489 mg, 59.9%) as a white foam.  
Melting point: 95-98
°
C (decomposition); Optical rotation: []D
20
 = -4.0
o
 (c 0.5, CH3Cl); 
1
H NMR (400 MHz, d-CHCl3)  8.03-7.92 (8H, m), 7.57-7.28 (16H, m), 4.01 and 3.81 
(4H, m), 1.70 (4H, m) ppm; 
13
C NMR (100 MHz, d-CHCl3)  148.75 (JC,P = 5.1 Hz), 
147.59, 132.87, 132.66, 131.57, 131.03, 130.45, 130.07, 128.41, 128.36, 127.03, 126.30, 
126.27, 125.08, 124.92, 124.15, 124.10, 122.73, 122.71, 121.90, 121.59, 64.63 (JC,P = 
6.07), 27.30 ppm; 
31
P NMR (162 MHz, d-CHCl3)  141.06 ppm; IR (neat) 3050, 1592-
1322, 940 cm
-1
; HRMS (ESI):  Calcd. For C44H32O6P2(M+H): 719.1752, found 719.1772 
m/z. 
 
 n5-alkyl BINOL L9 was prepared according to the general procedure starting with 1,5-
pentane diol (118 mg, 1.14 mmol) affording the product (502 mg, 60.31%) as a white 
foam.  Melting point: 102-109
°
C (decomposition); Optical rotation: []D
20
 = -3.4
o
 (c 0.5, 
CH3Cl); 
1
H NMR (400 MHz, d-CHCl3)  8.01-7.89 (8H, m), 7.54-7.26 (16H, m), 3.96 
and 3.77 (4H, m), 1.63-1.54 (4H, m), 1.46-1.40 (2H, m) ppm; 
13
C NMR (100 MHz, d-
CHCl3)  148.7 (JC,P = 5.1 Hz), 132.8, 132.6, 131.5, 131. 0, 130.4, 130.0, 128.4, 128.3, 
127.0, 126.3, 126.2, 125.0, 124.9, 124.1, 122.7, 121.9, 121.6, 65.0 (JC,P = 6.13), 30.5 (JC,P 
= 4.1 Hz), 21.9 ppm; 
31
P NMR (162 MHz, d-CHCl3) 141.4; IR (neat) 3043, 1585-1319, 
944 cm
-1
; HRMS (ESI):  Calcd. For C45H34O6P2(M+H): 733.1909, found 733.1909 m/z. 
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n6-alkyl BINOL L10 was prepared according to the general procedure starting with 1,6-
hexane diol (134 mg, 1.14 mmol) affording the product (528 mg, 62.3%) as a white foam.  
Melting point: 104-110
°
C (decomposition); Optical rotation: []D
20
 = -2.6
o
 (c 0.5, 
CH3Cl); 
1
H NMR (400 MHz, d-CHCl3)  8.01-7.90 (8H, m), 7.55-7.26 (16H, m), 3.95 
and 3.77 (4H, m), 1.65 (4H, m), 1.32 (4H, m); 
13
C NMR (100 MHz, d-CHCl3)  148.92, 
147.61 (JC,P = 2.08 Hz), 132.9, 132.7, 131.5, 131.0, 130.4, 13.0, 128.4, 128.3, 127.0, 
126.3, 126.2, 125.0, 124.9, 124.2, 122.8, 121. 9, 121.6, 65.1 (JC,P = 6.6 Hz), 30.9, (JC,P = 
4.0 Hz), 25.20 ppm; 
31
P NMR (162 MHz, d-CHCl3)  141.9; IR (neat) 3039, 1584-1319, 
940 cm
-1
; HRMS (ESI):  Calcd. For C46H36O6P2(M+H): 747.2065, found 747.2043 m/z. 
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CHAPTER THREE: UNEXPECTED REACTION PATHWAYS IN THE OXIME-
DIRECTED RHODIUM-CATALYZED ASYMMETRIC HYDROBORATION  
 
3.1 Introduction 
     The asymmetric hydroboration reaction, the net addition of B-H to a prochiral alkene, 
is a valuable synthetic transformation due in large measure to the versatile nature of the 
organoborane product’s carbon-boron bond; chiral organoboranes undergo an expanding 
number of stereospecific functional group transformations converting the C-B bond to C-
O, C-C, C-N, C-X (X = halide), or C-H (Figure 1).
1-6
  Recent studies on the formation of 
carbon-carbon bonds is of particular note. Ohmura, Awano, and Suginome reported the 
coupling of -(acylamino)benzyl boronic esters with aryl bromides with inversion of 
configuration.
3
  The high degree of enantiospecificity is attributed to the coordination of 
amide to boron hindering the approach of palladium from one of the faces.  In a 
complementary strategy, Crudden and co-workers showed that cross-couplings of 
secondary boronate esters precede with retention of configuration.
4
  Other recently 
reported transformations are also quite impressive. For example, Aggarwal and co-
workers found that C-B bonds could be transformed selectively to carbon-halide bonds 
with inversion of configuration.
5
  Several of the substrates examined in this study 
retained 99-100% of their enantiomeric purity. Miura and co-workers recently reported 
an in situ conversion of an aminoboronate to a diamine with retention of configuration.
6
   
These transformations illustrate the value in selective approaches chiral organoboronates.   
119 
 
 
Figure 1 Representative bond transformations for the versatile C-B bond 
 
     Below are several methods for preparation of chiral organoboranes. (Figure 2).  The 
oldest preparative method is the asymmetric hydroboration of an alkene with a 
stoichiometric equivalent of chiral borane; this will be discussed in detail in section 3.2 
(vide infra).  Alternatively, the catalytic asymmetric hydroboration (CAHB) is a powerful 
method to induce asymmetry from a chiral catalyst rather than the borane itself.
7-12
  
CAHB has a long history, and after a period of relative dormancy, recent results, obtained 
for new classes of substrates and simple chiral catalysts, have reinvigorated the field. 
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Takacs and co-workers found that simple TADDOL-derived monophosphites and 
phosphoramidites were effective ligands for the Rh-CAHB of a series of para-substituted 
styrene derivatives affording 90-95% ee; while the yields of the branched isomer (62-
79%) were moderate due to formation of the competing linear isomer, it was significant 
that, in contrast to prior dogma, both electron-donating and electron-withdrawing 
substituents were sucessful.
13
  The low regioselectivity problem was later solved by using 
TADDOL-derived supramolecular catalysts to give greater than 90% yields of chiral 
branched isomers in high enantiomeric excess.
14,15
 Alternative strategies began to 
emerge. For example, chiral organoboranes can be prepared in high enantiomeric purity 
by copper-catalyzed borylative conjugate additions to ,-unsaturated esters using 
diboranes.
16
  Hall and co-workers presented an alternative approach with a copper-
catalyzed hydride addition to -boronyl--alkyl-,-unsaturated  esters.17  In a related 
approach, the asymmetric hydrogenation of vinyl boronates has proven to be quite 
effective with rhodium
18
 and iridium
19,20
 catalysts.  
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Figure 2 Representative methods for formation of chiral C-B bond 
 
3.2 The challenging hydroboration of 1,1-disubstituted alkenes 
        The stoichiometric asymmetric hydroboration reaction was first reported by Brown 
and Zweifel for the selective hydroboration of cis-alkenes (99% ee) with 
diisopinocampheylborane (Ipc2BH) (Figure 2).
21-23
  This landmark achievement proved 
for the first time chiral reagents could achieve such high enantioselectivity.   The 
limitations of using Ipc2BH include limited substrate generality (low enantioselectivity 
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for trans-, tri-, and 1,1-disubstituted alkenes) and problematic reagent stability due to the 
competing dehydroboration.  Substrate generality was improved with the development of 
monoisopinocampheylborane (IPcBH2); this reagent increased the enantioselectivity to 
more useful values for trans-disubstituted (73% ee) and trisubstituted alkenes (53% 
ee).
24,25
  Masamune and co-workers developed a C2-symmetric borolane (DMB) giving 
excellent selectivity for cis- or trans-disubstittued and trisubstituted alkenes (97-99% 
ee).
26
  However, DMB is both relatively unstable and its synthesis of DMB requires 
seven steps decreasing its practicality.  Nonetheless, the one class of disubstituted alkenes 
for which there was no effective asymmetric hydroboration reagent was the 1,1-
disubstituted series (i.e., methylidene substrates); this is attributed to difficulty in 
differentiation between the prochiral enantiotopic faces.
27
  Recently, Soderquist reported 
a novel chiral borane derived from 10-substituted-9-borabicyclo[3.3.2]decanes which 
afforded quite good selectivity for some 1,1-disubstituted alkenes; however, there are two 
significant drawbacks with this reagent.
28
  (1) Synthesis of the chiral borane requires four 
linear steps from -methoxy-9-BBN including a chiral resolution.  (2) Good selectivity 
for 1,1-disubstituted alkenes was achieved only when the was a significant difference in 
steric demand between the alkene substituents, for example, methyl versus tert-butyl. 
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Figure 3 Chiral boranes for the asymmetric hydroboration reaction.  A) The first 
generation of chiral boranes were effective for all but the 1,1-disubstituted series.  B) 
Soderquist developed a series of bicyclic boranes giving high selectivity for 
hydroboration of 1,1-disubstitued alkenes that possess sterically-biased olefin 
substituents.   
 
          Thus while significant progress has been made, problems remain when using 
stoichiometric chiral boranes to achieve high selectivity.  Chiral boranes may require 
multiple difficult steps for preparation and do not have long shelf lives.  CAHB using a 
chiral metal catalyst with a racemic or achiral borane is, in principle, a more practical 
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approach, especially if it is feasible to design a library of catalysts screened against 
simple to prepare boranes for the various classes of alkenes.
7-12
  . 
          The discovery of catalyzed hydroboration originated from the observation by Kono 
and Ito that 4,4,6-trimethyl-1,3,2-dioxaborinane (tmdBH) or catecholborane (catBH) 
readily undergoes oxidative addition to Rh(PPh3)3Cl (Wilkinson’s Catalyst) at room 
temperature (Figure 4).
29
  Subsequently, it was found tmdBH
30
 and catBH
31
 only react 
with alkenes at elevated temperatures with little to no reaction at room temperature.  The 
metal-catalyzed variant was first realized by Männig and Nöth with their report of the 
rhodium catalyzed hydroboration of alkenes with Wilkinson’s catalyst and catBH at room 
temperature.
32
  They showed that the rhodium-catalyzed hydroboration preferred alkenes 
over ketones, which suggested this approach could be tolerant of other functional groups.   
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Figure 4 Discovery of oxidative addition of borane to Wilkinson’s catalyst led to 
development of metal catalyzed hydroboration 
 
     The generally accepted mechanism for the Rh-catalyzed hydroboration was proposed 
by Mannig and Noth with a representative mechanism shown (Figure 5).
32
  Rh(PPh3)3Cl 
must first disassociate a ligand to open a coordination site affording intermediate A, 
which upon alkene coordination forms intermediate B.  Oxidative addition of borane 
(intermediate C) followed by migratory insertion may form either a branched alkyl-Rh 
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intermediate (D) or a linear alkyl-Rh species (D’).  Reductive elimination affords the 
corresponding alkyl-borane product while regenerating the active catalytic species A.   
 
Figure 5 Proposed mechanism for Rh-catalyzed hydroboration with Wilkinson's catalyst 
 
     It has been a challenge to achieve high selectivity from the catalyzed asymmetric 
hydroboration reaction (CAHB) of 1,1-disubstitued alkenes (Figure 6).  Sato, Miyaura, 
and Suzuki reported a cationic Rh-BINAP catalyst and catecholborane afforded moderate 
selectivity in the Rh-CAHB of α-methyl styrene.33  Mazet and Gérard reported an iridium 
P,N-ligated catalyst which gave excellent selectivity using pinacolborane (92% ee).
34
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Pinacolborane was selected over catecholborane, because the corresponding 
pinacolboronate esters are easier to isolate.  To highlight the impact of ligand choice, 
when BINAP is substituted for the optimized chiral P,N-ligand, no reaction occurs.  
Hoveyda recently reported the hydroboration of α-methyl styrene (87% ee) using a 
copper catalyst ligated with a chiral N-heterocyclic carbene (NHC) and dipinacolborane 
(B2(pin)2).
35
  In this example, the B2(pin)2 reacts with (NHC)Cu-alkoxide forming 
(NHC)Cu-BPin.  Enantioselective Cu-B addition to the 1,1-disubstituted alkene forms an 
organocopper intermediate.  Protonolysis regenerates the copper alkoxide forming 
hydroboration products.  Aside from the directed examples discussed in section 3.3, a 
major limitation in the CAHB of 1,1-disubstiuted alkenes is the lack of substrate scope’ 
In the recent examples cited above, for example, only α-methyl substituted vinylarene 
derivatives are reported.  This is perhaps not surprising; the difference in size between the 
aryl and the methyl substituents likely helps differentiate the enantiotopic faces of the pi-
system.  
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Figure 6 CAHB of α-methyl styrene 
      
3.3 Directed hydroboration 
     An alternative strategy that proves useful in expanding the substrate scope beyond 
simple sterics uses a coordinating functional group to direct the catalytically-active metal 
to the prochiral alkene.  A cationic metal with an open coordination site is able to bind to 
the directing group and the alkene; two-point binding has long been proven effective for 
the Rh-catalyzed asymmetric hydrogenation (Rh-CAH) and a wide variety of other 
directed reactions.
36
  Evans, Fu, and Hoveyda pioneered the field of amide-directed 
hydroboration of ,-unsaturated acyclic alkenes catalyzed by achiral rhodium and 
iridium complexes (Figure 7).
37,38
  Excellent regioselectivity was observed when two 
considerations were met: (1) A secondary amide is required to prevent reduction of the 
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amide in the presence of catBH. (2)   Excess catBH is required since the borane 
decomposes under the reaction conditions.
39
 (This will be discussed furthermore in 
section 3.4).  
 
Entry Catalyst yield (%) 
Regioselectivity 
() 
1 [Rh(nbd)(dppb)]BF4 74 20:1 
2 [Ir(cod)(Pcy3)(py)]PF6 73 99:1 
 
Figure 7 First example of a directed catalytic hydroboration 
 
     A simple modification of the catalyzed hydroboration mechanism adapted for two-
point binding substrates is shown below.  Starting with a disolvated Rh(I) complex A, 
coordination of a substrate with a directing group (DG) and alkene affords Rh(I) complex 
B.  Oxidative addition of borane (X2B-H where X = a diol derivative such as pinacol, 
catechol, etc.) gives Rh(III) complex C.  Migratory insertion of the alkene gives the 
Rh(III)-alkyl complex D which undergoes reductive elimination expelling the alkyl 
borane and regenerating active catalyst A.  One can consider possible deviations from 
this simplified catalytic mechanism at several stages during the cycle.  For example, 
oxidative addition of X2B-H can place either the H or the boron in the apical position in 
the perspective drawn below potentially leading to diastereomeric intermediates.  Which 
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diastereomer is formed may dictate whether the alkene migratory insertion occurs into the 
Rh-H or Rh-BX2bond.  Secondly, if reductive elimination step is slow or disfavored, a 
competing -hydride elimination pathway can give undesired byproducts.40-43  Our group 
has recently submitted a publication (now accepted) on a collaborative computational 
study evaluating the different reaction pathways for the amide-directed Rh-catalyzed 
hydroboration. 
 
Figure 8 Proposed mechanism for 2-point binding hydroboration.  DG = directing group, 
L = ligating group, (R)2B-H = borane 
 
     Takacs et al envisaged that a chiral rhodium catalyst could potentially be effective for 
the directed CAHB of ,-unsaturated amides.  Previously, Takacs and co-workers found 
TADDOL-based phosphites and phosphoramidites gave high enantioselectivity in the 
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CAHB of styrene derivatives with pinacolborane (Figure 2).
44
  While the reactions went 
to near completion, the desired yields were only moderate due to formation of the 
undesired linear isomer.  It was proposed that the amide’s directing ability should negate 
this regioselectivity problem.  They found that Rh-CAHB of acyclic ,-unsaturated 
substrates using chiral TADDOL and BINOL-derived monophosphite and 
phosphoramidite ligands were effective for certain ,-unsaturated di- or trisubstituted 
alkenes directed by amides
45,46
 including published work not reported in this thesis which 
I carried out, as well as Weinreb amides.
47
  The successful results from directed 
hydroboration of di- and trisubstituted alkenes prompted exploration of the challenging 
class of 1,1-disubstituted alkenes (i.e., methylidene substrates).  Aniline-derived amides 
and tert-butyl esters were quite effective in the Rh-CAHB of 1,1-disubstituted ,-
unsaturated methylidene substrates.
48
  Regioselectivity favored gamma- over beta-
substitution ranged from 5:1 to 20:1 with good yields for gamma-borylated product 
(53%-78%) and excellent enantioselectivity (91-94% ee).   
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Figure 9 Directed CAHB of 1,1-disubstituted alkenes 
Studies into the CAHB of Oxime Ethers: Results and Discussion   
     A note to the readers:  the following portion of this chapter outlines our findings into 
an unexpected and unusually facile C-H insertion and its role in the oxime-directed Rh-
catalyzed hydroboration.  Our current understanding of the reaction is as follows: 
 Reduced products are not formed directly from H2 and Rh(I).  The Rh-catalyzed 
hydroboration is susceptible to influence of H2 on the reaction mechanism.    
 Ortho-metallation is only detected with a proximal alkene that reacts.  Saturated 
substrates do not readily ortho-metallate under standard reaction conditions.  
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Substitution of the alkene for alternate directing groups does not facilitate C-H 
insertion.   
 The mechanism by which oxime-directed hydroboration products are formed is 
dependent upon the nature of the borane.  With catecholborane, the reaction 
pathway is oxidative addition, migratory insertion, and reductive elimination.  
With tmdBH, the hydroboration products are likely formed from a 
dehydrogenative borylation followed by reduction.  
 The source of the “H-H” addition in the reduced products is not straightforward.  
During Rh-catalyzed hydroboration, isotopically-labelled boranes (>90% D 
incorporation) lose deuterium before transfer to the reacting alkene; the B-D is 
exchanged for B-H, presumably from the THF solvent. 
 
3.4 Oxime-directed hydroboration  
     Amides are relatively stable and often require relatively harsh reactions conditions 
to refunctionalize in the presence of other sensitive functionalities; this makes their 
presence less synthetically useful.  Oximes are more labile than amides and have the 
benefit of an extra heteroatom for further functionalization (Figure 10); in addition, 
oximes are much less common, and a route to their enantioselective synthesis may 
offer new possibilities for synthesis.  For example, the nitrogen protecting group may 
be removed forming hydroxylamines or the labile O-N bond may be cleaved giving 
alcohols.  Together with the possibilities for subsequent functionalization of the C-B 
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bond, investigating their CAHB chemistry seemed to be a potentially useful 
endeavor. 
 
Figure 10 Hydroboration of , unsaturated oximes provide access to wide variety of 
products  
     Oxime-directed catalysis to ,-unsaturated alkenes can be effective.  Recently, 
Sanford and co-workers reported an oxime-directed Pd-catalyzed dihydroxylation of 
a ,-unsaturated alkene (Figure 11).
49
  Using chiral aliphatic oximes, the Pd-
catalyzed diastereoselective dihydroxylation of ,-unsaturated alkenes gave up to 
80% diastereomeric excess.   
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Figure 11 Oxime-directed dioxygenation of ,-unsaturated alkenes  
 
     While the hydroboration of 1,1-disubstituted-,-unsaturated phenyl amide 
derivatives precedes smoothly affording the -isomer as the major product (53% 
yield), a significant amount of reduction product (22%) was also isolated (Figure 9).
48
 
It was presumed that this reduced product was the result of a competing side reaction 
wherein a Rh(III) dihydride catalyst was formed; it is believed the H2 is its source 
having been formed by catalyzed borane decomposition or through spontaneous 
disproportionation (Scheme 1)
39
 or a nucleophile-promoted pathway.
50
 Typically, 
these pathways can be avoided if the alkene is more reactive than the borane 
decomposition, but for slow-reacting or coordinating substrates these pathways 
become more of a concern.  With two-point directing substrates, an excess of borane 
is required to get complete conversion of starting materials suggesting the directing 
groups may promote borane disproportionation.     
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Scheme 1 Spontaneous disproportionation of catecholborane.  Adapted with 
permission from Inorg. Chem. 1962, 1, 744-748 ©2014 American Chemical Society  
 
3.5 The initial reactions of a simple oxime substrate were patterned after the 
amide substrates examined previously and initially seemed promising. 
     1,1-disubstituted-,-unsaturated oxime 1, originally prepared and investigated 
preliminarily by Mr. Andrew Geis, was subjected to Rh-CAHB under the identical 
reaction conditions used for the structurally similar 1,1-disubstituted-,-unsaturated 
N-phenyl amide discussed previously with Rh[(xTaddol)POPh]2BF4 as the catalyst 
(Figure 12).   Starting material was consumed after 16 h, but -alcohol 4 was isolated 
in only 6% yield.  Preliminary studies had indicated by chiral HPLC that oxime 1 
underwent CAHB with high enantioselectivity; however that turned out to be wrong.  
I confirmed that the enantiomers did not resolve upon chiral HPLC or chiral GC with 
the columns available.  Fortunately, derivatizing with Mosher’s acid chloride, (S)-
methoxy--(trifluomethyl)phenylacetyl chloride, gave diastereomeric esters that 
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could be used to determine the diastereomeric excess by 
19
F NMR; unfortunately, it 
was low (12% de).
51,52
   Two products in which the alkene had been reduced 
accounted for about 90% of the mass recovered in the reaction; these two products 
were formed in a 1:2 ratio and were isolated and characterized.  The minor of the two 
reduced product was the typical reduced product seen from net H2 reduction of the 
alkene; the major reduced product was missing an aromatic proton and an unusual 
singlet accounting for one exchangeable hydrogen at  11.2 ppm was seen.  NMR and 
high-resolution mass spectrometry analysis helped me to determine the product is the 
ortho-hydroxylated product 3.  We hypothesized this occurred through directed C-H 
activation followed by boryl substitution.  Under oxidative workup conditions, 
borylated product was converted to the ortho-hydroxy derivative.  [Readers note that 
the terms ortho-metallation and ortho-borylation will be used in the discussion below 
based on the observed formation of the ortho-hydroxy product.]  Attempts to isolate 
the borylated product for further characterization were unsuccessful; the ortho-
borylated and gamma-borylated products co-eluted and were inseparable.  Changing 
the catalyst to one using a phosphoramidite ligand (XTADDOL)PN(Me)Ph afforded 
the -alcohol as the major product (57%), but the enantioselectivity, although 
improved, was still low (33% ee by MTPA-derivatization) and the undesired reduced 
material was obtained in 41% yield.  
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Figure 12 Hydroboration of ,-unsaturated oximes afford gamma-hydroxylated and 
reduced products 
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     Since the often (annoying) competing reduction is now a major competing 
pathway with oxime substrates, it was postulated that ortho-metallation could be 
responsible for the increased yields of reduced material.  However, a simpler 
explanation is that borane decomposition forms H2 which is scavenged by Rh(I) to 
promote the Rh-catalyzed hydrogenation.  The stoichiometry of the reagents used in 
the reaction indicates that the borane could in principle provide enough H2 to account 
for the reduced products (Figure 13).  For example, the -borylated product requires 
consumption of one equivalent of borane.  H2 can be formed from 2 sources: (1) 
decomposition of two equivalents of borane gives one equivalent diborane and one 
equivalent H2; and/or (2) the ortho-borylated material arises from H/B exchange with 
liberation of one H2.   
      
Figure 13 Possible sources of H2 from borane decomposition and ortho-borylation 
 
3.6 Proof of the structure of the ortho-hydroxylated material 3 by alternative 
synthesis  
     To confirm the structure of ortho-hydroxylated product 3, an alternate synthetic 
scheme was developed (Figure 14).  Starting from commercially available 2-
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hydroxybenzophenone, the oxime was formed in good yield.  Alkylation with 1-
bromo-2-methyl propane afforded ortho-hydroxylated ether 3 whose spectral 
characterization proved identical to that isolated from the hydroboration reaction.  
The intramolecular hydrogen bonding of the ortho-hydroxy group suppresses 
intermolecular hydrogen exchange giving a sharp concentration independent singlet 
in the HNMR spectrum with an unusually far downfield chemical shift ( 11.2 ppm).   
 
Figure 14 Synthetic proof of ortho-hydroxylated product 
 
3.7 The observed ortho-hydroxylation to form 3 occurs at room temperature, but 
such mild conditions for C-H activation are not common in the literature.  
     The field of C-H activation chemistry has expanded rapidly over the past 10 years and 
continues to grow with an ever increasing number of new organometallic catalysts 
53-63
 
and organocatalysts.
64
  Nonetheless, metal-catalyzed C-H activation is rarely observed to 
be facile at room temperature; heating is usually required for efficient ortho-
metallation.
63
  There are only a few reports of Rh(III) catalyzed C-H activation at room 
temperature; out of over 150 reports, only 5 were accomplished at room temperature 
(Figure 15).
65-69
   A survey of the directing groups reported for C-H activation found N-
phenyl amides directed the rhodium-catalyzed C-H activation captured by an alkene, 
imine, or halide at 60-130 
o
C.
65,70-72
  If elevated temperatures are required, then it is 
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perhaps not surprising, that we did not observe the potential corresponding ortho-
metallation/borylation in our prior studies of amide-directed CAHB using N-phenyl 
amide substrates.  Relevant to the chemistry described in this chapter, oximes have been 
used as directing groups for C-H activation with Pd
73,74
 and Rh
75,76
, but all of these 
reports required harsh conditions (>60 °C) to effect reaction. 
 
Figure 15 Examples of Rh-catalyzed C-H activation at room temperature.  A) 
Carboxylation of arenes; B) Indoline and Pyrrole Synthesis; C) Using a self-oxidizing 
directing group 
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3.8 The reduced product is not formed simply by rhodium-catalyzed alkene 
hydrogenation 
     The simplest way to account for the formation of reduced alkene products is that Rh(I) 
scavenges adventitious H2 that is formed from borane decomposition, and the alkene 
simply undergoes rhodium-catalyzed hydrogenation; this is the generally assumed origin 
of reduced products in CAHB. If this is the case for the oxime substrate, then the ortho-
borylation occurs via an independent pathway (vide infra).  In testing the rhodium-
catalyzed hydrogen, we were surprised to find that running the reaction under a hydrogen 
atmosphere (H2 balloon) with the rhodium catalyst but no borane present did not reduce 
the alkene (Table 1, entry 1).   While this result doesn’t rule out the possibility that a 
Rh(III)-dihydride is responsible for alkene reduction, it does suggest the dihydride is not 
formed directly from Rh(I) and H2.   
     tmdBH is needed to effect alkene hydrogenation. The reaction was again run under a 
hydrogen atmosphere, but this time limiting amounts of tmdBH were present. With as 
little as 0.4 equivalents of tmdBH, exclusive formation of the reduced product 2 was 
found; neither hydroxylated product (i.e., 3 or 4) were formed in appreciable amounts 
(Table 1, entry 3). With 2.0 equivalents of tmdBH (i.e., the normal reaction conditions 
except under a hydrogen atmosphere), both 3 and 4 were present, but in amounts 
substantially below that seen in the absence of the hydrogen atmosphere (Table 1, entry 
4). Surprisingly, similar effects are not seen for the analogous CAHBs using 
catecholborane (catBH) under a H2 atmosphere (Table 1, entries 5-7).  This result is 
confirmed when CAHBs using catBH afforded similar yields under H2 atmosphere or N2 
atmosphere (Table 1, entry 8 vs 9). 
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. 
Table 1: Borane as an additive influences the hydrogenation reaction 
 
  
Starting Material 
Remaining (%) 
  
Entry Borane (equivalent) H2 product (%) -OH (%) 
1 0 equiv 100 0 0 
2 tmdBH (0.2 equiv) 50 50 0 
3 tmdBH (0.4 equiv) 5 95 0 
4 tmdBH (2.0 equiv) 0 61 21 
5 catBH (0.2 equiv) 94 1 0 
6 catBH (0.4 equiv) 92 2 3 
7 catBH (2.0 equiv) 0 8 58 
8
a
 catBH (2.0 equiv) 0 6 63 
a
Reaction under a N2 atmosphere without added H2. 
     A proposed mechanism to account for the formation of the hydrogenation product is 
described below (Figure 16A).  Oxidative addition of a borane (X2BH) to to 
Rh(I)(Ligand)2 (intermediate B) produces Rh(III)H(Ligand)2BR2 (intermediate C).  As 
H2 is introduced, -bond metathesis between the Rh-B and H-H would regenerate X2BH 
(the borane is effectively a co-catalyst) and form Rh-dihydride D. (A more detailed 
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explanation of the possible mechanism is in Section 3.15.)  Migratory insertion followed 
by reductive elimination forms the reduced product.  Perira and Srebnik exploit a similar 
“crossover” strategy in the Rh-catalyzed addition of CCl4 to alkenes using a sub-
stoichiometric amount of pinBH (Figure 16B) to promote the reaction pathway.
77
   
 
Figure 16: A) Proposed mechanism for role of borane activation for active reduction of 
alkenes B) Crossover occurs readily with Wilkinson's catalyst and pinBH in CCl4 
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3.9 The choice of borane has a large effect on the product distribution obtained in 
the Rh-CAHB of ,-unsaturated oximes 
     ,-unsaturated oxime 1 was screened with boranes differing only in diol backbone.  
tmdBH and pinBH are similar electronically and sterically, yet give substantially 
different product ratios in the Rh-CAHB of 1 (Table 2).  The new complication arises in 
that pinBH gives poor regioselectivity for hydroboration of the alkene; that is, competing 
formation of the -alcohol 6 lowers the yield of desired -alcohol 4.  CatBH affords only 
7% total reduced material, and less than 1% of ortho-hydroxlation 3; the latter suggests 
that C-H activation is disfavored by catBH.  Overall, the desired -alcohol is the 
predominant product with catBH (63% yield), but the enantioselectivity is poor (ca 6% 
ee).   
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Table 2 Nature of borane affects the hydroboration greatly 
 
Entry Borane 
Starting 
Material 
Remaining 
1(%) 
H2 product 2 
(%) 
o-OH / H2 3 
(%) 
-OH 6 
(%) 
-OH 4 
(%) 
1 
tmdBH 
B1 0 10 31 0 58 (33% ee) 
2 
pinBH 
B3 14 24 8 16 30 (11% ee) 
3 
catBH 
B2 0 6 1 7 63 (6% ee) 
 
3.10 Are the reduced products formed via the same pathway as chiral -products?  
     If a short-lived catalytic species is responsible for the formation of reduced product 2, 
its rate of formation would likely differ from that of the other products over the course of 
the reaction; that is what is found (Figure 16).  After completion of borane addition at 0 
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°C, the reaction mixture was stirred at 0 °C for 30 minutes and then allowed to warm to 
room temperature.  Aliquots were removed and quenched by oxidative workup. The 
crude products were extracted and purified by flash chromatography.  Their isolated 
yields are shown below (Figure 17).  The majority of reduced product 2 is formed within 
the first 30 minutes at 0 °C.  Meanwhile, the ortho-borylated product 3 and -borylated 
product 4 were formed, roughly in parallel, over the remaining course of the reaction.  
This result suggests reduced product 2 may be formed from a pathway independent of the 
ortho-borylated and gamma borylated products.  It is not clear how the proposed 
mechanism in Figure 15 accommodates this conclusion since the reduction stops shortly 
into the reaction; one possibility is that a limited amount of hydrogen remains or is 
generated after the initial phase of the reaction. 
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Figure 17 Rate reaction for oxime directed hydroboration indicates ortho-hydroxylated 
product and gamma-hydroxy product are formed concurrently 
 
3.11 The size of the vinyl substituent has only a small effect on the product 
distribution, but improves the selectivity. 
     Previous studies in the amide-directed CAHB of methylidene substrates found that 
substrates in which the vinyl methyl substituent is replaced by a larger, more sterically-
demanding substituent gave increased yields of -borylated product with decreased 
formation of reduced products.
48
  To probe this, two substrates were prepared, one 
bearing an isobutyl substituent and another with a cyclohexyl group.  Unfortunately, the 
substituents had little impact on the observed product distributions (Table 3).  However, 
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there was one significant benefit, the level of enantioselectivity increased as high as 70% 
ee giving some hope that a superior catalyst could ultimately be obtained. Perhaps 
increasing the size of the substituent helps to further differentiate the enantiotopic faces 
of the alkene.   
 
Table 3 Changing the vinyl substituent increases the enantioselectivity but total reduced 
products remain relatively unaffected 
 
Entry Borane R = substituent H2 product (%) o-OH / H2 (%) -OH (%) 
-OH (%) 
/ (% ee) 
1 tmdBH Isobutyl 16 29 0 52 (60) 
2 catBH Isobutyl 0 0 0 16 (0) 
3 tmdBH Cyclohexyl 28 11 0 60 (40) 
4 catBH cyclohexyl 5 2 7 52 (70) 
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3.12 The alkene is essential for efficient ortho-metallation/borylation and the 
formation of 3. 
     Having gathered some information on the formation of reduced product 2, we turned 
our attention to the formation of the ortho-borylated and reduced product 3. The C-H 
insertion could occur either before, during, or after reaction with the alkene.  As the 
ortho-borylated material with the alkene intact has never been observed, it is presumed 
that C-H insertion must occur during the hydroboration reaction.  To test this, the reduced 
product 2 was synthesized and subjected to hydroboration conditions. Only 3% of the 
ortho-hydroxylated product 3 was isolated after workup.  While not conclusive evidence 
that ortho-metallation requires the alkene be present, for example, one could imagine that 
ortho-metallation occurs but hydrogen is delivered back to its original position, the 
results obtained starting from 2 coupled with the evidence presented for its formation by 
an independent pathway is strongly suggestive that 2 is not converted to 3 under the 
reaction conditions (Figure 18).   
 
 
Figure 18 Ortho-borylation not promoted in saturated oxime 
 
     Is norbornadiene involved in the catalytic cycle?  Norbornadiene (nbd) is a common 
diene ligand used with metal precursors in catalysis; due to the strain in the pi-systems, 
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the diene ligand is thought to rapidly react via CAHB and thus be an innocuous bystander 
in the hydroboration reaction of interest.  However, olefin ligands have the ability to 
participate in catalytic reactions;
78,79
 for example, norbornene has a substantial role in 
catalysis in the palladium-catalyzed Catellani reaction.
80-82
  In the Catellani reaction, 
norbornene is thought to form a palladacycle intermediate which upon reductive 
elimination and depalladation reforms norbornene.  Hence, norbornene is part of the 
catalytic cycle or at the very least serves as a co-catalyst in that reaction.  In a similar 
vein, Hua, Nguyen, Scaggs, and Jeon found phosphorus ligating groups and norbornene 
cooperatively participated in the diastereoselective rhodium-catalyzed intramolecular 
alkene hydrosilyation reaction (Figure 19).
83
  When norbornene was used as a sub-
stoichiometric additive, excellent yield and diastereoselectivity were observed.  The 
proposed mechanistic cycle involves norbornene acting as a hydride shuttle.   
     If norbornadiene were responsible for C-H activation and subsequent formation of 
ortho-borylated product 3, replacement with an alternative diene ligand should result in a 
change in yield.  When Rh(1,5-cyclooctadiene)2BF4 was used,  there was no change in 
reduced or borylated yields.  Furthermore, norbornene rapidly undergoes CAHB.
84
  This 
suggests that while norbornadiene is expected to undergo CAHB, it should otherwise not 
interfere in the reaction of 1.  
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Figure 19 Norbornene-mediated rhodium-catalyzed intramolecular alkene 
hydrosilylation reactions 
 
          Is an active catalyst, not just the catalyst precursor and tmdBH, needed for ortho-
borylation of 2?  C-H activation using rhodium catalysts may proceed through either a 
rhodium(I) intermediate, which oxidatively adds to the ortho-C-H bond, or a Rh(III) 
intermediate via transmetallation or some variant of sigma-bond metathesis.
57
  While 
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reduced product 2 is not efficiently converted to ortho-borylated product 3 under the 
typical reaction conditions, it is possible the some rhodium intermediate along the 
reaction pathway can more efficiently effect the reaction.  To explore whether generation 
of a Rh(III)-alkyl species in the presence of saturated oxime 2 could facilitate ortho-
metallation, a fast-reacting sacrificial substrate was added.  Norbornene was used in 
previous studies as a sacrificial substrate to consume a non-selective catalyst during the 
Rh-CAHB reaction.
84
  Adding 0.3 equivalents of norbornene to the attempted reaction of 
2 did not increase the yield of the ortho-hydroxylated product 3 (Figure 20).  
 
 
Figure 20 Formation of Rh(III) through sacrificial substrate does not increase yield of 
ortho-borylated material 
      
     Alternative weak directing groups do not promote ortho-borylation suggesting that an 
intermediate along the pathway in which the alkene reacts leads to the attendant ortho-
metallation.  If the alkene substituent is required to promote ortho-metallation/borylation, 
then one can consider two possible modes; either ortho-C-H insertion occurs from an 
intermediate formed during hydroboration of the alkene, or the alkene simply serves as a 
weak directing group to promote ortho-C-H insertion.  To explore the latter possibility, 
the analogous ester and alkyne substrates were prepared (Figure 21).  When treated under 
the standard catalytic conditions, no ortho-borylated products were obtained from these 
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substrates.  This suggests an intermediate along the pathway in which the alkene reacts to 
form a Rh(III)-alkyl intermediate, leads to the attendant ortho-metallation. 
 
Figure 21 Determination whether alkene could act as directing group for agostic C-H 
interaction 
 
     The 1,1-,-unsaturated derivative was used to determine the effect of distancing the 
alkene by one carbon from the directing group.  Evans, Fu, and Hoveyda saw a reduction 
in reaction rate as the amide-directing groups were extended farther from the alkenes.
85
  
We observed a similar decrease in reactivity with only 31% -OH product isolated after 
16 hours (Figure 22).  Ortho-borylated product was not observed under these reaction 
conditions, although a substantial quantity of reduced product was isolated.   
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Figure 22 ,-unsaturated oxime affords -alcohol in high regioselectivity with no ortho-
borylation 
 
3.13 The proximal aryl group is necessary for effective hydroboration. 
     The oxime ether derived from benzophenone was initially chosen for these 
investigations because it (1) provided a convenient chromophore for UV-Vis detection, 
and (2) it was thought that the sterically demanding aryl substituents might enhance the 
facial bias of the alkene pi-system.  However, since ortho-borylation was a problem, it 
seemed reasonable to keep the chromophore, but move it away from the metal center 
(Figure 23).  Two 2-phenylisobutyraldehye oxime derivatives were therefore prepared.  It 
was expected that the phenyl substituent would be oriented away from the alkene to avoid 
unfavorable steric interactions, and the methyl groups would reside in a staggered 
confirmation relative to the nitrogen lone pair.  Unfortunately, these substrates proved 
inactive to hydroboration under conditions previously optimized for the benzophenone 
derived oximes.  Only starting material was recovered with no sign of reduction or 
hydroboration.   
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Figure 23 Moving the problematic phenyl group eliminates ortho C-H from borylation 
 
3.14 Deuterium-labeling reveals near quantitative ortho-metallation during tmdBH-
promoted rhodium-catalyzed reduction of 1 to 2 under a H2 atmosphere.   
          At this point we decided to look at the reactions of deuterium-labeled substrate 1, 
first focusing on reaction conditions that exclusively promote reduction of the alkene 
(i.e., reaction under a hydrogen atmosphere). The preparation of benzophenone-d
10
 was 
straightforward (Scheme 2).  Bromobenzene-d
5
 was converted to the aryl Grignard.  
Addition to 1,1’-carbonyldiimimidazole (CDI) affords benzophenone-d10 upon aqueous 
workup.  Benzophenone-d
10
 was used to prepare the ,-unsaturated substrate 16-d10 (the 
labeled version of 1) and a saturated analogue 18-d
10
 (a labeled version of 2) for further 
mechanistic studies. 
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Scheme 2 Preparation of deuterated analogues for mechanistic studies.  a) NaH, 3-Cl-2-
Me-1-propene, TBAI; b) NaH, 1-Br-2-Me-propane, TBAI. 
 
     Unexpected deuterium scrambling is observed for the reaction run under a hydrogen 
atmosphere. ,-Unsaturated substrate 16-d10 was subjected to the tmdBH-promoted 
hydrogenation conditions described above for substrate 1 (2 mol% 
[(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4, 0.4 equivalents tmdBH, 1 atm H2) (Figure 24).  
The crude product was filtered through a short plug of silica gel to remove trace metals.  
1
H NMR analysis showed a newly formed singlet at  7.52 ppm which was tentatively 
assigned the ortho-H shown in Figure 24.  The two hydrogens  to the oxime, a doublet 
at  4.00 pm, were used as the internal standard to quantitate deuterium incorporation in 
the reduced product 17.  Based on this standard, one ortho-deuterium was exchanged for 
hydrogen to the extent of 83% in the 17; ortho-metallation is occurring much more 
frequently than initially thought.  Most of the deuterium liberated by H/D-exchange is 
transferred to the alkene. Approximately 57% is transferred from the phenyl ring to the -
carbon of what was the alkene; a smaller amount of deuterium (approximately 12%) was 
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transferred to what was the -carbon of the alkene.  Only ca 14% of deuterium originally 
on the phenyl ring is missing, presumably lost as H-D under these reaction conditions.   
 
 
 
Figure 24 Rh-catalyzed hydrogenation of ,-Unsaturated substrate 16-d10 
 
        The reduced product is stable under the reaction conditions; labelled reduction 
product 18-d
10
 does not undergo H/D-exchange. The role of the alkene in the H/D-
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exchange was explored next.  In an atmosphere of with a large excess H2, exchange of 
H/D should occur frequently for an ortho-metallated intermediate if oxidative addition 
were occurring without alkene participation (Figure 25).  Saturated analogue 18-d
10
 was 
added to a H2 atmosphere, but no H/D exchange was observed.  This result suggests for 
C-H (or C-D) activation to occur, a , unsaturated alkene, borane, and an ortho C-H (or 
C-D) must be present.  
 
Figure 25 Ortho-metallation not observed with labeled saturated substrate under H2 
atmosphere 
           Chelation-assisted oxidative addition could explain the C-D/C-H exchange and 
deuterium scrambling in a pathway independent from hydroboration (Figure 25), but this 
proposed mechanism is not supported by experiment.  Chelation-assisted C-H activation 
has frequently been proposed in unrelated C-H metallation chemistry using rhodium(I) 
catalysts 
57,86,87
  This could in principle explain the observed deuterium scrambling in 17 
as follows. Two-point coordination of the substrate to Rh(I) species followed by 
oxidative addition of the ortho C-D would generate a Rh(III) intermediate.  Migratory 
insertion of the coordinated alkene into the Rh-D bond delivers deuterium generating an 
Rh(III)-alkyl intermediate.  -Hydride elimination leaves deuterium on either the alkene 
or the methyl substituent scrambling deuterium in the starting 16-d
10
.  Reductive 
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elimination generates an aryl C-H while regenerating the rhodium(I) catalyst.  
 
Figure 26  Ortho-metallation is not observed without the addition of borane.   
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      Deuterium is not scrambled in the starting material, 16-d
10
. To test the possible 
mechanism shown in Figure 26, ,-unsaturated analogue 16-d10 was treated in separate 
experiments with 2 mol% [(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 and with 2 mol% 
[(nbd)Rh((XTADDOL)POPh)2]BF4; the mixtures were stirred under N2 for 16 hours.  No 
deuterium/hydrogen exchange was observed for 16-d
10
.  Increasing the catalyst loading to 
20 mol% showed no evidence for deuterium scrambling.  In addition, a small amount 
(8%) of 16-d
10
 was observed from the reaction mixture described in Figure 24. Analyzing 
its 
1
H NMR spectrum showed no deuterium exchange or loss (NMR data:  4.98 (1H), 
4.93 (1H), 4.65 (2H), 1.78(3H) ppm).  From the experiments described above, we 
conclude that neither the starting material nor the reduced product undergo H/D-
scrambling to account for 17; furthermore, the mechanism for facile ortho-metallation 
H/D-exchange requires tmdBH and does not proceed independent of alkene reduction.    
 
3.15 Even in the absence of added hydrogen, ortho-metallation is virtually 
quantitative during concomitant Rh-CAHB 
     The results obtained in the reaction of 16-d10.  Having first focused on the reaction of 
,-unsaturated substrate 16-d10 under conditions that promote exclusive reduction of the 
alkene (i.e., reaction under a hydrogen atmosphere), we now return to reaction conditions 
that promote Rh-CAHB. 16-d
10
 was reacted under an inert atmosphere as described 
above for substrate 1 (2 mol% [(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 and  2 eq 
tmdBH).  Ignoring the isotope distribution, the labeled and unlabeled substrates give 
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virtually identical product distributions (Figure 27).  Surprisingly, we find evidence for 
ortho-metallation and H/D-exchange, not only for the reduced product as was found for 
reaction under a hydrogen atmosphere, but for all three products!  The isotope 
distribution for the reduced product 19 differs in small, but perhaps important ways, from 
17 described above. One ortho-deuterium is replaced by hydrogen virtually 
quantitatively, and the deuterium is cleanly incorporated into a methyl group in 19. The 
ortho-borylated and alkene reduced product 20 similarly shows clean redistribution of 
one ortho-deuterium to a methyl group, but with incorporation of boron in the ortho-
position. In this case, a second ortho-deuterium is partially exchanged for hydrogen. We 
will consider the distribution of the deuterium for the major product, the expected 
hydroboration product 21 later, but note here that one ortho-deuterium is replaced by 
hydrogen virtually quantitatively. 
 
Figure 27 Hydroboration of ,-Unsaturated substrate 16-d10 reveals D-transfer A) 
Reaction conditions:  2 mol% Rh(nbd)2BF4, 4.1 mol% (XTADDOL)PN(Me)Ph, 2.0 
equiv tmdBH, THF, rt, 16 h.  Oxidative workup:  NaBO3, THF/H2O 
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     Proposed mechanisms to account for the redistribution of deuterium in 16-d
10
 are 
discussed below.  Deuterium exchange of the ortho-C-D/C-H must be associated with 
hydroboration of ,-unsaturated alkene.  We propose the pathways diverge as the stage 
where X2B-H undergoes oxidative addition to the rhodium-substrate complex (Figure 28, 
steps A and A’).  Step A ultimately leads to formation of ortho-borylated product, while 
the diastereomeric pathway through the step labeled A’ leads to -borylated product; this 
is based on the proximity of the pi-system to the Rh-H bond.  In pathway A, migratory 
insertion of hydride to the -position leads to an intermediate with rhodium bound to the 
-carbon.   In pathway A’, migratory insertion forms a -Rh intermediate.  Two pathways 
can help explain the deuterium incorporation on the -borylated products as will be 
discussed in further detail below.  
 
Figure 28 Proposed mechanism for formation of ortho-borylated 3 and -borylated 4 
accounting for deuterium scrambling to substituent 
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     Formation of ortho-borylated product 3.  The details for a proposed mechanism to 
rationalize the formation of ortho-borylated product 3 is shown below (Figure 29).  
Coordination of substrate is followed by oxidative addition of tmdBH (Figure 29, steps A 
and B).  After migratory insertion, the rhodium bound to the -carbon may be situated 
such that it has an agostic interaction with the ortho C-D predisposing it towards -bond 
metathesis (Figure 29, steps C and D).
88
  -bond metathesis substitutes the boron for 
deuterium on the ortho-carbon; reductive elimination can then account for deuterium 
incorporation on the -carbon (Figure 29, step E).   
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Figure 29 Proposed mechanism for borylated/reduced products 
      
    The proposed mechanism seems to account for several of the unusual observations 
made for this reaction. It accounts for the reduction of the alkene as well as the ortho-
borylation and the fact that experimentally, no ortho-borylated product with the alkene 
intact has been found.  It suggests that the mild C-H activation may be due to the unique 
electronics of the rhodium-alkyl intermediate, an intermediate that is unlike those in the 
vast majority rhodium-catalyzed C-H activation reactions. The need for a rhodium-alkyl 
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intermediate might explain the ineffectiveness of alternative directing groups.  It may 
also account for why the nature of the borane is critical; recall, catBH does not promote 
ortho-metallation. Similarly, why substrates in which the aryl C-H is more distal or the 
alkene is more remote might not favor a structure having a strong agostic interaction with 
the ortho C-D predisposing it toward -bond metathesis. 
     Precedence for increased reactivity from an ortho-metallated hydrogenation catalyst 
species has recently been described.  Pfaltz and co-workers demonstrated an ortho-
metallated iridium catalyst was efficient in the asymmetric hydrogenation of aliphatic 
imines (Figure 30).
88
  Iridium P,N-ligated catalyst Pfaltz-L1 rapidly converted to the 
metallocycle Pfaltz-L2 at 0 °C in the presence of phenyl methyl ketimine under a H2 
atmosphere (1 bar).  The ortho-metallocycle was observed by NMR; attempts to isolate 
failed due to decomposition.  Generally, alkyl ketimines suffer from low reactivity to 
hydrogenation relative to aryl ketimines; Pfaltz speculated the poor reactivity from 
aliphatic ketimines could be due to inability to form catalytically active ortho-
metallocycle complexes.  Ir-catalyzed asymmetric hydrogenation of cyclohexyl methyl 
ketimine with Pfaltz-L2 did indeed give higher reactivity than the parent catalyst Pfaltz-
L1.    
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Figure 30 Pfaltz’s discovery of an ortho-iridacycle with improved catalyst efficiency in 
the iridium-catalyzed asymmetric hydrogenation of dialkyl ketimines. 
 
    The Rh-BX2/C-D -bond metathesis is a particularly interesting aspect of the proposed 
mechanism. Whether rhodium is formally oxidized to the Rh(V) oxidation state or 
whether the Rh(III) intermediate reacts through a -bond metathesis has been the subject 
of recent debate.
89,90
  For example, hydride exchange in the rhodium-catalyzed 
hydrosilyation reaction has been studied by Vyboishchikov and Nikonov.
91
  Rh(V)-silyl 
hydride complexes were isolated and characterized.
92-97
  DFT calculations on a series of 
silyl hydride complexes formally assigned as Rh(V) complexes were found to have 
varying degrees of interligand Si-H interactions (Figure 31).  This finding led the authors 
to eliminate a classical oxidative addition as the mechanism; instead the interaction was 
considered “sophisticated” and “multicentral.”   
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Figure 31 Four-centered intermediates may be a better description than discrete Rh(V) 
complexes in Rh-H/Si-H exchange reactions  
 
     Recently, an alternative to traditional -bond metathesis, -complex assisted 
metathesis (-CAM), has been suggested.89  While -bond metathesis occurs in a single 
concerted step, -CAM is said to proceeds through multiple rearrangements of -ligands 
leading to bond metathesis.  Hall and Hartwig proposed catalytic cycles supported by 
DFT calculations that involve -CAM for the borylation of alkanes; this was supported 
by experimental observation of key intermediates associated with multiple ligand 
exchanges (Figure 32A).
98
  Adapting this to the oxime-directed hydroboration would 
involve formation of a tmdB-D intermediate that subsequently reacts to form the ortho-
borylated -Rh species (Figure 32B).   
 
Figure 32 -CAM mechanism for ortho-borylation and deuterium exchange.  A)  
Hartwig observed formation of tris-borated Rh complexes likely formed from -CAM. 
B) Proposed mechanism for -CAM in oxime-directed CAHB. 
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     Returning to the redistribution of deuterium for the major product in the expected 
hydroboration product 21.  -alcohol 21 also showed quantitative replacement of 
deuterium at the ortho-position of the aromatic ring by hydrogen and complete transfer of 
deuterium to the propenyl moiety.  Curiously, the deuterium incorporation added to two 
positions on what was the propenyl moiety in a 50:50 ratio.  This seems indicative of a 
pseudo symmetric intermediate or an isomerization reaction.  The latter seems more 
reasonable and a proposed mechanism accounting for the observed redistribution of 
deuterium is described below (Figure 33).   
     Formation of ortho-borylated product 21. The proposed mechanism for the formation 
of 21 is more difficult to formulate than that accounting for the formation of 3. As 
suggested in the previous mechanism, the catalytic cycle is initiated by oxidative addition 
of tmdBH to the rhodium-complexed substrate (Figure 33, steps A and B). This cycle 
differs from that described in Figure 29 in that we propose migratory insertion of the 
alkene into the Rh-BX2 bond affording a -rhodium(III)-alkyl intermediate.  We need to 
once again, suppose a strong agostic interaction, in this case involving the ortho-C-D and 
Rh(III)-D bond (Figure 33, steps C and D).  After -bond metathesis (or -CAM), 
competing -hydride elimination is apparently preferred over reductive elimination.  This 
gives either the ,-unsaturated vinyl boronate or alkene and a rhodium dihydride (i.e., H-
Rh-D). Stepwise readdition of H and D to the two isomeric alkenes could afford the 
observed products with deuterium placed appropriately.   
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Figure 33 Proposed mechanism for deuterium transfer to both gamma carbons in 
formation of gamma alcohols 
 
     Dehydrogenative borylations. Figure 33 suggests that the -borylated products do not 
come from the envisaged mechanism for two-point binding hydroboration, but instead via 
a dehydrogenative borylation/reduction; the latter pathway has precedence in the 
literature.  Dehydrogenative borylation has been reported for directed and non-directed 
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systems.
40-43
  For example, Westcott and co-workers found the hydroboration of 
enamides proceeds through a dehydrogenative borylation followed by hydrogenation 
(Figure 34).
43
  The vinyl boronate (the product from dehydrogenative borylation) was 
isolated in 15% yield along with the net hydroboration product (i.e., 70% of the reduced 
boronate ester).  To distinguish between a classical hydroboration mechanism and the 
two-step dehydrogenative borylation/hydrogenation mechanism, a trisubstituted enamine 
resistant to hydrogenation was used; hydroboration of 1-pyrrolidino-1-cyclopentene gave 
80% conversion to the vinyl boronate (observed by NMR).  
 
Figure 34 Dehydrogenative borylation and subsequent reduction reported by Westcott 
and co-workers 
 
     The dehydrogenative borylation/hydrogenation mechanism is admittedly not a perfect 
fit for the oxime-directed Rh-CAHB. We have not found the signature vinyl boronate (or 
the corresponding aldehyde upon oxidation) in crude reaction mixtures.   
11
B NMR 
analysis of the crude product mixtures before oxidative workup show peaks 
corresponding to trace amounts of unreacted tmdBH, the ortho- and gamma-borylated 
products, and borane degradation products (tris-tmdB);
39
  there are no peaks 
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corresponding to what one would expect for a vinyl boronate.  Finally, there isn’t a 
compelling explanation at this stage for the facile reduction of the presumed vinyl 
boranate with hydrogen. 
     The nature of the borane had a significant impact on the propensity to ortho-
metallate.  Treating ,-unsaturated substrate 16-d10 with 2 mol% 
[(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 and 2 equivalents catBH (in place of tmdBH) 
gives -alcohol 22 in low yield (20%), but no H/D exchange is not observed in 22 or the 
recovered starting material (Figure 35).  This suggests either a very different mechanism 
(perhaps the standard two-point binding CAHB mechanism) as a consequence of a 
lowered tendency for -bond metathesis as a function of borane.  To explore whether 
lack of ortho-H/D exchange is due to the non-catalyzed hydroboration by catBH, 
attempted hydroboration using only catBH resulted in 1-2% -alcohol
 
Figure 17 Catecholborane produces products with no H/D exchange 
 
          To summarize, tmdBH and catBH both form the -alcohol in comparable yields but 
labeling studies suggest different mechanisms account for unlabeled product formation 
(58% and 63%).  From the deuterium distribution, tmdBH may form the product through 
a dehydrogenative borylation followed by H2 (or HD) reduction; catBH affords the 
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product through the expected oxidative addition / reductive elimination pathway (Figure 
36).   
 
Figure 18 The nature of the borane determines how the -borylated products are formed. 
 
3.16 Competition and double labeling experiments indicate little or no crossover  
     The deuterium transfer observed in 21 seems to suggest that the deuterium is 
transferred intramolecularly, although it must be noted that there is a net loss of 
deuterium in 20, so there must be intermolecular pathways as well. To further probe the 
question of whether deuterium is mostly transferred inter- or intramolecularly, a series of 
competition and double labeling experiments were carried out.  First, ,-unsaturated 
substrate 6 and saturated analogue 2 were combined under the standard Rh-CAHB 
conditions with tmdBH (Figure 37).  It was possible to isolate most of the reactions 
products via flash chromatography, but unfortunately, the oxidized isobutyl derivative 
and the reduced starting material 2 proved inseparable.  However, 
1
H NMR analysis of 
the inseparable mixture indicates that saturated substrate 2 remains unchanged.  We 
therefore conclude that presence of the saturated substrate does not affect the yield of -
alcohol formation (52%).   
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Figure 19 Competition reaction between a saturated and unsaturated substrate produces 
no crossover in hydroboration products 
 
     The next series of experiments are double labeling experiments looking for deuterium 
crossover from isotopically labeled to unlabeled substrates; this would confirm whether 
the ortho-metallation liberated some undetermined, as of yet, deuterated intermediate.  
Chromatographic conditions were found to separate the hydroboration products derived 
from 1 (vinyl methyl substitutent) and 10 (cyclohexyl substituent).  For comparison 
purposes, ,-unsaturated substrates 16-d10 and 10 were individually reacted under the 
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standard standard Rh-CAHB conditions with 2 mol% 
[(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 and 2 equivalents tmdBH; each giving a 
mixture of reduced product, ortho-borylated and reduced product, and the expected -
alcohol hydroboration product (Figure 38).  A 1:1 mixture of 16-d
10
 and 10 were 
similarly reacted and the products separated after oxidation. While some differences can 
be noted, the mixture of substrates gave results that were overall quite similar to the 
individual experiments. First and foremost, the yields of -alcohol (i.e., 21 and 13) were 
unchanged in the competition reaction compared to the individual reactions, and most 
importantly, no deuterium crossover was found between labeled and unlabeled substrates.  
The ortho-borylated/reducted products 12 and 20 were also essentially unchanged in 
yield, the distribution of deuterium was unchaged in 20, and 12 did not pick up any 
deuterium via crossover. The reduced products 19 and 11 behaved quite differently. The 
isotopically labeled 19 was obtained in somewhat lower yield under the completion 
conditions (i.e., 3% versus 10%), although given the complex mixture obtain, it is not 
clear how significant that difference is; its deuterium distribution is, however, unchanged. 
Reduced product 11 (7% yield compared to 28% performed in the individual reaction) 
surprisingly incorporates one deuterium via aryl H/D-exchange.  In addition, recovered 
10 (7%) is now doubly deuterated on the alkene; note that the latter could not be 
separated from the starting material so its assignment is tentative but might be taken as 
evidence of the previously described dehydrogenative borylation/reduction pathway. The 
source of the deuterium which transfers to the unlabeled material is likely from ortho-
borylated product 20 since, as in its individual experiment, a total of 1.6 deuterium atoms 
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undergo H/D-exchange, of which 1 is transferred intramolecularly.  It seems remarkable, 
but totaling the deuterated crossover products accounts for essentially all of the 0.6 
deuterium atoms lost in forming 20.  
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Figure 20 Competition experiment with labeled and unlabeled substrates reveal no 
crossover in gamma-alcohol formation - only reduced.  Reaction conditions A:  2 mol% 
Rh(nbd)2BF4, 4.1 mol% (XTADDOL)PN(Me)Ph, 2.0 equiv tmdBH, THF, rt, 16 h.  
Oxidative workup:  NaBO3, THF/H2O 
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    One possible explanation for presence of deuterium on the alkene in recovered 10 is a 
decreased rate of hydrogenation; recall no recovered starting material had shown the 
wash in of deuterium into substrate 1.  Experimentally, this indeed seems to be the case. 
Attempted rhodium-catalyzed hydrogenation of 10 using the standard reaction conditions 
with 0.4 equivalents tmdBH and a hydrogen atmosphere, 10 affords only 54% of the 
reduced product 11; in contrast, 1 gives the reduced product quantitatively under these 
conditions (Figure 39).   
 
Figure 21 Hydrogenation with cyclohexyl substituent has reduced reactivity compared to 
methyl substituent 
 
     Due to the slow reduction of 10, we wondered whether a labeled oxime derivative 
with a cyclohexyl alkene substituent would also show exchange of the vinyl hydrogens.  
,-Unsaturated substrate 23-d10 was synthesized and treated under Rh/tmdBH/H2-
hydrogenation conditions using 2% [(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4, 0.4 
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equivalents tmdBH under a H2 atmosphere (Figure 40).  The reduced product was 
isolated with 82% ortho-D substitution; this is comparable to the 83% ortho-D exchange 
from ,-unsaturated substrate 10-d10 under identical reaction conditions in a H2 
atmosphere (Figure 24).  The 
1
H NMR spectrum is shown below with deuterium 
incorporation at the -methyl ( 0.87 ppm) (Figure 40).  
 
 
Figure 40 Hydrogenation ,-unsaturated substrate 23-d10 incorporates deuterium into 
the products.  H NMR of portion of isolated reduced product 
 
     Rh-CAHB of ,-unsaturated substrate 23-d10 affords a product distribution not too 
dissimilar from its unlabeled isomer 10 (Figure 41) and all reaction products show 
quantitative ortho-H/D exchange.  There are some subtle differences in the redistribution 
of that deuterium. The reduced products incorporated one deuterium on the -methyl as 
before, but the -alcohol 25 incorporates only 50% deuterium on the methyl substituent 
and no deuterium is incorporated on the -carbon or the cyclohexyl ring; this differs from 
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16-d
10
 for which there was complete deuterium transfer to two positions in the product.  
Whether this has significance to the mechanism is not clear
 
Figure 41 Hydroboration of d
10
-labeled benzophenone oxime with cyclohexyl substituent 
gives deuterium incorporation onto the product 
 
3.17 Synthesis of deuterium-labeled boranes and the unusual loss of label in the 
oxime-directed Rh-CAHB. 
          Deuterated boranes are commonly used for exploring the mechanism of the 
hydroboration reaction, and we sought to carry out studies with tmdBD to compare to 
those described above; however, this proved to be problematic.  While there are several 
reports of the preparation of deuterated borane reagents, many authors using such 
reagents do not isotopic purity of the borane used.  The most common methods for 
preparing deuterated boranes is via the reaction of BD3-THF or PhN(Et)2-BD3
99,100
 with 
the diol backbone of choice.  In our hands reacting with the 2-methyl-2,4-pentadiol, we 
find up to 20% tmdBH contaminates the tmdBD after distillation.  Since BD3 is prepared 
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from 99% D-incorporated NaBD4, we attribute the source of hydrogen to exchange from 
the diol.      
     To address this problem, two routes were recently reported to facilitate H/D exchange 
using iridium catalysts and D2 (Figure 42).  Hartwig and co-workers reported an iridium 
catalyst reported to reduce dipinacolborane (B2pin2) to pinBD in 80% yield.
101
  
Alternatively, Nolan and co-workers reported low catalyst loadings (0.1 mol% Ir catalyst) 
for the deuteration of boranes under relatively mild conditions 10 atm D2.
102
  Nolan’s 
approach was reported for a series of boranes structurally similar to those used in our 
research, so this approach was attempted first.   
 
Figure 42 Preparation of tmdB-D with a high degree of isotopic purity 
 
     Nolan’s iridium-NHC catalyst was prepared as described in Figure 43.103   The 
catalyst is labile, so only small quantities of catalyst (<100 mg) were prepared used fresh. 
Repeating Nolan’s deuteration conditions (0.1 mol% catalyst loading with 10 psi D2) 
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afforded tmdBD with approximately 86% deuterium incorporation as determined by 
1
H 
NMR analysis.  Fortunately, increasing the catalyst loading to 0.3 mol% and the D2 
pressure to 30 psi improved the H/D-exchange; isotopic incorporation of greater than 
90% D was achieved as estimated from 
1
H NMR and 
11
B NMR (Figure 43).  
 
 
Figure 43 Ir-NHC catalyst affords deuterated tmdBD 
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     The reaction of ,-unsaturated substrate 1 with 2 equivalents of freshly prepared 
tmdBD under the standard reaction conditions (2 mol% 
[(nbd)Rh((XTADDOL)PN(Me)Ph)2]BF4 catalyst in THF) gave quite unexpected results 
(Figure 44).  While the yields of the now expected reduced, ortho-hydroxylated and 
reduced, and -alcohol hydroboration products were comparable to those obtained with 
tmdBH, there is little to no deuterium incorporation on the  or -substituents.  Only the 
ortho-hydroxylated and reduced product has a low percentage (ca. 35%) of deuterium 
incorporation at the -position of the reduced material.  In contrast, neither the reduced 
product nor the -alcohol had deuterium incorporated at the  or -positions.  
Furthermore, aryl H/D-exchange was also low; only about 50% deuterium incorporation 
was observed for the reduced and hydroboration products. 
   
Figure 44 CAHB with labeled borane reveals a loss of deuterium label in the 
hydroboration products. 
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          The source of the hydrogen to account for lost deuterium is puzzling and currently a 
topic under investigation in the Takacs labs.  Finding the source of the hydrogen is 
important.  The competing formation of reduced products compromises the efficiency of 
our CAHB reactions, and not only ours, those of other researchers, too. Thus far, it has 
been assumed that the reduced products arise from H2 produced in the decomposition of 
the borane. The decomposition of tmdBD should generate D2, but we find no deuterium 
incorporation into the reduced product and the regioselective incorporation of 35% 
deuterium in the ortho-borylated and reduced product above is not consistent with 
hydrogenation by D2.  Why would the latter reaction be regioselective, if the deuterium 
comes from D2?  The source of reduction seems in reality be more complicated than a 
simple scavenging of available H2 or D2; it is time to get that story sorted out.   
     As for potential sources of hydrogen, we know is that the mass balance accounts for 
ca 90% of the material, largely eliminating substrate decomposition as a viable source of 
hydrogen.  Hydrogen involved in reduction must come from a source previously believed 
to be innocuous; the likely sources are ligand, diene (i.e., norbornadiene or 1,5-
cylooctadiene), or solvent (tetrahydrofuran).  The substoichiometric amounts of ligand 
and diene available do not seem to be a viable source of hydrogen, but there is some 
precedent suggesting that THF could be an option.  Yi and Leung reported that a 
rhodium(III)-alkyl complex catalyzed the H/D-exchange of THF from D2O, albeit at high 
temperature and long reaction times (135 °C, 40 h) (Figure 45).104  For the oxime-
directed CAHB, experiments in deuterated solvents are currently underway to investigate 
whether THF is the source of H.   
185 
 
 
Figure 45 Deuteration of THF with a Rh(III) catalyst.  Adapted from Ref 104 with 
permission from John Wiley and Sons. 
 
     Others in the Takacs lab have picked up the study of oxime ethers at this point.  To 
prevent aryl-H/D exchange, acetone-, cyclohexyl, and cyclopentyl-derived oxime ethers 
are currently under investigation (Figure 46).    
 
Figure 46 Next generation of functionalized oximes for the directed CAHB. 
 
3.18 Conclusions and Future Directions 
     At this point in the studies, the mechanistic understanding of oxime-directed Rh-
CAHB is still not complete.  However, many important observations have been found for 
planning future studies.  Isolation of the ortho-hydroylated material proved Rh-catalyzed 
ortho-metallation transpired.  Had the C-H not been functionalized, this reaction pathway 
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may have gone unnoticed.  The proximity of the alkene to the ortho-H was key for ortho-
metallation to occur.  ,-unsaturated alkenes were required for ortho-metallation to 
occur suggesting a Rh(III)-alkyl intermediate is likely involved.  Subsequent labelling 
studies of the benzophenone oximes revealed metallation to be selective.  Deuterium 
transfer to the reacting alkene was observed in both reduction and hydroboration 
products.  In contrast, deuterium-labeled borane afforded hydroboration products missing 
deuterium incorporation suggesting the borane-D(H) was lost before migratory insertion 
of the alkene.  More importantly, this loss of deuterium gives mechanistic evidence for 
the source of reduced product formation; Reduction during Rh-CAHB may turn out to be 
more sophisticated than a simple H2 reduction.  This has broad implications not only to 
future labeling studies, but to sequestering the troublesome reduction step encountered in 
various organic transformations.   
     For future studies, either the hydroboration or the C-H activation could be further 
optimized.  To exploit the hydroboration reaction, varying the borane or the ligating 
groups could lead to higher yields of desired hydroboration products.  Takacs et al 
previously reported that the influence of the borane has a substantial role in selectivity 
and reactivity for Rh-CAHB.
47
    Exploration of boranes may provide a catalyst system 
capable of avoiding C-H activation as was found with Rh-CAHB with catecholborane.  
Screening monodentate and bidentate ligands with various electronic and steric properties 
may dissuade the reaction from progressing through the undesired C-H activation 
pathway.   
187 
 
     A more interesting approach is taking advantage of the C-H activation.  Additives 
could be used to trap the ortho-metalated species for further product functionalization.  
For example, reactions run under a carbon monoxide atmosphere could form aldehydes.  
Furthermore, ortho-D was transferred quantitatively to the -substituents in the Rh-
CAHB of deuterium-labeled oximes.  If fluorine were substituted for deuterium, fluorine 
transfer generates a new stereocenter with a net addition of H-F to the alkene (Figure 47).  
 
Figure 47 Rh-CAHB of flourinated benzaldehydes may reveal valuable transformations 
   
     In conclusion, this ongoing study has demonstrated the complexity of the Rh-CAHB.  
The mechanism may vary from depending on the choice of directing group, catalyst, 
borane, and proximity of directing group to the alkene.  While selectivity and yields 
obtained in these studies were modest, the ortho-metallation under mild conditions may 
be further exploited in future studies.  The largest contribution from this challenging 
study was observation of reduction products being formed through an indirect 
hydrogenation or hydroboration.  Further insight into the reduction mechanism and 
source of H2 could prove generally beneficial to organometallic catalysis.   
 
3.19 Experimental 
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 Reactions were carried out under a dry nitrogen atmosphere.  Tetrahydrofuran (THF) 
was freshly distilled from sodium metal and benzophenone.  Dichloromethane (DCM), 
methanol (MeOH), benzene, and toluene were dried with 4Å molecular sieves.  All 
synthesized compounds were purified using flash chromatography with the indicated 
solvents on Silica Gel 60 Geduran®.  Thin layer chromatography analyses were 
performed on Silica Gel HLF (250 microns) precoated analytical plates and visualized 
with use of handheld short wavelength UV light, vanillin stain (ethanol, H2SO4, and 
vanillin), or ninhydrin stain (ethanol, acetic acid, and ninhydrin).  NMR spectra were 
recorded on a 400 MHz spectrometer using CHCl3 ( 7.27 ppm), CDCl3 ( 77.0 ppm), 
DMSO ( 2.54 ppm), or d6-DMSO ( 40.45 ppm).  Peaks are expressed as m (unresolved 
multiplet), q (quartet), t (triplet), d (doublet), s (singlet), bs (broad singlet).  IR spectra 
were recorded by FT-IR using the ATR technique (ZnSe).  Optical rotations were 
measured in solutions, 1.0 g/100 mL CHCl3 unless indicated otherwise and recorded 
using a Rudolph Autopol III automatic polarimeter.  HRMS analyses were performed by 
the Nebraska Center for Mass Spectrometry.   
 
 
A mixture of benzophenone (5.00 g, 27.4 mmol), hydroxylamine hydrochloride (2.48 g, 
35.7 mmol), and sodium acetate (2.92 g, 35.7 mmol) in MeOH (100 mL) was placed in 
250 mL round-bottomed flask with a reflux condensor.  The reaction mixture was heated 
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to reflux for 4 hours.  The reaction mixture was cooled to room temperature.  The crude 
reaction mixture was concentrated under reduced pressure.  The remaining solid was re-
dissolved in EtOAc (100 mL) and washed with water (3 x 30 mL).  The organic extract 
was dried with Na2SO4, filtered, and concentrated yielding a white solid.  The solid was 
recrystallized from ethyl acetate/hexanes and dried under white vacuum affording 27 
(4.87 g, 90%) as a white powder-like solid (mp 138-140 °C).  TLC analysis (30:70 ethyl 
acetate/hexanes) showed a spot at Rf 0.3; 
1
H NMR (400 MHz, CDCl3)  9.29 (1H, s), 
7.54-7.36 (10H, m); 
13
C NMR (100 MHz, CDCl3)  158.0, 136.2, 132.7, 129. 6, 129.3, 
129.2, 128.4, 128.3, 127.9; IR (neat) 3419 (N=OH), 3074 (Aromatic C-H) cm
-1
 
 
 
2-hydroxy-benzophenone (1 g, 5.04 mmol) was converted to 2-hydroxybenzophenone 
oxime 28 using the procedure for benzophenone oxime 27 affording 28 (989 mg, 92%) as 
a white powder.  TLC analysis (70:30 ethyl acetate/hexanes) showed a spot at Rf 0.2; 
1
H 
NMR (400 MHz, CDCl3)  11.24 (1H, s), 7.57-7.52 (3 H, m), 7.38-7.35 (2H, m), 7.31-
7.30 (2H, m), 7.28-7.25 (2H, m), 7.06-7.03 (1H, m), 6.91-6.85 (1H, m), 6.78 (1H, t, J = 
7. 9 Hz); 
13
C NMR (100 MHz, CDCl3)  162.3, 126.1, 157.9, 139.4, 131.1, 131.0, 131.0, 
130.8, 130.8, 130.7, 129.3, 126.2, 128.5, 128.5, 128.5, 128.4, 127.9, 119.1, 119.1, 118.7, 
118.6, 117.1, 117.1 IR (neat) 3377 (N-OH), 3311 (ArOH), 3031 (Aromatic C-H) cm
-1
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D10-benzophenone (5.29 g, 27.5 mmol) was converted to D10-benzophenone oxime 29 
using the procedure for benzophenone oxime 27 affording 29 (5.23 g, 92%) as a white 
powder.  TLC analysis (30:70 ethyl acetate/hexanes) showed a spot at Rf 0.3; 
1
H NMR 
(400 MHz, CDCl3)  9.44 (1H, s), 7.52-7.34 (.06 H, m); 
13
C NMR (100 MHz, CDCl3)  
157.9, 136.1, 132.5, 129.3, 129.2, 129.1, 128.9, 128.7, 128.1, 128.0, 127.9, 127.8, 127.7, 
127.5, 127.3; IR (neat) 3233 (N-OH) cm
-1
; HRMS (EI):  Calcd. For C13HD10NO (M): 
207.1468, found 207.1464 m/z. 
Preparation of allylic alcohols 
 
 
A mixture of magnesium (14.3 g, 589 mmol) and iodine (catalytic) in THF (10 mL) was 
placed in a 500 mL 3-neck round-bottomed flask with a reflux condenser and addition 
funnel.  2-methyl-1-bromo-propane (80.6 g, 589 mmol) in 200 mL THF was added to the 
addition funnel and slowly added to magnesium solution with applied heat until reaction 
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initation.  Rate of addition was adjusted to safely maintain reflux.  To a separate 1 L 
round bottomed flask was added propargyl alcohol (10.0 g, 178 mmol) and copper iodide 
(34.0 g, 178 mmol).  The reaction mixture was purged with N2 three times.  A 1:1 
mixture of THF/benzene (400 mL) was added to the copper iodide flask and the reaction 
mixture was cooled to -78 °C.  The solution of isopropenylmagnesium bromide was 
added dropwise.  The reaction was allowed to warm to room temperature and stirred 
overnight.  The crude reaction mixture was washed with NH4Cl (satd) (100 mL) and 
extracted with EtOAc (3 x 100 mL).  The organic extracts were combined and washed 
with brine (1 x 50 mL).  The organic extract was dried with MgSO4, filtered, 
concentrated yielding an orange oil.  Flash chromatography on silica gel (30:70 
EtOAc/hexanes) afforded 30 (12.8 g, 62%) as a clear oil.  TLC analysis (25:75 ethyl 
acetate/hexanes) showed a spot at Rf 0.3; 
1
H NMR (400 MHz, CDCl3)  5.07 (1H, s), 
4.87 (1 H, s), 4.07 (2H, d, J = 6.0 Hz), 1.97-1.73 (1H, m), 0.91 (3H, d, J = 6.6 Hz); 
13
C 
NMR (100 MHz, CDCl3)  147.9, 110.3, 65.9, 42.8, 26.3, 22.5; IR (neat) 3376 (OH), 
3051 (alkene C-H),2961 (C-H),  1773 (C=C), 976 (C-O) cm
-1
 
 
Cyclohexyl bromide (102 g, 743 mmol) was converted to cyclohexyl substituted allylic 
alcohol 31 using the procedure for 30 affording 31 (15.5 g, 56%) as a clear oil.  TLC 
analysis (30:70 ethyl acetate/hexanes) showed a spot at Rf 0.3; 
1
H NMR (400 MHz, 
CDCl3)  9.44 (1H, s), 7.52-7.34 (.06 H, m); 
13
C NMR (100 MHz, CDCl3)  157.9, 
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136.1, 132.5, 129.3, 129.2, 129.1, 128.9, 128.7, 128.1, 128.0, 127.9, 127.8, 127.7, 127.5, 
127.3; IR (neat) 3300 (OH), 2921 (alkene C-H), 2838 (C-H), 1639 (C=C), 1010 (C-O) 
cm
-1
 
 
Preparation of Allylic Carbonates  
 
 
To a cooled solution (0 °C) of isobutyl allylic alcohol 30 (10.0 g, 87.6 mmol) and DMAP 
(535 mg, 4.38 mmol) in DCM (150 mL) was slowly added pyridine (13.9 g, 175 mmol).  
Ethyl chloroformate (11.4 g, 105 mmol) was added dropwise over the course of 15 
minutes.  The reaction mixture was allowed to warm to room temperature overnight. The 
reaction mixture was washed with water (3 x 25 mL).  The organic extracts were dried 
with Na2SO4, filtered,  and concentrated yielding a faint yellow oil.  The crude reaction 
mixture was purified via flash chromatography on silica gel (30:70 DCM/hexanes) 
afforded 32 (15.0 g, 92%) as a clear oil.  TLC analysis (30:70 DCM/hexanes) showed a 
spot at Rf 0.5; 
1
H NMR (400 MHz, CDCl3)  5.11 (1H, s), 4.95 (1 H, s), 4.22 (2H, q, J = 
7.2 Hz), 1.98 (2H, d, J = 7.2 Hz), 1.82-1.76 (1H, m), 1.33 (3H, t, J = 7.1 Hz), 0.89 (6H, d, 
J = 9.8 Hz); 
13
C NMR (100 MHz, CDCl3)  155.1, 142.3, 113.8, 69.9, 64.0, 42.8, 26.2, 
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22.4, 14.3; IR (neat) 2954 (C-H stretch), 1739 (C=O stretch), 1649 (C=C stretch), 1250 
(C-O stretch) cm
-1
 
 
 
Cyclohexyl allylic alcohol 31 (13.6 g, 88.2 mmol) was converted to cyclohexyl 
substituted ethyl carbonate 31 using the procedure for 32 affording 33 (17.8 g, 95%) as a 
clear oil.  TLC analysis (30:70 DCM/hexanes) showed a spot at Rf 0.6; 
1
H NMR (400 
MHz, CDCl3)  5.06 (1H, s), 4.97 (1 H, s), 4.62 (2H, s), 4.23 (2H, q, J = 6.4 Hz), 1.98 
(1H, t, J = 11.5 Hz), 1.84-1.69 (5H, m), 1.35-1.17 (8H, m); 
13
C NMR (100 MHz, CDCl3) 
 155.1, 148.7, 111.1, 69.4, 64.0, 41.2, 32.1, 26.6, 26.2, 14.3; IR (neat) 2928 (C-H 
stretch), 1744 (C=O stretch), 1721 (C=C stretch), 1237 (C-O stretch)cm
-1
 
 
Preparation of unsaturated and saturated substrates 
Substrates were alkylated with oximes via 2 methods:  Method A (Alkylation) or Method 
B (Pd-catalyzed substitution) 
Method A:  Alkylation 
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To a cooled solution of benzophenone oxime (2.00g, 10.1 mmol) and catalytic t-butyl 
ammonium iodide (187 mg, 0.51 mmol) in a mixture of 1:1 DMF/THF (100 mL) was 
added dry NaH (316 mg, 13.2 mmol).  3-chloro-2-methyl-1-propene (1.19g, 13.2 mmol) 
was added dropwise.  The reaction mixture was stirred for 30 minutes at 0 °C.  The 
septum was removed and an oven-dried reflux condenser flushed with N2 was added to 
the round bottom flask.  The reaction mixture was heated at 70 °C for 4 hours.  The 
reaction mixture was cooled to 0 °C and water was added dropwise (2 mL).  A 3:1 
Et2O/water was added to the reaction mixture.  The organic extracts were dried with 
Na2SO4, filtered, and concentrated affording a yellow oil.  The crude reaction mixture 
was purified via flash chromatography on silica gel (30:70 DCM/hexanes) afforded 1 
(2.14 g, 84%) TLC analysis (30:70 DCM/hexanes) showed a spot at Rf 0.6; 
1
H NMR 
(400 MHz, CDCl3)  7.52-7.32 (10H, m), 4.97 (1H, s), 4.92 (1H, s), 4.64 (1H, s), 1.77 
(3H, s); 
13
C NMR (100 MHz, CDCl3)  156.7, 142.1, 136.6, 133.5, 129.2, 128.8, 128.2, 
128.1, 127.9, 112.2, 78.24, 19.7; IR (neat) 3054 (C-H aromatic stretch), 2908 (C-H 
aliphatic), 1652 (C=C stretch), 1501 (C=N stretch), 1441 (N-O stretch), 979 (C-O stretch) 
cm
-1
 
 
 
D10-benzophenone oxime 29 (2 g, 9.65 mmol) was converted to isotopically labeled 
benzophenone oxime 16 using the procedure for 1 affording 16 (2.02 g, 80%) as a white 
195 
 
powder.  TLC analysis (70:30 DCM/hexanes) showed a spot at Rf 0.5; 
1
H NMR (400 
MHz, CDCl3)  4.97 (1H, s), 4.92 (1H, s), 4.64 (2H, s), 1.77 (3H, s); 
13
C NMR (100 
MHz, CDCl3)  142.11, 112.24, 78.24, 19.66; IR (neat) 2910 (C-H aliphatic), 1659 (C=C 
stretch), 1438 (N-O stretch), 982 (C-O stretch) cm
-1
 
 
 
To a cooled solution of benzophenone oxime 27 (2.00g, 10.1 mmol) and catalytic t-butyl 
ammonium iodide (187 mg, 0.51 mmol) in a mixture of 1:1 DMF/THF (100 mL) was 
added dry NaH (316 mg, 13.2 mmol).  1-bromo-2-methylpropane (1.72 g, 13.2 mmol) 
was added dropwise.  The reaction mixture was stirred for 30 minutes at 0 °C.  The 
septum was removed and an oven-dried reflux condenser flushed with N2 was added to 
the round bottom flask.  The reaction mixture was heated at 70 °C for 4 hours.  The 
reaction mixture was cooled to 0 °C and water was added dropwise (2 mL).  A 3:1 
Et2O/water was added to the reaction mixture.  The organic extracts were dried with 
Na2SO4, filtered, and concentrated affording a yellow oil.  The crude reaction mixture 
was purified via flash chromatography on silica gel (30:70 DCM/hexanes) afforded 2 
(2.24 g, 92%) as a clear oil.  TLC analysis (30:70 DCM/hexanes) showed a spot at Rf 
0.6; 
1
H NMR (400 MHz, CDCl3)  7.51-7.31 (10H, m), 3.98 (2H, d, J = 6.8 Hz), 2.12-
2.02 (1H, m), 0.93 (6H, d, J = 6.7 Hz); 
13
C NMR (100 MHz, CDCl3)  156.1, 136.44, 
135.6, 129.3, 129.1, 128.6, 128.2, 128.0, 127.8, 81.2, 28.1, 19.2; IR (neat) 3054 (C-H 
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aromatic stretch), 2958 (C-H aliphatic), 1588 (C=N stretch), 1438 (N-O stretch), 996 (C-
O stretch) cm
-1
 
 
 
2-hydroxylbenzophenone oxime  28 (500 mg, 2.34 mmol) was converted to ortho-
hydroxylated oxime 3 using the procedure for 2 affording 3 (126m g, 20%) as a clear oil.  
TLC analysis (10:90 EtOAc/hexanes) showed a spot at Rf 0.7; 
1
H NMR (400 MHz, 
CDCl3)  11.2 (1H, s), 7.52-7.47 (3H, m), 7.32-7.24 (3H, m), 7.03 (1H, d, J = 8.9 Hz), 
6.84-6.77 (1H, m), 6.73 (1H, t, J = 8.0 Hz), 3.94 (2H, d, J = 6.9 Hz), 2.10-2.00 (1H, m), 
0.90 (2H, d, J = 6.72 Hz); 
13
C NMR (100 MHz, CDCl3)  160.3, 158.2, 132.0, 130.7, 
130.5, 128.9, 128.4, 128.3, 118.8, 118.8, 117.1, 81.5, 27.9, 19.0; IR (neat) 3055 (C-H 
aromatic stretch), 2958 (C-H aliphatic), 1588 (C=N stretch), 1438 (N-O stretch), 996 (C-
O stretch) cm
-1
 
 
Methyl-2-(((diphenylmethylene)amino)oxy) acetate (methyl ester analogue 14) Methyl 
bromoacetate (814 mg, 5.3 mmol) and benzophenone oxime 27 (1.0 g, 5.1 mmol) were 
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converted to methyl ester 14 (784 mg, 61%) as a colorless oil using the procedure for 
benzophenone alkylation for 2.  TLC analysis (30:70 EtOAc/hexanes) showed a spot at 
Rf 0.7; 
1
H NMR (400 MHz, CDCl3)  7.51-7.32 (10H, m), 4.76 (2H, s), 3.80 (3H, s); 
13
C 
NMR (100 MHz, CDCl3)  170.6, 158.5, 136.02, 133.0, 129.6, 129.4, 129.1, 128.2, 
128.2, 128.1, 71.0, 51.9; IR (neat) 3070(C-H aromatic stretch), 2945 (C-H aliphatic), , 
1747 (C=O), 1435 (N-O stretch), 1084 (C-O stretch) cm
-1 
 
Benzophenone O-prop-2-yn-1-yl-oxime (alkyne analogue 15) Propargyl bromide (633 
mg, 5.32 mmol) and benzophenone oxime 27 (1.0 g, 5.1 mmol) were converted to ,-
alkyne 15 (924 mg, 77%) as a colorless oil using the procedure for benzophenone 
alkylation for 2.  TLC analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.9; 
1
H NMR 
(400 MHz, CDCl3)  7.55-7.34 (10H, m), 4.80 (2H, d, J = 2.4 Hz), 2.49 (1H, t, J = 2.3 
Hz); 
13
C NMR (100 MHz, CDCl3)  158.3, 136.2, 133.0, 129.6, 129.4, 129.0, 128.3, 
128.2, 128.1, 80.0, 74.4, 62.0; IR (neat) 3280 (sp C-H stretch), 2910 (C-H aliphatic), 
1446 (N-O stretch), 1011 (C-O stretch) cm
-1
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D10-benzophenone oxime 29 (500 mg, 2.41 mmol) was converted to isotopically labeled 
benzophenone oxime 18 using the procedure for 2 affording 18 (604 mg, 95%) as a 
colorless oil.  TLC analysis (70:30 DCM/hexanes) showed a spot at Rf 0.5; 
1
H NMR 
(400 MHz, CDCl3)  3.98 (2H, d, J = 6.8 Hz), 2.11-2.02 (1H, m), 0.93 (6H, d, J = 6.7 
Hz); 
13
C NMR (100 MHz, CDCl3)  81.2, 28.1, 19.2 
 
Method B:  Pd-catalyzed substitution  
 
 
To a mixture of benzophenone oxime 27 (2.00 g, 10.1 mmol), Pd2(dba)3  (194 mg, 0.21 
mmol), and dppb (216 mg, 0.51 mmol) in  THF (40 mL) was added isobutyl carbonate 32 
(1.58 g, 8.47 mmol). The reaction mixture was stirred overnight at room temperature.  
The reaction mixture was concentrated in vacuo and purified via flash chromatography 
on silica gel (20:80 DCM/hexanes) affording 6 (2.33 g, 94%) as a clear oil.  TLC analysis 
(10:90 EtOAc/hexanes) showed a spot at Rf 0.9; 
1
H NMR (400 MHz, CDCl3)  7.52-7.32 
(10H, m), 5.03 (1H, s), 4.89 (1H, s), 4.65 (2H, s), 1.96-1.84 (2H, m), 1.83-1.74 (1H, m),  
0.88 (6H, d, J = 6.5 Hz); 
13
C NMR (100 MHz, CDCl3)  156.7, 144.8, 136.6, 133.5, 
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129.2, 128.7, 128.2, 128.0, 127.9, 112.9, 77.3, 43.3, 26.0, 22.5; IR (neat) 3058 (C-H 
aromatic stretch), 2951 (C-H aliphatic), 1655 (C=C stretch), 1488 (C=N stretch), 1437 
(N-O stretch), 969 (C-O stretch) cm
-1
 
 
Cyclohexyl carbonate  33 (1.80 g, 8.46 mmol) was converted to ,-unsaturated 
cyclohexyl substrate 10 using the procedure for 6 affording 10 (2.48 g, 92%) as a clear 
oil.  TLC analysis (10:90 EtOAc/hexanes) showed a spot at Rf 0.9; 
1
H NMR (400 MHz, 
CDCl3)  7.49-7.31 (10H, m), 4.97 (1H, s), 4.89 (1H, s), 4.71 (1H, s), 1.95 (1H, t, J = 
11.3 Hz), 1.80-1.67 (5H, m), 1.32-1.11 (5H, m); 
13
C NMR (100 MHz, CDCl3)  156.7, 
151.0, 136.6, 133.6, 129.2, 128.7, 128.2, 128.0, 127.9, 109.9, 76.9, 41.4, 32.2, 26.8, 26.3; 
IR (neat) 3084 (C-H aromatic stretch), 2925 (C-H aliphatic), 1642 (C=C stretch), 1441 
(N-O stretch), 976 (C-O stretch) cm
-1
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Typical reduction reaction procedure with sub-stoichiometric tmdBH addition 
 
To a vial containing Rh(nbd)2BF4 (3.0 mg, 7.93 μmol) was added L2 (11.4 mg, 16.0 
μmol) in THF (1 mL) and stirred for 1 hour for complexation (solution changes from 
colorless to yellow instantaneously).  A 1 mL aliquot of the resulting Rh[(L2)2(nbd)]BF4 
solution was added to a 50 mL round bottom flask with stir bar.  The resulting yellow 
solution was added ,-unsaturated oxime 1 (66.3 mg, 0.11 mmol) as a solution in THF 
(2 mL).  The reaction mixture was stirred for 30 minutes at RT and then cooled in an ice 
bath.  To the cooled solution (0 °C) was added dropwise (over the course of 2 minutes) a 
solution of 4,4,6-trimethyl-1,3,2-dioxaborinane (tmdBH, B1, 13.5 mg, 0.53 mmol) in 
THF (1 mL).  The reaction vessel was evacuated and added a H2 balloon.  The mixture 
was allowed to warm to room temperature and stirred for 16 hours.  The reaction mixture 
was added a 1:3 water/THF mixture (4 mL).  NaBO3-monohydrate (300 mg, 300 mmol) 
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was added and the reaction mixture was stirred vigorously.  After a 6 hour stir, the 
resultant mixture was extracted with EtOAc (3 x 15 mL) and the combined organic 
extracts were dried with Na2SO4, filtered, and concentrated under reduced pressure.  The 
crude reaction mixture was purified via flash chromatography on silica gel (30:70 
DCM/hexanes) afforded 2 as a colorless oil. 
 
Benzophenone O-isobutyl  oxime (Reduced product 2) TLC analysis (10:90 
EtOAc/hexanes) showed a spot at Rf 0.9; 
1
H NMR (400 MHz, CDCl3)  7.51-7.31 (10H, 
m), 3.98 (2H, d, J = 6.8 Hz), 2.12-2.02 (1H, m), 0.93 (6H, d, J = 6.7 Hz); 
13
C NMR (100 
MHz, CDCl3)  156.1, 136.44, 135.6, 129.3, 129.1, 128.6, 128.2, 128.0, 127.8, 81.2, 
28.1, 19.2; IR (neat) 3054 (C-H aromatic stretch), 2958 (C-H aliphatic), 1588 (C=N 
stretch), 1438 (N-O stretch), 996 (C-O stretch) cm
-1
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Typical hydroboration reaction 
 
To a vial containing Rh(nbd)2BF4 (3.0 mg, 7.93 μmol) was added L2 (11.4 mg, 16.0 
μmol) in THF (1 mL) and stirred for 1 hour for complexation (solution changes from 
colorless to yellow instantaneously).  A 1 mL aliquot of the resulting Rh[(L2)2(nbd)]BF4 
solution was added to a 50 mL round bottom flask with stir bar.  The resulting yellow 
solution was added ,-unsaturated oxime 1 (66.3 mg, 0.26 mmol) as a solution in THF 
(2 mL).  The reaction mixture was stirred for 30 minutes at RT and then cooled in an ice 
bath.  To the cooled solution (0 °C) was added dropwise (over the course of 20 minutes) 
a solution of 4,4,6-trimethyl-1,3,2-dioxaborinane (tmdBH, B1, 67.6 mg, 0.53 mmol) in 
THF (1 mL).  The mixture was allowed to warm to room temperature and stirred for 4 
hours.  Afterwards, the reaction mixture was concentrated and reduced product 2 was 
separated via flash chromatography on silica gel (20:80 EtOAc/hexanes) as a clear oil.  
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The inseparable ortho-borylated and -borylated products were concentrated and added a 
1:3 water/THF mixture.  NaBO3-monohydrate (300 mg, 300 mmol) was added and the 
reaction mixture was stirred vigorously.  After a 6 hour stir, the resultant mixture was 
extracted with EtOAc (3 x 15 mL) and the combined organic extracts were dried with 
Na2SO4, filtered, and concentrated under reduced pressure.  The crude reaction mixture 
was purified via flash chromatography on silica gel (20:80 EtOAc/hexanes) afforded 3 
and 4 as colorless oils. 
 
Benzophenone O-isobutyl  oxime (Reduced product 2) ,-unsaturated substrate 1 (66.3 
mg, 0.24 mmol) was converted to reduced product 2 (6.8 mg, 10%) as a colorless oil.  
TLC analysis (10:90 EtOAc/hexanes) showed a spot at Rf 0.9; 
1
H NMR (400 MHz, 
CDCl3)  7.51-7.31 (10H, m), 3.98 (2H, d, J = 6.8 Hz), 2.12-2.02 (1H, m), 0.93 (6H, d, J 
= 6.7 Hz); 
13
C NMR (100 MHz, CDCl3)  156.1, 136.44, 135.6, 129.3, 129.1, 128.6, 
128.2, 128.0, 127.8, 81.2, 28.1, 19.2; IR (neat) 3054 (C-H aromatic stretch), 2958 (C-H 
aliphatic), 1588 (C=N stretch), 1438 (N-O stretch), 996 (C-O stretch) cm
-1
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(2-hydroxyphenyl)(phenyl methanone O-isobutyl oxime (Ortho-hydroxylated and 
reduced product 3) ,-unsaturated substrate 1 (66.3 mg, 0.24 mmol) was converted to 
ortho-hydroxylated / reduced product 3 (22.3 mg, 31%) as a colorless oil.  TLC analysis 
(10:90 EtOAc/hexanes) showed a spot at Rf 0.8; 
1
H NMR (400 MHz, CDCl3)  11.2 (1H, 
s), 7.52-7.47 (3H, m), 7.32-7.24 (3H, m), 7.03 (1H, d, J = 8.9 Hz), 6.84-6.77 (1H, m), 
6.73 (1H, t, J = 8.0 Hz), 3.94 (2H, d, J = 6.9 Hz), 2.10-2.00 (1H, m), 0.90 (2H, d, J = 6.7 
Hz); 
13
C NMR (100 MHz, CDCl3)  160.3, 158.2, 132.0, 130.7, 130.5, 128.9, 128.4, 
128.3, 118.8, 118.8, 117.1, 81.5, 27.9, 19.0; IR (neat) 3055 (C-H aromatic stretch), 2958 
(C-H aliphatic), 1588 (C=N stretch), 1438 (N-O stretch), 996 (C-O stretch) cm
-1
 
 
Benzophenone O-(3-hydroxy-2-methylpropyl) oxime (gamma-hydroxyl product 4) 
,-unsaturated substrate 1 (66.3 mg, 0.24 mmol) was converted to gamma-hydroxylated 
product 3 (40.7 mg, 57%) as a colorless oil. TLC analysis (30:70 EtOAc/hexanes) 
showed a spot at Rf 0.3; 
1
H NMR (400 MHz, CDCl3)  7.50-7.33 (10H, m), 4.29 and 
4.13 (2H, ddd, J1 = 4.6= Hz, J2 = 7.5 Hz), 3.64-3.52 (2H, m), 2.18-2.11 (1H, m), 2.01 
(1H, t, J = 5.5 Hz), 0.94 (3H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3)  157.2, 136.1, 
133.3, 129.5, 128.9, 128.9, 128.3, 128.2, 127.8, 77.9, 66.3, 35.8, 13.5; IR (neat) 3360 (O-
H stretch), 3041 (C-H aromatic stretch), 2924 (C-H aliphatic), 1585 (C=N stretch), 1434 
(N-O stretch), 989 (C-O stretch) cm
-1
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Benzophenone O-2-cyclohexylpropyl oxime (reduced product 11) ,-unsaturated 
substrate 10 (84.4 mg, 0.24 mmol) was converted to reduced product 11 (25.0 mg, 28%) 
as a colorless oil using the procedure for typical Rh-CAHB described for 1.  TLC 
analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.9; 
1
H NMR (400 MHz, CDCl3)  
7.52-7.33 (10H, m), 4.20 and 4.02 (2H, dd, J1 = 6.0 Hz, J2 = 10.2 Hz), 1.80-1.62 (6H, m), 
1.30-1.08 (6H, m), 0.88 (3H, d, J = 6.9 Hz); 
13
C NMR (100 MHz, CDCl3)  156.2, 136.7, 
133.6, 129.3, 129.1, 128.9, 128.6, 128.2, 127.9, 127.8, 78.3, 40.0, 37.8, 30.8, 28.9, 26.9, 
26.8, 26.7, 13.7; IR (neat) 3058 (C-H aromatic stretch), 2921 (C-H aliphatic), 1588 (C=N 
stretch), 1443 (N-O stretch), 980 (C-O stretch) cm
-1
 
 
Benzophenone O-2-cyclohexyl-3-hydroxypropyl oxime (gamma-hydroxyl product 13) 
,-unsaturated substrate 10 (84.4 mg, 0.24 mmol) was converted to gamma-
hydroxylated product 13 (53.5 mg, 60%) as a colorless oil using the procedure for typical 
Rh-CAHB described for 1.  Chiral HPLC analysis (Chiralcel OD, 70:30 
hexanes:isopropanol) showed peaks at 7.82 min and 8.47 min; TLC analysis (30:70 
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EtOAc/hexanes) showed a spot at Rf 0.3; 
1
H NMR (400 MHz, CDCl3)  7.51-7.33 (10H, 
m), 4.44-4.31 (2H, unresolved ddd), 3.68 (2H, t, J = 6.4 Hz), 2.01 (1H, t, J = 5.5 Hz), 
0.94 (3H, d, J = 7.0 Hz), 2.07-2.03 (1H, m), 1.75-1.00 (13 H, m);  
13
C NMR (100 MHz, 
CDCl3)  157.4, 136.0, 133.3, 129.5, 129.0, 128.8, 128.3, 128.3, 127.8, 75.7, 63.5, 46.0, 
36.9, 30.7, 30.5, 26.7, 26.6, 26.5; IR (neat) 3360 (O-H stretch), 3058 (C-H aromatic 
stretch), 2917 (C-H aliphatic), 1490 (C=N stretch), 1441 (N-O stretch), 981 (C-O stretch) 
cm
-1
 
 
Benzophenone O-(2-hydroxymethyl)-4-methylpentyl oxime (gamma hydroxylated 
product 9) ,-unsaturated substrate 6 (77.5 mg, 0.24 mmol) was converted to gamma-
hydroxylated product 3 (40.7 mg, 57%) as a colorless oil.  Chiral HPLC analysis 
(Chiralcel OD, 70:30 hexanes:isopropanol) showed peaks at 9:01 min and 9:55; min TLC 
analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.3; 
1
H NMR (400 MHz, CDCl3)  
7.51-7.34 (10H, m), 4.35 and 4.14 (2H, ddd, J1 = 4.0 Hz, J2 = 10.8 Hz), 3.64-3.63 (1H, 
m), 3.57-3.51 (1H, m), 2.12(1H, t, J = 5.5 Hz,),  2.04-2.02 (1H, m), 1.71-1.64 (1H, m), 
1.21-1.11 (2H, m), 0.97-0.93 (6H, m); 
13
C NMR (100 MHz, CDCl3)  157.3, 136.0, 
133.2, 129.5, 129.0, 128.9, 128.3, 128.3, 127.8, 77.0, 65.1, 38.5, 37.2, 25.3, 22.9, 22.8; 
IR (neat) 3376 (O-H stretch), 3081 (C-H aromatic stretch), 2961 (C-H aliphatic), 1595 
(C=N stretch), 1448 (N-O stretch), 976 (C-O stretch) cm
-1
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MTPA characterization of gamma alcohol for enantiomeric excess assignment 
Determination of enantiomeric excess of 4 could not be determined with with chiral 
HPLC columns.  Synthesis of the corresponding diastereomers from (S)-(+)--Methoxy-
α-trilfluoromethylphenylacetyl chloride  (S)-MTPA-Cl allows for NMR determination of 
the diastereomeric excess. 
 
(2R)-3-(((diphenylmethylene)amino)oxy)-2-methylpropyl-3,3,3-trifluoro-2-methoxy-
2-phenylpropanoate (4-(R)-MTPA.  To a vial containing gamma-hydroxylated product 
4 (5.0 mg, 18.6 μmol) and excess triethylamine (3 drops) was added DCM (3 mL).  (S)-
MTPA-Cl (25.0 μmol, 0.25 mL of a freshly prepared 0.1 M solution in toluene) was 
added dropwise under N2.  DMAP (1.86 mmol, 0.1 mL from a freshly prepared 0.1 M 
stock solution in DCM) was added and the resulting reaction mixture was stirred at room 
temperature for 4 hours.  The salt was filtered with a small silica plug which was 
subsequently flushed with EtOAc (2 x 1 mL).  The combined organic filtrates were 
concentrated in vacuo.  The crude reaction mixture was purified via flash 
chromatography on silica gel (10:90 EtOAc/hexanes) which afforded 4-(R)-MTPA (8.8 
mg, 98 %) as a colorless oil.  TLC analysis (10:90 EtOAc/hexanes) showed a spot at Rf 
0.8; 
1
H NMR (400 MHz, CDCl3)  7.48-7.28 (15H, m), 4.35-4.23 (2H, m), 4.17-4.02 
(2H, m) 3.55 (3H, s), 2.42-2.36 (1H, bs), 0.99 (3H, t, J = 7.6 Hz); 
13
C NMR (100 MHz, 
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CDCl3)  166.6, 157.2, 157.1, 136.3, 133.3, 132.3, 129.6, 129.4, 129.1, 129.0, 128.8, 
128.4, 128.3, 128.1, 128.1, 127.8, 127.4, 124.8, 121.9, 84.6, 75.4, 68.1, 55.4, 32.8, 13.8; 
19
F NMR (357.5 MHz, CDCl3)  -71.56, -71.64 ; IR (neat) 3038 (C-H aromatic stretch), 
2924 (C-H aliphatic), 1742 (C=O), 1451 (N-O stretch), 1000 (C-O stretch) cm
-1
 
   
 
Rh-CAHB of deuterated benzophenone derivatives with tmdB-H  
Using a procedure for typical Rh-CAHB with deuterium-labeled substrate 16 and tmdBH, 
the products isolated as described below. 
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(D9H)-Benzophenone O-isobutyl  oxime (reduced product 19) ,-unsaturated substrate 
16 (69.1 mg, 0.24 mmol) was converted to reduced product 19 (6.82 mg, 10%) as a 
colorless oil.  TLC analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.9; 
1
H NMR 
(400 MHz, CDCl3)  7.50 (1H, s), 3.98 (2H, d, J = 6.7 Hz), 2.11-2.02 (1H, m), 0.94-0.90 
(5H, m); 
13
C NMR (100 MHz, CDCl3)  127.7, 81.2, 28.0, 19.2 
 
 
(2-hydroxyphenyl)(phenyl methanone O-isobutyl oxime (ortho-hydroxylated and 
reduced product 19) ,-unsaturated substrate 16 (69.1 mg, 0.24 mmol) was converted to 
ortho-hydroxylated product 20 (22.2 mg, 30%) as a colorless oil.  TLC analysis (30:70 
EtOAc/hexanes) showed a spot at Rf 0.85; 
1
H NMR (400 MHz, CDCl3)  11.2 (1H, s), 
6.83 (0.6H, s), 3.94 (2H, d, J = 6.9 Hz), 2.09-1.99 (1H, m), 0.91-0.88 (4.7H, m); 
13
C 
NMR (100 MHz, CDCl3)  160.3, 158.2, 131.8, 130.4, 128.3, 128.0, 127.8, 127.5, 118.8, 
118.7, 81.5, 27.9, 27.8, 19.0, 18.9, 18.7, 18.5; IR (neat) 3085 (O-H phenol),  2920 (C-H 
aliphatic), 1585 (C=N stretch), 1441 (N-O stretch), 1025 (C-O stretch) cm
-1
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Benzophenone O-(2-hydroxymethyl)-4-methylpentyl oxime(gamma-hydroxylated 
product 21) ,-unsaturated substrate 16 (69.1 mg, 0.24 mmol) was converted to gamma-
hydroxylated product 21 (38.7 mg, 52%) as a colorless oil.  TLC analysis (30:70 
EtOAc/hexanes) showed a spot at Rf 0.5; 
1
H NMR (400 MHz, CDCl3)  7.49 (1H, s), 
4.30 and 4.13 (2H, ddd, J1 = 4.5 Hz, J2 = 10.9 Hz), 3.62-3.53 (1.5H, m), 2.17-2.10 (1H, 
m), 2.04 (1H, bs), 0.95-0.92 (2.5H, m); 
13
C NMR (100 MHz, CDCl3)  127.7, 77.9, 66.3, 
35.8, 13.5; IR (neat) 3339 (O-H stretch), 2924 (C-H aliphatic), 1595 (C=N stretch), 1454 
(N-O stretch), 972 (C-O stretch) cm
-1
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D10-Benzophenone O-(2-hydroxymethyl)-4-methylpentyl oxime(gamma-
hydroxylated product 21) ,-unsaturated substrate 16 (69.1 mg, 0.24 mmol) was 
converted to gamma-hydroxylated product 22 (15.1 mg, 20%) as a colorless oil.  TLC 
analysis (30:70 EtOAc/hexanes) showed a spot at Rf 0.5; 
1
H NMR (400 MHz, CDCl3)  
4.30 and 4.13 (2H, ddd, J1 = 4.6 Hz, J2 = 10.9 Hz), 2.18-2.10 (1H, m), 2.03 (1H, bs), 0.94 
(3H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3)  157.1, 136.0, 133.0, 77.9, 66.3, 35.8, 
13.5. ; IR (neat) 3342 (O-H stretch), 2931 (C-H aliphatic), 1588 (C=N stretch), 1451 (N-
O stretch), 969 (C-O stretch) cm
-1
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(D9H)Benzophenone O-2-cyclohexylpropyl oxime (reduced product 26) ,-
unsaturated substrate 23 (87.0 mg, 0.24 mmol) was converted to reduced product 19 
(4.60 mg, 5%) as a colorless oil.  TLC analysis (30:70 EtOAc/hexanes) showed a spot at 
Rf 0.9; 
1
H NMR (400 MHz, CDCl3)  7.50 (1H, s), 4.11 (2H, dd, J1 = 5.8 Hz, J2 = 10.3 
Hz), 1.81-1.57 (6H, m), 1.31-0.97 (7H, m), 0.88-0.85 (2H, m); 
13
C NMR (100 MHz, 
CDCl3)  127.7, 78.3, 33.9, 37.8, 37.8, 30.7, 28.8, 26.9, 26.8, 26.7, 13.7, 13.6; IR (neat) 
2914 (C-H aliphatic), 1587 (C=N stretch), 1428 (N-O stretch), 972 (C-O stretch) cm
-1 
  
213 
 
 
(D9H)Benzophenone O-2-cyclohexyl-3-hydroxypropyl oxime (gamma hydroxylated 
product 25) ,-unsaturated substrate 23 (87.0 mg, 0.24 mmol) was converted to gamma-
hydroxylated product 19 (40.2 mg, 44%) as a colorless oil.  TLC analysis (30:70 
EtOAc/hexanes) showed a spot at Rf 0.5; 
1
H NMR (400 MHz, CDCl3)  7.50 (1H, s), 
4.20 and 4.02 (2H, ddd, J1 = 3.8 Hz, J2 = 10.6 Hz), 3.70-3.66 (1.4H, m), 2.29-2.22 (0.5H, 
m), 2.06-2.02 (1H, m), 1.75-1.58 (6H, m), 1.44-1.40 (1H, m), 1.28-1.02 (5.5 H, m); 
13
C 
NMR (100 MHz, CDCl3)  157.4, 133.0, 127.7, 75.7, 63.5, 46.0, 36.9, 30.7, 30.5, 26.4, 
26.6, 26.5; IR (neat) 3358 (O-H stretch), 3062 (aromatic C-H), 2926 (C-H aliphatic), 
1575 (C=N stretch), 1450 (N-O stretch), 972 (C-O stretch) cm
-1
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Synthesis of tmdB-D 
Labeled-boranes prepared with an iridium catalyst and D2 were reported by Nolan et 
al.
103
  The catalyst was readily prepared from commercially available tBu NHC and 
[Ir(coe)2Cl]2.   
 
Ten open-faced vials, each with several glass beads to aid in stirring, were each added 
tmdBH (0.19 g, 1.48 mmol) in DCM (0.2 mL).  A stock solution of Ir[t-BuNHC] catalyst 
was prepared by dissolving catalyst (28.8 mg, 49.0 μmol) in DCM (2.2 mL) creating a 
.022 M solution.  To each open-faced reaction vial was added freshly prepared Ir[t-
BuNHC] stock solution (0.2 mL, 4.4 μmol).  The reaction vials were loaded into a high 
pressure chamber.  The chamber was charged with D2 (30 psi) and lightly shaken (ca 100 
revolutions/min) at ambient temperature for 24 h, at which point the deuterium pressure 
was released.  The reaction mixtures were combined into one vial and carefully 
concentrated under reduced pressure at 0 °C.  Bulb-to-bulb distillation (1 atm, 180 °C) 
afforded tmdB-D (1.1 g, 58%) as a colorless oil.  
1
H NMR (400 MHz, CDCl3)  4.21 
(1H),  1.82 (1H, d, J = 14 Hz), 1.56 (1H, t, J = 12.4 Hz), 1.32-1.26 (9H, m); 
13
C NMR 
(100 MHz, CDCl3)  71.0, 64.7, 46.2, 31.0, 28.2, 23.0; 
11
B NMR (128 MHz, CDCl3)  
25.1 (s) 
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CHAPTER FOUR:  SYNTHESIS OF D-CYCLOSERINE AND 
13
C-LABELED D-
CYCLOSERINE 
 
4.1 Tuberculosis - A constantly evolving worldwide threat 
     In 1993, the World Health Organization (WHO) declared tuberculosis (TB) a global 
public health emergency with 7-8 million reported cases resulting in a staggering 1.3-1.6 
million deaths.
1
  TB is caused by bacillus Mycobacterium tuberculosis.   Current drug 
treatment from TB has led to a mortality rate reduction of 41% since 1990.  Two 
obstacles slowing the WHO’s target of 50% reduction by 2015 are (1) the co-infection 
with HIV makes treatment more difficult and (2) effective treatment to multidrug-
resistant (MDR-TB) and extensively drug-resistant (EDR-TB) strains remains elusive.  In 
2011, one in five reported TB cases was classified as MDR-TB.  With the numbers of 
drug-resistant strains increasing, the demand for new drug treatments will remain.   
     D-Cycloserine (DCS) is a second-line drug for the treatment of TB.  While the 
mechanism of action is not fully understood, it is believed to serve as a D-alanine mimic, 
which competitively inhibits the D-alanine pathway of peptidoglycan biosynthesis.
2
  
Finding therapeutic targets that inhibit the D-alanine pathway is believed to be 
important,
3
 because M. tuberculosis is comprised of a lipid rich structure comprised of a 
D-alanine cross-linked peptidoglycan backbone.
4
    This backbone gives the cell wall its 
tensile strength, and thus inhibition of the cross-linking leads to less virulent strains. 
     In a collaboration with Professors Robert Powers (UNL-Chemistry) and Raul Barletta 
(UNL Veterinary and Biomedical Sciences) experiments were proposed to elucidate on 
the mechanism of action for DCS.  To carry out these experiments, an effective route for 
226 
 
an isotopically labeled derivative was needed to prepare sufficient quantities for 
metabolic experiments.  The synthesis of DCS has been reported in both the unlabeled
5,6
 
and labeled
7,8
 forms.  However, these routes were not suitable for producing 
13
C-labeled 
DCS starting from commercially available 
13
C-labeled serine, the latter is typically sold 
only in milligram quantities.     During the preparation of our manuscript, several other 
synthetic routes were published on the synthesis of D-cycloserine from D-serine.
9,10
  
While these methods may have been effective, several considerations argued against their 
use.  (1) The isotopically labeled racemic serine is much less expensive than the 
enantiomerically pure form.  (2) When using isotopically labeled D-serine as the starting 
material, the -stereocenter must be carefully monitored throughout the synthesis for 
unwanted racemization.  Additionally, our route employed a late stage resolution that 
allowed access to both enantiomers of the labeled cycloserine for subsequent 
experiments.  Herein, the synthetic route that will be described was used to produce both 
unlabeled and 
13
C-labeled DCS starting from 250 mg of the corresponding DL-serine. 
4.2 Synthesis of DL-Cycloserine 
  
Scheme 1 Synthesis of DL-cycloserine 
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     DL-serine was converted to the corresponding methyl ester upon treatment with 
SOCl2 in MeOH.  The Mitsunobu reaction with serine derivatives can be challenging due 
to a competing elimination reaction.  Cherney and Wang reported that a bulky amino-
protecting group is required for sufficient conversion.
11
  A trityl group was chosen due to 
its relative ease of installation and removal; the latter effected by either H2 or acid.  The 
diisopropyl azodicarboxylate (DIAD) promoted Mitsunobu reaction with trityl-protected 
serine methyl ester proceeded smoothly affording the desired hydroxy succinimide 
derivative 3 in 80% yield.   
     Two common methods for succinimide deprotection use either hydrazine
12,13
 in protic 
solvents or methyl hydrazine
14
 in polar solvents at elevated temperatures.  Treatment of 3 
with hydrazine in refluxing EtOH led to hydrazine attack on the methyl ester.  
Conversely, deprotection in EtOH at room temperature afforded hydroxyl amine 4 in 
only 35% yield with trityl-protected cycloserine being the major product formed.  
Originally optimistic that this could be an entry into the DCS synthesis, attempts at trityl 
deprotection by acid or hydrogenation catalyzed by Pd/C only led to decomposition of 
the cycloserine – likely resulting from N-O bond cleavage.15  Fortunately, treating 3 with 
hydrazine in CH2Cl2 affords the deprotected hydroxylamine derivative 4 in near 
quantitative yield.  Addition of dry HCl (3M in Et2O) affords the doubly-protonated salt 
5, a similar intermediate to that used in the original DCS synthesis reported by 
Stammer.
5,6
  Using the reaction conditions, with respect to concentration and equivalents 
base, Stammer’s report gave a low yield of (DL)-cycloserine in our hands.  This is likely 
the result of the high solubility of cycloserine in H2O.  Optimization of reaction 
conditions found a 2:1 mixture of MeOH / H2O with 3 equivalents base gave  (DL)-
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cycloserine 6 in moderate yields (51%).  The high solubility of cycloserine in water can 
be explained by its zwitterionic nature. The IR spectra of 6 has a strong C-O stretch at 
1527 cm
-1
, while the C=O stretch is absent in the spectrum. 
 
Figure 1  Equilibrium favors zwitterionic form of cycloserine 
 
4.3 Corrected resolution of DCS with L-tartaric acid 
     The first synthesis of DCS reported addition of L-tartaric acid to DL-cycloserine 
facilitated precipitation of the desired DCS/D-tartrate salt.  However, when the salt 
formation was practiced with commercially available DCS, no precipitation occurred 
upon addition of D-tartaric acid (Figure 2).  Conversely, addition of one equivalent of L-
tartaric acid to DCS led to spontaneous precipitation of a fine white crystalline powder.  
After filtration, this powder was identified to be the DCS/L-Tartrate salt 7.  The optical 
rotation of the isolated DCS/L-Tartrate salt 7 ([a]D
20
 = +43.2) is identical to that 
previously reported for the DCS/D-tartrate salt.
6
  We conclude that the literature report 
was made in error.  Additionally, when one equivalent of L-tartaric acid was added to the 
water soluble DCS/D-tartrate salt, compound 7 slowly precipitated from the solution.  
This latter observation suggested that both enantiomers of the cycloserine could be 
resolved through sequential salt formation, crystallization, and filtration.   
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Figure 2  Resolution of D-cycloserine with L-tartaric acid 
 
     Given the literature, we were somewhat surprised by the solubility of the 
cycloserine/tartrate salts; it proved to be somewhat problematic and required careful 
optimization of the reaction conditions.  As expected, addition of D-tartaric acid to DCS 
does not precipitate a salt either at 0.78 M or 2.61 M (Figure 3, entries A and C).   
However, when L-tartaric acid is added to duplicate aqueous solutions of DCS/D-tartrate 
salt, DCS-L-tartrate salt spontaneously precipitates out of solution at higher 
concentrations but not at the more dilute conditions (Figure 3, entry B and D); even after 
stirring for 24 h, no salt precipitation was observed for the dilute sample at 0.78 M.   
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Figure 3 Resolution of DCS is concentration dependent in water. A) DCS, D-tartaric acid 
(0.78 M) ; B) DCS, D-tartaric acid, L-tartaric acid (0.78 M); C) DCS, D-tartaric acid 
(2.61 M); D) DCS, D-tartaric acid, L-tartaric acid (2.61 M) 
 
4.4 Resolution of (DL)-cycloserine  
 
 
Figure 4 Sequential resolution of DL-cycloserine 
 
     After addition of L-tartaric acid to DL-cycloserine 6, the DCS/L-tartrate salt 7 
precipitated and was separated by filtration and then dried under vacuum.  To the filtrate 
was added D-tartaric acid and the resulting solid precipitate was filtered affording 
LCS/D-tartrate salt 8.  The two salts have nearly identical but opposite optical rotations 
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([a]D
20
 = +43.2 and -42.8, c = 0.7 H2O respectively) as to be expected for an effective 
resolution.  Ion exchange chromatography on Amberlite® IR-120 PLUS resin followed 
by lyophlization of the eluents afforded DCS and L-cycloserine (LCS) with a minimal 
amount of unidentified impurities.  Careful recrystallization of the resolved cycloserine 
affords DCS 9 and L-cycloserine 10 in 64-65% yield.  The moderate yields are likely the 
resulting from the high solubility of cycloserine in water during the recrystallization.  The 
degree of optical rotation of synthesized 9 matches that of commercially purchased DCS 
([a]D
20
 = +120.3° (c = 1.0, H2O)). 
 
 
Figure 5 Ion exchange resin effectively removes tartrate 
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4.5 Synthesis of isotopically labeled DCS 
 
Scheme 2 Synthesis of D-cycloserine-1-
13
C 
 
     Starting from isotopically labeled DL-serine-1-
13
C, D-cycloserine-1-
13
C 16 was 
synthesized in 16.4% overall yield.  Yields for each step were comparable to that of the 
unlabeled material.  
1
H NMR, 
13
C NMR, and high-resolution mass spectrometry were 
used to characterize the isotopically-labeled material.   
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Figure 6 High resolution mass spectrometry finds peaks for unlabeled DCS (9) and 
13
C-
labeled DCS (16) 
 
4.6 Experimental  
 
Reactions were carried out under a dry nitrogen atmosphere.  Dichloromethane (DCM), 
tetrahydrofuran (THF), and methanol (MeOH) were freshly distilled under the following 
conditions:  DCM from calcium hydride, THF from sodium metal and benzophenone, 
and MeOH from Mg.   All synthesized compounds were purified using flash 
chromatography with the indicated solvents using EMD Silica Gel 60 Geduran®.  Thin 
layer chromatography analyses were performed on Analtech Silica Gel HLF (250 
microns) precoated analytical plates and visualized with use of handheld short 
wavelength UV light, vanillin stain (ethanol, H2SO4, and vanillin), or ninhydrin stain 
(ethanol, acetic acid, and ninhydrin).  NMR spectra were recorded on a 400 MHz Bruker 
Advance NMR spectrometer using CHCl3 ( 7.27 ppm), CDCl3 ( 77.0 ppm), DMSO ( 
2.54 ppm), or d6-DMSO ( 40.45 ppm).  Peaks are expressed as m (unresolved multiplet), 
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q (quartet), t (triplet), d (doublet), s (singlet), bs (broad singlet).  IR spectra were recorded 
using an Avatar 360 FT-IR.  Optical rotations were measured in solutions, 1.0 g/100 mL 
H2O unless indicated otherwise, and recorded using an Autopol III automatic polarimeter.  
HRMS analyses were performed by the Nebraska Center for Mass Spectrometry. 
 
Synthesis of D-cycloserine 
DL-Serine methyl ester hydrochloride (1).  To a cooled (0 °C) solution of DL-serine 
(250 mg, 2.38 mmol) in MeOH (2 mL) was added dropwise SOCl2 (0.17 mL, 2.4 mmol).  
The solution was stirred for 16 h at room temperature, at which point it was concentrated 
with rotary evaporation.   To the resulting oil, hexanes were added (3 mL), and the 
solution was concentrated.  The resulting solid was then recrystallized from MeOH/Et2O 
to afford 1 (352 mg, 95%) as a white crystalline solid (mp 124–126 °C (decomp.)). 1H 
NMR (400 MHz, d6-DMSO) d 8.64 (3H, bs), 5.64 (1H, s), 4.08 (1H, t, J = 7 Hz), 3.83 
(2H, s), 3.74 (3H, s); 
13
C NMR (100 MHz, d6-DMSO) d 168.93, 59.89, 54.84, 53.18; IR 
(ATR) 3381 (OH stretch), 3023 (N-H stretch), 1736 (CO2CH3 stretch), 1499 (C-H bend), 
1245 (C-N stretch) cm
-1
. 
 
DL-Methyl 3-hydroxy-2-(tritylamino)propanoate (2).  To a cooled (0 °C) solution of 1 
(350 mg, 2.25 mmol) in DCM (10 mL) was added dropwise triethylamine (0.69 mL, 4.9 
mmol) over the course of 5 minutes.  Triphenylmethyl chloride (659 mg, 2.36 mmol) in 
DCM (2.5 mL) was then added over the course of 15 minutes.  The resulting cold 
reaction mixture was stirred (2 h), and then warmed to room temperature overnight.  The 
reaction mixture was washed (1 x 10 mL NaHCO3) and extracted with DCM (3 x 15 
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mL).  The organic extracts were combined and washed with brine (1 x 5 mL).  The 
organic extract was dried with MgSO4, filtered, and concentrated yielding a white solid.  
This solid was recrystallized from ethyl acetate/hexanes and dried under high vacuum 
affording 2 (804 mg, 99%) as a white powder-like solid (mp 135–137 °C).  TLC analysis 
(30:70 ethyl acetate/hexanes) showed a spot at Rf 0.3; 
1
H NMR (400 MHz, CDCl3) d 
7.56–7.53 (6H, m), 7.34–7.25 (6H, m), 7.24–7.22 (3H, m), 3.79–3.75 (1H, m), 3.65–3.57 
(2H, m), 3.33 (3H, s); 
13
C NMR (100 MHz, CDCl3) d 174.0, 145.7, 128.8, 128.0, 126.7, 
71.0, 65.0, 57.9, 52.0; IR (ATR) 3465 (OH stretch), 3309 (N-H stretch), 1720 (CO2CH3 
stretch), cm
-1
. 
 
DL-O-(1,3-dihydro-2,5-dioxo-1-pyrolidinyl)-N-(triphenylmethyl) methyl ester  (3).  
A solution containing PPh3 (580 mg, 2.22 mmol), N-hydroxysuccinimide (255 mg, 2.22 
mmol), and 2 (800 mg, 2.22 mmol) in THF (10 mL) was prepared.  The reaction mixture 
was purged with N2 three times.  The reactants were stirred for 10 minutes to dissolve 
most of the solid (some solid was not dissolved).  The reaction was cooled to 0 °C, and 
DIAD (0.46 mL, 2.22 mmol) was added dropwise over 3 minutes.  The reaction was 
allowed to warm to room temperature and stirred overnight.  The crude reaction mixture 
was concentrated under reduced pressure.  Flash chromatography on silica gel (20:80 
acetone/hexanes) afforded 3 (813 mg, 80%) as a white powder-like solid (mp 156–159 
°C).  TLC analysis (30:70 acetone/hexanes) showed a spot at Rf 0.30; 
1
H NMR (400 
MHz, CDCl3) d 7.56–7.55 (6H, m), 7.31–7.27 (6H, m), 7.23–7.22 (3H, m), 4.42 and 4.01 
(2H, dd, J1 = 9.1 Hz, 4.0 Hz, J2 = 9.1 Hz, 5.8 Hz), 3.70–3.65 (1H, m), 3.36 (3H, s), 3.12 
(1H, d, J =10 Hz), 2.64 (4H, s); 
13
C NMR (100 MHz, CDCl3) d 172.5, 170.6, 145.6, 
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128.8, 128.0, 126.6, 79.0, 71.2, 55.7, 52.2, 25.4; IR (ATR) 3658 (N-H stretch), 2977 (C-
H aromatic stretch), 1722 (CO2CH3 stretch), cm
-1
; HRMS (ESI) calcd. For C27H26N2O5 
(M+H):459.1920, found 459.1914 m/z. 
 
DL-Methyl--aminooxy-α-amino(triphenylmethyl)butyrate  (4).  To a cooled (0 °C) 
solution of 3 (810 mg, 1.77 mmol) in DCM (5 mL) was slowly added hydrazine (0.16 
mL, 5.09 mmol).  The resulting solution was stirred at 0 °C for an additional 30 minutes 
and then allowed to warm to room temperature overnight.  The reaction mixture was 
filtered through Celite® and concentrated.  Flash chromatography on silica gel (3:97 
methanol/dichloromethane) afforded 4 (664 mg, 98%) as a colorless oil.  TLC analysis 
(8:92 methanol/dichloromethane) showed a spot at Rf 0.35; 
1
H NMR (400 MHz, CDCl3) 
d 7.64–7.62 (6H, m), 7.36–7.33 (6H, m), 7.27–7.24 (3H, m), 5.50 (2H, s), 4.11 (1H, dd, J 
= 10.2 Hz, 4.8 Hz), 3.84–3.77 (1H, d overlapping with 1H), 3.29 (3H, s), 2.89 (1H, d, J = 
10.1 Hz) ; 
13
C NMR (100 MHz, CDCl3) d 174.4, 146.0, 128. 9, 128.0, 126.7, 78.1, 71.0, 
55.8, 51.8; IR (ATR) 3313 (N-H stretch), 3056 (C-H aromatic stretch), 1726 (CO2CH3 
stretch) cm
-1
; HRMS (ESI) calcd. For C23H24N2O3 (M+Na):399.1685, found 399.1695 
m/z. 
 
DL--aminoxyalanine methyl ester dihydrochloride (5).  To a cooled solution 0 °C of 
4 (658 mg, 1.75 mmol) in THF (5 mL) was added dropwise 3.0 M HCl in diethyl ether 
(2.62 mL, 7.87 mmol).  The resulting mixture was allowed to warm to room temperature 
and stirred overnight.  The reaction mixture was filtered and the precipitate was washed 
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with THF (4 x 10 mL THF) and dried under vacuum affording 5 (358 mg, 99%) as a 
white fluffy solid (mp 144–146 °C (decomp.)). 1H NMR (400 MHz, d6-DMSO) d 11.80–
7.80 (5H, bs), 4.61–4.59 (1H, m), 4.56–4.47 (2H, m), 3.76 (3H, s) 13C NMR (100 MHz, 
d6-DMSO) d 164.3, 71.7, 53.7, 51.3; IR (ATR) 2848 (N-H stretch), 2639 (ON-H stretch), 
1740 (CO2CH3 stretch) cm
-1
; HRMS (ESI) calcd. For C4H11N2O3 (M+H): 135.0770, 
found 135.0769 m/z. 
 
DL-Cycloserine (6).  To a cooled (0 
o
C) solution of 5 (350 mg, 1.69 mmol) in 
MeOH/water (0.5 mL/0.1 mL) was added KOH (332 mg, 5.92 mmol) in water (0.4 mL) 
dropwise over a period of 10 minutes.  The pH was carefully monitored and kept between 
11-11.5.  The solution was stirred for 30 minutes at 0 °C and 30 minutes at room 
temperature.  The reaction solution was cooled (0 °C) and 2 mL of a mixture of isopropyl 
alcohol/ethanol (50:50) was added.  The reaction mixture was then stirred for 10 minutes 
and filtered.  The solids were washed with 0.5 mL of a mixture of cold isopropyl 
alcohol/ethanol (50:50).  The filtrate was cooled (0 °C) and the pH of the solution was 
adjusted to 6.0 with the addition of glacial acetic acid.  The precipitation occurred over 
30 minutes at 0 
o
C once the pH reached 6.0.   The supernatant liquid was removed and 
the remaining precipitate was washed (1 x 0.5 mL of isopropyl alcohol/ethanol (50:50)) 
and then diethyl ether (1 x 1 mL).  The solid was dried under high vacuum yielding 6 
(88.0 mg, 51%) as a white powder-like solid (mp 146–149 °C (decomp.)).  1H NMR (400 
MHz, d6-DMSO) d 5.50–4.75 (3H, bs), 4.46–4.39 (1H, m), 3.79–3.72 (2H, m); 
13
C NMR 
(100 MHz, d6-DMSO) d 174.9, 75.5, 54.1; IR (ATR) 3399 (NH3 stretch), 1536 (C-O 
stretch) cm
-1
. 
238 
 
 
D-Cycloserine-L-Tartrate (7) and L-Cycloserine-D-Tartrate (9).  To a cooled (0 °C) 
solution of 6 (80.0 mg, 0.784 mmol) in H2O (0.3 mL) was added L-Tartaric Acid (118 
mg, 0.784 mmol) in H2O (0.2 mL).  A white solid precipitated immediately and the 
reaction mixture was stirred for 30 minutes at 0 
o
C.  The supernatant liquid was 
transferred to a clean vial.  The crystalline precipitate was washed with cold water (1 x 1 
mL) and cooled acetone (1 x 1 mL). The solid was dried under high vacuum affording D-
Cycloserine-L-Tartrate 7 (82.0 mg, 82%) as a white crystalline powder.    The 
supernatant liquid was cooled (0 °C) and D-Tartaric acid (80.0 mg, 0.784 mmol) was 
added.  The reaction mixture was stirred for 30 minutes at 0 °C, and cold acetone (1 x 1 
mL) was added.  The supernatant liquid was decanted , and the white precipitate was 
washed with cold water (1 x 1 mL).  The water was decanted off.  The solid was then 
washed with cold acetone (0 °C, 1 x 1 mL) and dried under vacuum affording L-
Cycloserine-D-Tartrate 8 (62.2 mg, 63%) as a white crystalline solid.  7: mp 158–160 °C 
(decomp.); Optical rotation: [a]D
20
 = +43.2° (c 0.7, H2O); 
1
H NMR (400 MHz, d6-
DMSO) d 8.48–6.83 (7H, bs),  4.49 (1H, t, J = 8.08  Hz), 4.17 (1H, s), 3.99 and 3.90 (2H, 
dd, J1 = 9.7 Hz, 7.9 Hz, J2 = 9.7 Hz, 8.3 Hz); 
13
C NMR (100 MHz, d6-DMSO) d 174.34, 
170.95, 73.38, 52.73; IR (ATR) 3322 (N-H stretch), 3036 (OH stretch), 2786 (CO2H 
stretch), 1683 (C=O stretch) cm
-1
.  9:  mp 158–160 °C (decomp.); Optical rotation: [a]D
20
 
= - 42.8° (c 0.7, H2O); 
1
H NMR (400 MHz, d6-DMSO) d 8.48–6.83 (7H, bs), 4.49 (1H, t, 
J=8.08  Hz), 4.17 (1H, s), 3.99 and 3.90 (2H, dd, J1 = 9.7 Hz, 7.9 Hz, J2 = 9.7 Hz, 8.3 
Hz); 
13
C NMR (100 MHz, d6-DMSO) d 174.3, 171.0, 73.4, 52.7; IR (ATR) 3322 (N-H 
stretch), 3036 (OH stretch), 2786 (CO2H stretch), 1683 (C=O stretch) cm
-1
.   
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D-Cycloserine (9).  L-Tartrate salt 7 (75.0 mg, 0.297 mmol) was dissolved in water (0.5 
mL) and added to a short plug of Amberlite® IR-120 PLUS ion exchange resin (ca 1.0 g, 
sodium form).  The column was washed with water (ca. 2.0 mL) until the effluent tested 
negative to ninhydrin stain.  D-Cycloserine 9 was then eluted with 2% aq. NH4OH (ca 10 
mL) until the effluent test negative to ninhydrin stain.  The latter eluent was lyophilized, 
and the white flaky solid dissolved in 4% aq. NH4OH (0.1 mL) and a mixture of 
ethanol/isopropanol (50:50, 1.0 mL).  The solution was cooled (0 °C) and glacial acetic 
acid added dropwise until the solution reached pH 6; a precipitate formed over the course 
of ca. 30 minutes.  The precipitate was washed with ether and dried affording D-
Cycloserine (9) (19.7 mg, 65%) as a white powder-like solid (mp 146–149 °C 
(decomp.)).  [a]D
20
 = +120.3° (c 1.0, H2O); 
1
H NMR (400 MHz, d6-DMSO) d 5.50–4.75 
(3H, bs), 4.46–4.39 (1H, m), 3.79–3.72 (2H, m); 13C NMR (100 MHz, d6-DMSO) d 
174.9, 75.5, 54.1; IR (ATR) 3040 (NH3 stretch), 1528 (C-O stretch) cm
-1
.  
 
L-Cycloserine (10).  D-Tartrate salt 8 (58.0 mg, 0.23 mmol) was converted to L-
Cyloserine (11) using the general procedure described for tartrate salt 9 giving 10 (15.3 
mg, 64%) as a white powder-like solid (mp 146–149 °C (decomp.)).  [a]D
20
 = -118.4° (c 
1.0, H2O); 
1
H NMR (400 MHz, d6-DMSO) d 5.50–4.75 (3H, bs), 4.46–4.39 (1H, m), 
3.79–3.72 (2H, m); 13C NMR (100 MHz, d6-DMSO) d 174.9, 75.5, and 54.1; IR (ATR) 
1938 (NH3 stretch), 1528 (C-O stretch) cm
-1
.  
 
Synthesis of labeled D-Cycloserine-1-
13
C 
240 
 
DL-Methyl-3-hydroxy-2-(tritylamino)propanoate-1-
13
C (11).  Commercially available 
DL-Serine-1-
13
C (250 mg, 2.36 mmol) was converted to DL-Serine-1-
13
C methyl ester 
hydrochloride using the procedure for unlabeled material (1). This material was used 
immediately without subsequent purification.  DL-Serine-1-
13
C methyl ester 
hydrochloride was converted to DL-Methyl-3-hydroxy-2-(tritylamino)propanoate-1-
13
C 
(11) using the procedure for unlabeled material (2) affording 11 (738 mg, 86% over 2 
steps) as a white powder.  
1
H NMR (400 MHz, CDCl3) d 7.53–7.51 (6H, m), 7.32–7.28 
(5H, m), 7.24–7.21 (3H, m), 3.78–3.72 (1H, m), 3.64–3.55 (2H, m), 3.32 (3H, d, J = 3.8 
Hz), 3.05-2.96 (1H, m), 2.37 (1H, t, J = 12.56 Hz); 
13
C NMR (100 MHz, CDCl3) d 174.0; 
HRMS (ESI) cald. For 
13
CC22H23NO3 (M+Na): 385.1609, found 385.1612 m/z. 
 
DL-O-(1,3-Dihydro-2,5-dioxy-1-pyrolidinyl)-N-(triphenylmethyl)-1-
13
C methyl ester 
(12).  11 (733 mg, 2.02 mmol) was converted to DL-O-(1,3-Dihydro-2,5-dioxy-1-
pyrolidinyl)-N-(triphenylmethyl)-1-
13
C methyl ester (12) using the procedure for 
unlabeled material (3) affording 12 (660 mg, 71%) as a white powder. 
1
H NMR (400 
MHz, CDCl3) d 7.56–7.53 (6H, m), 7.31–7.26 (6H, m), 7.23–7.18 (3H, m), 4.44–4.40 
(1H, m), 4.03–3.98 (1H, m), 3.70–3.63 (1H, m), 3.35 (3H, d, J = 3.8 Hz), 3.10 (1H, dd, J1 
= 10.0 Hz, J2 = 3.8 Hz), 2.69 (4H, s); 
13
C NMR (100 MHz, CDCl3) d 172.6; HRMS (ESI) 
cald. For 
13
CC26H26N2O5 (M+Na): 482.1773, found 482.1781 m/z. 
  
DL-Methyl--Aminooxy-α-amino(triphenylmethyl)butyrate-1-13C (13).  12 (653 mg, 
1.42 mmol) was converted to DL-Methyl--Aminooxy-α-
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amino(triphenylmethyl)butyrate-1-
13
C (13) using the procedure for unlabeled material (4) 
affording 13 (526 mg, 98%) as a colorless oil.  
1
H NMR (400 MHz, CDCl3) d 7.55–7.52 
(6H, m), 7.31–7.26 (6H, m), 7.23–7.18 (3H, m), 5.47 (2H, bs), 4.06–4.01 (1H, m), 3.77–
3.68 (2H, m), 3.24 (3H, d, J = 3.8 Hz), 3.78 (1H, bs); 
13
C NMR (100 MHz, CDCl3) d 
174.3; HRMS (ESI) cald. For 
13
CC22H24N2O3 (M+Na): 400.1718, found 400.1727 m/z. 
 
DL-Cycloserine-1-
13
C (14).  13 (520 mg, 1.38 mmol) was converted to the Di-HCl salt 
using the procedure for unlabeled material (5) and used without further purification.  Di-
HCl salt of 13 was then converted to DL-Cycloserine-1-
13
C (14) using the procedure for 
unlabeled material (6) affording 14 (87.2 mg, 61% over 2 steps) as a white powder. 
 1
H 
NMR (400 MHz, d6-DMSO) d 4.44–4.36 (1H, m), 3.76–3.69 (2H, m); 
13
C NMR (100 
MHz, d6-DMSO) d 175.0; HRMS (ESI) cald.  For 
13
CC2H6N2O2 (M+H): 104.0541, found 
104.0542 m/z. 
 
D-Cycloserine-1-
13
C-L-Tartrate (15).  14 (80.3 mg, 0.787 mmol) was converted to D-
Cycloserine-1-
13
C-L-Tartrate (15) using the procedure for unlabelled material (8) 
affording 15 (76.7 mg, 77%) as a white crystalline powder.  
1
H NMR (400 MHz, d6-
DMSO) d 4.46 (1H, s), 4.05 (2H, s), 3.80 (2H, s); 
13
C NMR (100 MHz, d6-DMSO) d 
174.2; HRMS (ESI) cald. For 
13
CC6H12N2O8 (M+H): 254.0705, found 254.0700 m/z. 
 
D-Cycloserine-1-
13
C (16).  15 (73 mg, 0.288 mmol) was converted to D-Cycloserine-1-
13
C (16) using the procedure for unlabelled material (9) affording 16 (16.9 mg, 57%) as a 
white powder.  
1
H NMR (400 MHz, d6-DMSO) d 4.43–4.40 (1H, m), 3.76–3.71 (2H, m), 
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3.60–3.10 (3H, bs); 13C NMR (100 MHz, d6-DMSO) d 175.0; HRMS (ESI) cald. For 
13
CC2H6N2O2 (M+H): 104.0541, found 104.0543 m/z. 
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